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dalena Götz, Stephen P. Robertson, Barbara Treutlein and Silvia Cappello
Nature Medicine 25(4) (2019)
* shared first authors
BIBLIOGRAPHISCHE DARSTELLUNG
Sabina Kanton





196 Seiten, 331 Literaturangaben, 43 Abbildungen, 31 Tabellen
During the last years, important progress has been made in modeling early brain development
using 3-dimensional in vitro systems, so-called cerebral organoids. These can be grown from
pluripotent stem cells of different species such as our closest living relatives, the chimpanzees and
from patients carrying disease mutations that affect brain development. This offers the possibility
to study uniquely human features of brain development as well as to identify gene networks altered
in neurological diseases. Profiling the transcriptional landscape of cells provides insights into how
gene expression programs have changed during evolution and are affected by disease. Previously,
studies of this kind were realized using bulk RNA-sequencing, essentially measuring ensemble
signals of genes across potentially heterogeneous populations and thus obscured subtle changes
with respect to transient cell states or cellular subtypes. However, remarkable advances during the
last years have enabled researchers to profile the transcriptomes of single cells in high throughput.
This thesis demonstrates how single-cell transcriptomics can be used to dissect human-specific
features of the developing and adult brain as well as cellular subpopulations dysregulated in a
malformation of the cortex.
In chapter 1, cerebral organoids generated from human and chimpanzee induced pluripotent
stem cells are used to identify similarities and differences in neural progenitor cells and neurons
of the developing cortex using single-cell RNA-sequencing. Many features of cortex development
are remarkably similar between human and chimpanzee, however, cell type-specific gene expression
differences at the level of progenitor cells and neurons are detected, thus showing the feasibility of
applying organoids for modeling evolutionary differences in controlled culture environments.
Chapter 2 presents a temporally resolved atlas of organoid development using an extended
set of individuals, species, time points and cells compared to the data set presented in chapter
1. Moreover, gene expression changes are integrated with regulatory information from single-cell
chromatin accessibility measurements to dissect potential regulatory mechanisms underlying gene
expression differences between species. In addition, single-nucleus transcriptomes from human,
chimpanzee/bonobo and macaque adult prefrontal cortex tissue are analyzed to identify species-
specific expression differences that can be detected only in adult stages or such that are commnon
to both the adult and the developing cortex.
Chapter 3 presents a comparative analysis of cerebral organoids derived from patients with
cortical malformations (e.g. periventricular heterotopia, PH) and control organoids, showing that
PH-related malformations can be modeled in the cerebral organoid system. Single-cell RNA-seq
analyses on cerebral organoids and 2-dimensional neuronal cultures reveal subpopulations of cells
displaying dysregulated gene expression patterns and migratory behavior, suggesting that an altered
navigation system in a subset of neurons underlie this form of PH.
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Humans live in intricately organized societies and have developed technologies that allow
them to cope with diverse habitats and living conditions. This can only be achieved through
a high level of cooperation, communication via language and complex planning, that allow for
adaptation and knowledge transmission across multiple generations [1]. Although our closest
living relatives, the great apes, and more specifically chimpanzees, show higher order cognitive
abilities such as tool use and even behaviors that have been associated with tradition and
culture [2, 3], humans are unique in the extent of their technological advancements and the
way they have shaped the environment. These cognitive differences between humans and
chimpanzees have a basis in the form, function and cellular composition of the brain, and
these differences likely have a root during early developmental phases. However, to date, little
is known about how brain development differs between humans and great apes and it has been
difficult to address mechanisms underlying potential differences due to the lack of a tractable
system that effectively models great ape brain development.
Brain development and human-specific brain characteristics
Early phases of brain development
The brain develops from the neuroectoderm which forms the neural plate and folds into the
neural tube after closure. The neural tube then divides into three vesicles, the forebrain (pros-
encephalon), midbrain (mesencephalon) and hindbrain (rhombencephalon) with the cerebral
cortex arising from the prosencephalon which is subsequently termed the telencephalon. The
neural tube consists of a monolayer of cells known as the neuroepithelium which harbors stem
cells that are oriented along an apico basal axis from the lumen (apical side) of the tube to
the outer side (basal side). Neuroepithelial cells are the stem cells of the developing brain and
divide and give rise to radial glial cells with restricted fate potential that in turn differentiate
into different progenitor cell types [4].
The various cortical progenitor cells differ in their proliferative and differentiation potential,
location of mitosis and contact to the apical and basal lamina [5] and are located in different
germinal zones of the developing cortex. The most apical zone is called the ventricular zone
(VZ), followed by the subventricular zone (SVZ), intermediate zone, subplate, cortical plate
and the so-called marginal zone. During neurogenesis in the cortex, excitatory glutamatergic
neurons arise from the progenitor cells and migrate along the radial glia fibers in an inside-out
fashion to their location at the basal side of the cortex where they eventually constitute six
cortical layers characterized by distinct cell composition [6–9]. Other cell types, such as the
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majority of GABAergic inhibitory neurons (interneurons) in the cortex, develop from distinct
germinal zones, called the ganglionic eminences and migrate into the neocortex to integrate
into neuronal circuits [10–12].
Later during development, glia cells such as astrocytes and myelinating oligodendrocytes de-
velop from the radial glia cells. Moreover, neuronal circuits are established and refined by
synapse formation. Brain development is not completed upon birth, many processes such as
brain growth, synaptogenesis, gliogenesis and myelination extend beyond fetal development
into postnatal stages and for example myelination even still undergoes changes in the adult
brain [4, 13]. The adult brain eventually harbors around 86 billion neurons [14] with 10-20
billion neurons and 15-30 billion glial cells located in the cerebral cortex [15] that accounts for
more than 80% of the total brain mass [16]
Aberrations during cortical development lead to variable malformations which can be caused
by e.g. impairments in progenitor behavior, neuronal migration and circuit integration. As
a result, alterations in brain size (microcephaly, macrocephaly), folding of the cortex (e.g.
lissencephaly) and mislocalization of neurons (heterotopia) [17] can be observed. Many of
these conditions lead to epileptic seizures and cognitive disability. Moreover, it has been
proposed that even neuropsychiatric diseases such as autism [18–21] and schizophrenia [19]
have a developmental component and might be rooted in human-specific features of brain
development.
Human-specific features of the developing and adult brain
One of the major characteristics distinguishing the human brain from that of our closest
living relatives, the great apes, is the enlargement of the neocortex. Consequently, humans
display an approximately three fold increase in brain mass compared to chimpanzees [22]. This
enlargement could be due to cell cycle or developmental timing differences, or changes in the
characteristics of neural stem and progenitor cells. For example, the neurogenic period in
humans is longer than in macaques with 100 days compared to 60 days [23]. Moreover, this
enlargement has in part been attributed to the SVZ which is thickened in primates compared
to mice and further subdivided in an inner (ISVZ) and outer portion (OSVZ) which is delimited
by an inner fiber layer [24]. The OSVZ harbors a special cell type called basal radial glia (also
termed outer radial glia) with increased proliferative capacity and therefore neuronal output
thus potentially contributing to increased brain size [25, 26]. Basal radial glia are nearly
absent in mice [27], less prominent in ferrets [26] and macaque [28] and are marked by specific
transcriptional profiles [29], morphological variability [30], complex lineage trajectories [28]
and the retainment of stem-like and proliferative features by generating their own proliferative
niche [29, 31]. In addition to the overall increase in size of the human brain, it is still a matter
of debate whether some brain regions, such as the prefrontal cortex, responsible for higher
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order processing, planning and social abilities [32], underwent a disproportionate enlargement
in humans [33–38].
Aside from the above mentioned brain size difference, other morphological, cellular, physi-
ological and molecular distinctions of the human brain have been described. For example,
magnetic resonance imaging of human and chimpanzee brains revealed increased plasticity in
cortical organization and morphology in humans and hypothesized that this could contribute
to human-specific learning capabilities [39]. In the frontal pole, pyramidal neurons in layer
III of the cortex are more widely spaced in humans than in apes [40] and generally show
more complex morphology [41]. Moreover, humans are characterized by an enlargement of
the superficial cortical layers (II+III) which could lead to changes in signaling between cortical
regions [42].
Some human-specific brain differences might be caused by cell type innovations or enrichment
of cell types. Van Economo neurons, a pyramidal cell type that can be found in many mammals
with large brains, for example occurs more frequently in humans than in other great apes and
is characterized by a bigger cell body in humans [43–45]. Profiling gene expression in different
regions of the human, chimpanzee and macaque brain identified an interneuron subtype which
also expressed dopamine synthesis markers [46]. This cell type was more prominent in the
human striatum and only present in the neocortex of humans compared to great apes [46].
Another recently identified human interneuron cell type, designated ’rosehip cells’, located in
layer I of the cortex, was discovered based on morphological and gene expression analysis.
However, it is not yet clear if this cell type is unique to humans since the study compared only
humans and mice [47]. Astrocyte morphology and function also have diverged, for example so-
called varicose projection astrocytes in layer V/VI which are absent in mice and lower primates
but can be found in human and chimpanzee, although in the chimpanzee with decreased size
and complexity [48]. Furthermore, humans have developed an increased glia/neuron ratio
across different areas of the frontal cortex [49].
Comparative investigations into the composition of metabolites [50, 51] and lipids [52, 53]
have shed light on dynamic and species-specific differences during brain development. For
example, changes in glutamate metabolism have been detected in human prefrontal cortex but
not cerebellum when comparing human, chimpanzee and macaque tissues [50]. In addition,
there are generally more metabolic changes in the prefrontal cortex in humans compared to
chimpanzee, macaque and mice [51]. Similar findings have been made with respect to lipids
where more changes were detected in the neocortex compared to the cerebellum [52].
Human brain development appears to be slowed down, compared to that of chimpanzees and
macaques, a phenomenon known as neoteny. It has been hypothesized that the elongated
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phases of development might allow for more flexibility and extended phases of learning needed
to navigate in complex social constructs [54]. Gene expression studies have revealed subsets
of genes showing similar timing shifts reminiscent of neoteny highlighting genes involved in
synapse development [55–57]. Moreover, in humans a process called synaptic pruning is
prolonged and also myelination takes longer [13, 58]. Similar timing differences might also
play a role during prenatal development as modeled in in vitro systems [59] but these differences
remain poorly understood.
Potential genetic underpinnings of human-specific brain features
The genetic underpinnings of human-specific features of the brain are not well understood yet
and only some candidates have been functionally characterized in more detail. For example,
human-specific deletions [60] and gene duplications [61] have been identified to be associated
with evolutionary brain differences. The human-specific segmental duplication ARHGAP11B
[62] has been shown to increase basal progenitor amplification and causes folding of the cortex
in mice which points to a potential role in the evolution of brain size in humans. One more
prominent example is NOTCH2NL [63, 64] which is expressed in radial glia cells in the fetal
human brain and is involved in prolonged radial glia proliferation and could thus lead to brain
size increase. SRGAP2C, another segmental duplication, induces a delay in dendritic spine
maturation and leads to higher spine density when tested in the mouse neocortex [65, 66].
A candidate gene present in humans and great apes, GLUD2 [67], could play a role in lipid
biosynthesis during postnatal brain development.
Conserved sequences being deleted in humans (hCONDELs) might also contribute to evo-
lutionary changes. One of those human-specific conserved deletions abrogates a putative
enhancer of the gene GADD45G and could be responsible for increased brain size due to its
role in tissue proliferation. Generally, human conserved deletions seem to be overrepresented
near genes involved in neurogenesis of the cortex and often link to genes likely involved in
increased proliferation [60].
The most distinguished example at the level of protein coding sequence differences to date is
FOXP2, which is characterized by two amino acid changes specifically on the human lineage
and has been attributed to differences in vocalization and learning when humanized in mice
[68, 69]. Studies in mouse embryos electroporated with the human FOXP2 version suggested
that it might also be involved in early development by changing the relative proportion of
radial glia to more differentiated neural progenitors [70].
GPR56, a gene involved in progenitor proliferation and cortical folding, exhibits increased
number of promoters compared to mice and the deletion of one of these regulatory elements
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led to regionally restricted folding differences in the human brain, suggesting specification of
cortex folding patterns by regulatory diversification [71].
Human accelerated regions (HARs) are genomic segments that exhibit an excess of sequence
changes on the human lineage but are conserved in other species [72]. Generally, many of
these accelerated regions are located in non-coding genomic regions and have been linked
to enhancers active in brain development [73]. The gene which has the most HARs in its
proximity is NPAS3 and it was shown in mice that the human version of one of these HARs,
2xHAR142, leads to a broader activity pattern in humans that also includes the forebrain
compared to the mouse and chimpanzee version [74]. Another interesting example represents
human accelerated region 5 (HARE5) which controls gene expression of FZD8. When tested
in mice, the human version leads to a faster cell cycle in neural progenitors and an increase in
brain size compared to the chimpanzee sequence [75]. Human accelerated region 1 is one more
prominent example, which accumulated 18 substitutions on the human lineage and is located
within a regulatory RNA gene, a long noncoding RNA (lncRNA), HAR1F. The regulatory RNA
is expressed in the cortex during early development in so called Cajal-Retzius cells which play
an important role in establishing the laminar organization of the cortex and it is a rare example
of a regulatory RNA that could play a role in the evolution of human brain development [72].
The above described studies have aided in linking human-specific genetic changes to evolution-
ary differences in brain development. However, most of them were conducted in mice and not
in the endogenous human genetic context. Thus it would be desirable to use model systems
that more faithfully recapitulate human biology.
Advanced in vitro model systems to study development
Previous models and the advent of induced stem cells
It has been hypothesized that many of the changes that can be observed in the human brain are
rooted in early development, thus highlighting the significance of comparative developmental
investigations. Studying human brain development, its malformations and evolution has mainly
relied on using either fetal tissue [76] or model organisms such as mice [8], rats [6], ferrets
[77] and macaques [57]. However, the use of fetal tissue presents ethical issues and technical
limitations and it is impossible to obtain fetal tissues from great apes. Moreover, primary
tissue cannot be easily manipulated via genetic tools to study the effect of selected genes.
Transgenic model organisms such as mice on the other hand have often only partially been
able to mirror the phenotypes seen in humans [78, 79] most likely due to their phylogenetic
distance. Thus, new model systems are required that recapitulate human development in a
more faithful manner to study evolution and disease.
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A major breakthrough towards this goal was the discovery that somatic cells can be repro-
grammed into pluripotent cells by administering certain factors [80] on comparatively easily
accessible cell sources such as fibroblasts [80] or blood cells [81]. This has made it possible
to generate stem cells from different primate species [82–84] and patient-specific stem cells
to study diseases [85]. Due to their differentiation capacity, these cells can be coaxed into
virtually any cell type and offer the potential to study different tissues from multiple individuals
and species across multiple stages of development to decipher temporally resolved develop-
mental programs. To investigate human-specific differences of brain development, a set of
differentiation protocols in 2D have been developed [86–88]. Although these systems provide
only a limited amount of complexity compared to the native tissue context, they for instance
have proven useful in revealing differences in developmental timing across primate species [59,
89].
Organoids as state-of-the-art 3-dimensional in vitro models
During the last years, so-called organoid technologies have been introduced that allow mod-
elling early stages of development using adult, embryonic or induced pluripotent stem (iPS)
cells and thereby revolutionized the field of stem cell engineering. Organoids are 3-dimensional
(3D) models that self organize into organ-like structures with an increased degree of complex-
ity and recapitulate some functionality of the tissue including the appearance of tissue-specific
cell types [90]. Organoids can for instance be generated from induced pluripotent stem cells or
embryonic stem cells from humans. A plethora of different tissues has been modeled to date
such as intestine [91], brain [92–94], liver [95], kidney [96], lung [97], pancreas [98], optic cup
[99] and inner ear [100]. One of the key advantages of using stem-cell derived organoids over
primary tissue is their accessibility to genetic manipulation by using e.g. CRISPR/Cas9 [101,
102] to study the effect of specific genes and variants as well as the 3D culture environment
that more faithfully mimics developmental processes.
Types of brain organoids
Brain organoids generated from human embryonic stem cells have been introduced in 2008
by the Sasai group [103] with later modifications by Lancaster et al. [92] and Kadoshima et
al. [93]. The system introduced by Lancaster et al. produces different regions of the brain
in one organoid, which also led to the term ’cerebral organoids’ for this system. Alternative
methods are optimized towards coaxing cells into specific regional identities such as forebrain
[93, 104], midbrain [104, 105] and hypothalamus [104], choroid plexus and hippocampus
[106], hindbrain [107] and pituitary [108]. Numerous modifications and further enhancements
of these protocols have been introduced including miniaturized organoids that are grown in
3D-printed bioreactors and so called assembloids to study the interaction between different
brain regions [109–112]. Investigations of histological [92, 104, 113], transcriptomic [20, 114–
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117], epigenomic [115, 116] and electrical network activity features [118] have corroborated
the feasibility of organoids to study developmental processes reminiscent of early to mid-fetal
development in humans.
Applications and prospects
Brain organoids were utilized to study neurodevelopmental disorders, such as microcephaly
[92], cortical folding differences [102, 119] or neuronal migration defects [109, 120], Down
Syndrome [121] as well as neuropsychiatric diseases with a developmental component such
as autism [122]. For example, organoids were applied to model Miller-Dieker Syndrome, a
form of lissencephaly leading to absence of folding of the cortex and reduced brain size. The
authors detected differences in outer radial glia cell division and increased cell death in neural
stem cells [119]. Moreover, organoids were utilized to elucidate mechanisms of Zika virus
(ZIKV) infection [104, 123, 124], to test ZIKV infection inhibitors [125], to study the effect of
bisphenol A on neurodevelopment [104] and even to model neurodegenerative diseases such
as Alzheimer’s disease [126, 127]. Hence, brain organoids have already proven valuable in
tackling diverse questions related to brain development and disease.
Current drawbacks of organoids, however, encompass a limited maturation capacity with pre-
mature layering of cortical regions [104] as well as limitations in size due to the absence of
external signaling cues and nutrient supply. Furthermore, the majority of protocols is marked
by variability in composition, in particular, regarding the abundance of cells with specific brain
regional identities, as well as from batch to batch [113, 128]. Thus, recent efforts focusing
on improving the organoid system are geared towards increasing reproducibility [117, 129],
controlling regionalization [104, 117, 129], introducing currently missing cell lineages such as
oligodendrocytes [130, 131] and microglia [132] and improving maturation by extended cultiva-
tion times [133], supplementing additional growth factors [104, 128] or introducing vasculature
[134] to expand the applicability of organoids even further.
Studying early brain development in humans and great apes has been a challenge due to
ethical and technical limitations. Cerebral organoids that can be generated from pluripotent
stem cells offer the possibility to model early developmental differences between those species
in controlled cell culture environments. Previous studies [20, 59] have already shown the
potential to study differences that distinguish early human brain development from that of




High throughput sequencing studies of brain development
Gene expression studies
Humans and chimpanzees share 98.8% of their DNA sequence, however phenotypic distinctions
are apparent despite this high similarity [135]. It has been proposed that many differences that
set humans apart from chimpanzees are due to noncoding regulatory sequence differences and
changes in gene expression rather than sequence differences in protein-coding genes [136,
137]. Thus, profiling genome-wide patterns of gene expression and regulatory signatures are
promising approaches to dissect global changes during brain development and in the adult
brain that set humans apart from great apes.
Transcriptome sequencing efforts in the human brain have revealed changes during prena-
tal [76, 138] and postnatal brain development [138] and described dynamic gene expression
changes with an excess of differences detected in the prenatal period [138]. In studies inves-
tigating postnatal stages of brain development, human developmental patterns seemed to be
more diverged especially in the prefrontal cortex [139] and synapse-related gene expression in
humans was characterized by a shift towards later time points in development compared to
chimpanzee and macaque [56]. Similarly, investigating the prenatal and postnatal macaque
brain in comparison to humans [57] revealed a longer maturation in the human brain linked to
genes playing a role in myelination and synaptogenesis [140].
By dissecting layer-resolved gene expression patterns in prefrontal cortex of human, chimpanzee
and macaque, differences indicating reorganization of layer expression patterns were detected
and were observed more frequently in humans than chimpanzee suggesting cortical reorgani-
zation on the human lineage [141]. Moreover, the construction of gene coexpression networks
offers an integrated view on gene relationships [142–145] and has revealed transcription fac-
tors such as Krüppel-associated box-zinc finger proteins (KRAB ZNFs) to be overrepresented
among transcription factors with gene expression changes between human and chimpanzee in
prefrontal cortex [143] and identified human-specific gene expression modules in frontal pole
[144].
Nevertheless, in a broader context, it is not yet fully resolved if the human brain underwent
accelerated evolution indicating an excess of changes on the human lineage or if the changes
accumulated linearly over evolutionary divergence time [146–150]. Moreover, it is not well
resolved yet if particular cell types underwent accelerated evolution.
Gene regulatory differences
A number of studies investigated evolutionary changes in transcriptional regulation such as
DNA methylation, histone modifications or expression of regulatory RNAs such as micro RNAs
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and lncRNAs. For example, a comparison of histone modifications between human, macaque
and mouse in prenatal developing brain found that regions of activity gains specific to humans
were among others connected to cell proliferation and extracellular matrix [151]. A similar
study conducted in adult brain of human, chimpanzee and macaque reported a small set of
human-specific active regions with 139 enhancers that gained activity and 45 that lost activity
in humans [152]. Comparable results were obtained when active transcription start sites in
neurons of the prefrontal cortex were examined revealing 410 loci that gained and 61 loci
that lost activity specifically in humans [153]. A recent study showcased the use of iPSC-
derived neural crest cells to study epigenomic differences between human and chimpanzee
that can explain craniofacial divergence, highlighting the versatility of stem cell models to
study evolutionary differences [154]. Regulatory RNAs such as microRNAs [46, 139, 155]
or lncRNAs [156] have only started to be explored in the context of human-specific brain
differences. DNA methylation might also play a role in gene expression differences as was
indicated by comparing prefrontal cortex of human and chimpanzee with higher methylation
levels detected in chimpanzee [157].
Although these studies present valuable resources to dissect human-specific gene expression
differences and their potentially underlying regulatory logic, the majority relies on bulk mea-
surements. Thus, some of the changes observed might be due to compositional differences in
the tissue and more subtle cell type-specific changes are obscured by ensemble averaging.
The landscape of single-cell technologies
Technological advances in the last years have made it possible to study the gene expression
profiles of single cells [158] and single-cell analysis has become a widely used method due to its
power to resolve complex tissue compositions, detect rare cell types and compare orthologous
cell types across different species [159] at unprecedented resolution.
The first single-cell transcriptome methods were based on manual cell isolation and low
throughput library generation in tubes [158]. An increase in throughput was achieved by
valve-based microfluidic devices geared towards separating and isolating cells (Fluidigm C1
system) [160–162], cell sorting and automatic handling in low volumes (MARS-seq, massively
parallel RNA single-cell sequencing) [163] or using micropatterned plates with nanowells for
cell isolation [164]. The introduction of droplet-based microfluidic techniques that rely on
separating cells into water-in-oil droplets as distinct reaction containers has however substan-
tially advanced the throughput of single-cell studies, making it amenable to profile thousands
of cells in one experiment [165, 166]. Additional efforts, so called split and pool approaches,
have enlarged the amount of cells that can be profiled in parallel even further allowing for the
detection of rare cell types [167].
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These single-cell transcriptomic techniques already had a substantial impact on the study of
differentiation dynamics [161, 168], cell state transitions [169] cellular composition of tissues
[170–173], lineages [174, 175] and effects of perturbations [176, 177]. Recent collaborative
efforts have used single-cell transcriptomics to profile the cellular composition of all major
organs of the mouse [178] as well as of humans [179] in order to create cell atlases in normal
[163, 169, 180–184] and disease conditions [184–188]. Further, cellular reference maps were
also generated for commonly [189–192] and less commonly used model organisms [168, 193].
Single-cell analysis has expanded from studying transcriptomes [194, 195] to genomes [196],
epigenomes [197, 198], proteomes [199], chromosome conformations [200, 201] and various
combinations thereof [202–207] leading to an integrated view on single cell states.
Studying the brain at single cell resolution
In the neuroscience field, single-cell transcriptomics has evolved into an invaluable tool to
dissect brain cell type diversity in the mouse [208–211]. Approaches have been extended
to combine single-cell sequencing with additional modalities such as cell morphology and
electrophysiological properties [212, 213] as well as to interrogate gene expression patterns
from frozen and archived tissue [214–216]. Single-cell transcriptome analysis has been applied
to shed light on mechanisms of the developing [114, 217–220] and adult [215, 218, 221]
human brain including the characterization of 3D cell culture models both from human [20,
114, 117, 128] as well as non-human primates [20, 222]. Finally, a comparison between mouse
and human identified patterns of conservation and species-specific innovations [159].
Aim of the thesis and outline
The availability of methods to recapitulate human brain development in controlled culture
environments, together with technologies to dissect tissues with single-cell transcriptomics,
enable exciting opportunities to understand the mechanisms underlying human brain evolution
and disease. In this thesis, stem cell-derived cerebral organoids and single-cell transcriptomics
methods are used to explore human-specific features of neocortical development and adult
prefrontal cortex cell diversity, as well as to investigate aberrant cell populations in a cortical
malformation.
The first two chapters focus on using cerebral organoids to understand human-specific brain
development. In chapter 1, cerebral organoids generated from iPS cells of human and chim-
panzee are used to model early developmental changes on the human lineage using single-cell
transcriptomics to decipher cell type-specific differences that likely contribute to human-specific
cell type signatures and behavior.
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Chapter 2 expands on the project described in chapter 1 by analysing single-cell transcriptomes
from an increased number of cells, individuals, species and time points to study dynamic
differences occurring during early brain development as recapitulated in cerebral organoids.
The observed gene expression changes are further integrated with differences in chromatin
accessibility between the species as well as with differential gene expression analysis performed
on single-nucleus transcriptomic data of adult brain tissue from humans, chimpanzee/bonobos
and macaques.
In chapter 3, cerebral organoids are used to understand cell states that emerge during a form
of cortical malformation. Cerebral organoids generated from patient-derived iPS cells are
applied to model periventricular neuronal heterotopia (PH), which is caused by mutations in
the cadherin receptor-ligand pair DCHS1-FAT4. In this context, single-cell RNA-sequencing is
applied to dissect aberrant gene expression programs at the level of specific cell types in the
organoids as well as 2D cultures of neurons.
Chapter 1
Differences and similarities between human and chimpanzee neural
progenitors during cerebral cortex development
The human neocortex underwent remarkable changes during evolution, most prominently an
increase in size, which has been attributed to higher cognitive abilities in humans [223]. Thus,
early developmental distinctions between species likely contribute to the differences that can
be observed between humans, and our closest living relatives, the chimpanzees. In this study,
cerebral organoids were adopted to study early development between human and chimpanzee
using histology, live imaging (performed by collaborators in the group of Wieland Huttner)
and single-cell RNA-Seq, to pinpoint cellular and molecular changes potentially contributing
to evolutionary differences.
To decipher molecular differences between the species at cell type resolution, human and chim-
panzee organoids were profiled using single-cell RNA-seq. Single-cell transcriptomic analyses
of chimpanzee organoids showed clusters of cortical neural progenitor cells (NPCs) and neurons
that could be aligned on a developmental pseudotime, very similar to single-cell transcriptomes
from human organoids and fetal brain [114]. This demonstrated that the main lineage con-
version from NPCs to neurons is conserved between the species and can be properly modeled
in cerebral organoids.
Differential gene expression analysis between both species for major cell types showed that
most cell type-specific genes were not differentially expressed between the species, confirming
16
SUMMARY
that most features are conserved. Nevertheless, a number of genes could be detected as dif-
ferentially expressed between human and chimpanzee apical progenitors (APs) and neurons,
respectively, with a similar number being more highly expressed in human cells and chim-
panzee cells. Functional enrichment analysis for these differentially expressed genes identified
membrane and intercellular signaling, and interesting candidate genes more highly expressed
in humans were integrin beta 8 (ITGB8) in APs and insulin receptor (INSR) in neurons.
Moreover, inspecting the histological architecture in human and chimp organoids revealed very
similar organization of germinal zones reminiscent of the developing fetal cortex with consistent
numbers of cell types and cycling cells between both species. Measurements of the length of
specific phases of the cell cycle using time-lapse imaging showed an intriguing elongation in
metaphase in humans during mitosis, specifically in APs at early stages (day 30) of organoid
development.
Overall, this work stresses the applicability of cerebral organoids as a useful in vitro model
to perform comparative developmental studies, thus adding to previous 2D studies comparing
species [59].
Chapter 2
Organoid single-cell genomic atlas uncovers human-specific features
of brain development
Previous studies using cerebral organoids to study evolutionary development, have applied
single-cell transcriptomics to decipher cell type-specific changes, however at lower throughput
and without including many time points across differentiation to investigate stage-specific gene
expression changes [20, 222]. In addition, current comparative studies of early development
focused on gene expression, however investigating the underlying regulatory mechanisms still
need to be explored.
In this study, we profiled thousands of cells from cerebral organoids generated from iPS and ES
(embryonic stem) cells of human, chimpanzee and macaque using droplet-based microfluidic
single-cell transcriptomics [224]. By analyzing the development of human and chimpanzee
organoids from pluripotency to 4 months, we could reconstruct a trajectory where cells traverse
different stages such as neuroectoderm, neuroepithelium and neural progenitor states until they
diversify into different regional identities such as dorsal and ventral forebrain, midbrain and
hindbrain. We extended the single-cell dataset of human organoids at 2 months to a total of
7 human lines and could observe different propensities of these lines for generating regional
identities, similar to what has been described in previous research [113]. However, gene
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expression patterns of cells derived from the same organoid region showed high correlation,
suggesting that gene expression programs were highly reproducible.
Reconstructing the same organoid developmental trajectory using open chromatin signatures
from ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) data [197]
revealed dynamic temporal changes in the regulatory landscape. To illuminate species-specific
differences, pseudotime-based gene expression trajectories [225] of human and chimpanzee cells
were aligned. This analysis identified cells in the chimpanzee organoids that did not map to a
human equivalent, due to an increased maturation suggesting timing differences between the
species [55, 59, 222]. Indeed, whereas in chimpanzee, upper layer neurons had already formed,
only very few of those cells were observed in human organoids at the corresponding time
points. Moreover, chimpanzee and macaque neurons appeared to be more mature compared
to human neurons based on gene expression patterns related to neuron maturation.
By placing cells onto a pseudotime path [225] and aligning trajectories of 2-month old organoids
generated from human, chimpanzee and macaque cells, cell type-specific patterns of differential
gene expression (DE) were revealed and integrated with differential accessibility (DA) signals
obtained from open chromatin profiling. This revealed cadherin 7 (CDH7) as well as a nearby
putative regulatory region as interesting candidates for follow-up studies. The regulatory region
overlapped with a human-accelerated region and single nucleotide changes fixed in humans,
highlighting its potential evolutionary importance.
To dissect which species-specific gene expression changes persisted in the adult brain, single
nuclei from frozen prefrontal cortex tissue from humans, chimpanzees/bonobo and macaques
were investigated. The tissue was sliced from apical to basal positions and thus allowed for
a spatial reconstruction of gene expression signatures. In general, glial cells, in particular
astrocytes, showed the highest degree of gene expression changes and a lower conservation
compared to neurons. Some gene expression differences, for example of the gene COL6A1
were commonly found in organoids and the adult brain, thus emphasizing the relevance of
organoids to study changes which possibly still impact later developmental phases. However,
other genes were exclusively differentially expressed in either stage, thus stressing the power
of complementary approaches using organoids and adult tissue to dissect brain differences.
Taken together, this study represents a comparative temporal atlas of gene expression and
chromatin accessibility differences during early brain development of human, chimpanzee and
macaque and links differences in the organoid to species differences in the adult brain, rep-
resenting a valuable resource for the neuroscience community. It extends and complements
recent investigations focusing on the human brain [116, 215, 219–221] and comparative single-
cell studies using organoids with lower throughput [20, 222]. Future functional dissection of the
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candidates identified here has high potential to shed light on the multidimensional molecular
basis of human-specific cognitive abilities.
Chapter 3
Altered neuronal migratory trajectories in human cerebral organoids
derived from individuals with neuronal heterotopia
Brain development constitutes a finely orchestrated process in which aberrations lead to vari-
able phenotypes and conditions. For example, erroneous behavior of neural progenitor cells
or neurons can lead to various malformations of the cortex including anomalies in brain size,
cortex folding and localization of neurons [17]. Periventricular neuronal heterotopia (PH) is
a cortical malformation characterized by atypical locations of neurons along the ventricles in
the brain, forming either clusters (nodular) or layers (laminar) of incorrectly placed neurons.
However, the aberrant phenotype is limited to only a subgroup of neurons which remain at the
ventricle and do not properly integrate into the cortex whereas a large fraction of the neurons
behave properly. Patients presenting this pathology often suffer from epilepsy and intellectual
disability [79, 226].
Investigations of genetic underpinnings of PH via sequencing of affected individuals highlighted
DCHS1 and FAT4, a cadherin receptor-ligand pair, as causal genes. Effects of mutations in
DCHS1 and FAT4 were modeled in mice to shed light on the molecular mechanisms involved
in disease etiology [79, 227]. However, mice did not fully recapitulate the phenotype observed
in humans, potentially due to the differences in genetic background compared to humans and
due to the fact that mice with their lissencephalic (smooth) cerebral cortex present a poor
model for the gyrencephalic (convoluted) human cerebral cortex.
The availability of iPS cells reprogrammed from blood cells or fibroblasts opened the door to
recapitulate disease mechanisms using patient-specific cells [80, 81] and new genome engi-
neering tools such as CRIPSR/Cas9 allow for the introduction of patient-specific mutations
in isogenic cell lines. To study PH, iPS cells from patient fibroblasts carrying the disease
mutations were generated using reprogramming as well as isogenic FAT4 and DCHS1 knock-
out and control stem cells using CRISPR/Cas9 genome editing. These cells were used to
culture cerebral organoids, which have already proven useful for the study of diseases such as
microcephaly and lissencephaly [92, 119].
Histological and cellular characterization of organoids produced from patient-derived and iso-
genic KO iPS lines (performed by our collaborators in the group of Silvia Cappello) indeed
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revealed phenotypes reminiscent of the PH condition, with neurons accumulating at the ven-
tricles as well as disordered germinal zones. These observations were further corroborated by
morphological changes of NPCs in the organoids and premature delamination from the apical
membrane, thus leading to more differentiated neurons. Moreover, tracking the dynamic mi-
gration behavior of neurons in the organoids downregulated for DCHS1 and FAT4 and in 2D
culture revealed a subgroup of neurons with an altered migratory phenotype.
To dissect the molecular mechanisms and gene regulatory networks potentially underlying
the above described observations, single-cell RNA-sequencing of control and patient cerebral
organoids was performed. Although the main characteristics of NPCs and neurons were similar
between control and mutant organoids, mutant cells displayed a specific set of dysregulated
genes, among them RND3 whose role in neurogenesis and neuronal migration has been noted
before [228]. Computational reconstruction of a developmental trajectory furthermore revealed
a subgroup of neurons in the mutant organoids with upregulated gene expression patterns
linking to axon guidance, neuronal migration and patterning including state-specific genes
such as ROBO3 and CNTN2. Contrarily, genes related to synapse formation and cytoskeleton
associated genes were downregulated in this subpopulation. Interestingly, a similar subgroup
enriched in mutant neurons was identified in neurons differentiated in a 2D culture system,
corroborating the findings from histological and cellular analyses that showed a subpopulation
of cells with changed migration behavior.
The underlying mechanisms as to why only a subset of neurons shows different migrational
phenotypes even though harboring the same mutations, still need to be explored in upcom-
ing studies. Nevertheless, combining cerebral organoids and single-cell RNA-seq holds great
potential to decipher the mechanisms of neurodevelopmental diseases, such as heterotopia,
and the knowledge gained from these studies could ultimately lead to targeting strategies for
inaccurately organized neuronal circuits.
Conclusions and outlook
Single-cell sequencing and cerebral organoid technologies are influential technological innova-
tions developed in recent years and have been used in this work to shed light on human-specific
features of brain development resolved to distinct cell types and states. By comparing these
differences to single-nucleus data generated from frozen adult tissue, it was possible to de-
fine differences that are specific to the developing brain as well as changes that still can be
detected in the adult brain. Moreover, single cell RNA-seq was applied on patient-derived
cerebral organoids to dissect the gene expression programs and mechanisms of neuronal het-
erotopia, a cortical malformation, whose phenotype was not fully recapitulated so far by using
the mouse as a model system [79]. These studies thus emphasize the relevance of utiliz-
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ing organoids to investigate comparative and aberrant brain development integrated with the
benefit of single-cell sequencing to dissect gene expression programs at high resolution.
Studying primate organoids over a time course from pluripotent stem cells to 4 months has
revealed timing differences in neuron maturation. Analyzing older organoids could inform
about additional transcriptional or morphological differences in neuron maturation as well as
in the timing of gliogenesis since astrocytes were only observed in the late stages of organoid
development. Ongoing improvements in organoid cultivation protocols leading to enhanced
maturation [94, 104, 128] could further aid in interrogating these later stages of development
and would also help identifying pathogenic processes of more mature cell types when studying
cortical malformations such as PH.
Recent studies have also measured electrical activity in organoids [118, 128] and comparing
these features across different primates and during extended periods of cultivation could lead
to insights about electrophysiological divergence during early brain development as well as
potential timing differences in neuronal network establishment. Since cortical malformations
often are accompanied by epileptical seizures, suggesting different electrical activity in neuron
subpopulations, measuring electrical activity in patient-derived organoids represents a useful
addition to examine how well disease conditions can be modeled in vitro [118, 128].
Assessing the transcriptome and chromatin accessibility in primate organoids has revealed an
exciting set of cell type-specific candidate genes and regulatory regions likely playing a role
in human-specific developmental divergence from chimpanzees, some of which retain into
adulthood. Genes with expression changes could be further analyzed in organoids by using
single-cell high throughput knock-out screens [177] to dissect the genes’ function on gene
regulatory networks. This would allow to isolate gene expression changes that have an effect
during development and to narrow down candidates that could be investigated in more detail by
using knock-outs introduced using CRISPR/Cas9 genome editing or overexpression of single
genes. In addition, some genes with species-specific expression differences and accessibility
overlap with interesting evolutionary signatures such as single nucleotide variants or human
accelerated regions. Advances in single cell assays allow to test sets of regulatory elements
in high troughput at the single cell level [229] in organoids. Moreover, genome editing would
also allow for changing human-specific single nucleotide variants back to the chimpanzee state,
which could be an interesting approach for CDH7 that shows human-specific single nucleotide
variants in its regulatory region. Moreover, it is higher expressed in human neurons compared
to chimpanzee, thus potentially playing a role in neuron maturation.
Cells undergo complex developmental trajectories during development which could be dis-
entangled by using lineage tracing methods with single cell readout [174, 175, 230, 231].
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Comparing human and chimpanzee organoids using this method offers the possibility to reveal
differences in the lineages that progenitor cells undergo to become neurons and glia cells. This
could help to resolve the timing differences in neuronal development that were found in our
study. Moreover, when comparing patient-derived and healthy organoids to study periventricu-
lar heterotopia, subsets of NPCs and neurons were identified by clustering and in silico lineage
reconstruction. It is not clear how the cells that show altered behavior are related to the cells
that have a normal phenotype despite carrying the same disease mutations. Lineage tracing
would offer a useful approach to illuminate how these different cell types are related to one
another, thereby gaining a better understanding of the mechanisms of the disease.
In addition, recent extensions of single-cell sequencing methods to interrogate additional
modalities such as lncRNAs, microRNAs [232], chromosome conformation and methylation
[207] would contribute to a multi-layered view on cell type specification and diversity [205,
206] both in the adult brain as well as in organoids from different species or patient-derived
organoids. This would provide a more detailed view on the regulatory logic of cell type-specific
gene expression differences in the context of evolution and disease.
Single-cell transcriptomics delivers a high resolution portrait of cell states and cell types,
however, the spatial context is lost during dissociation of tissues. Consecutive sectioning
of cubes from prefrontal cortex allowed for reconstructing spatial gene expression patterns
of differentially expressed genes in this study. Validating these expression patterns in tissue
using quantitative FISH (fluorescence in situ hybridisation) methods such as single molecule
FISH would be a next question to address [233]. Furthermore, during the last years, spatial
transcriptome profiling methods have been deployed that allow for the quantitative visualization
of hundreds to thousands of transcripts in single cells [171, 173, 234]. This would allow to
integrate morphological imformation and cell type-specific gene expression profiles.
Lastly, in the studies presented here, mainly human, chimpanzee, bonobo and macaque were
studied to identify species differences at the transcriptome level. Thus, both for studying brain
development in organoids as well as cellular diversity in the adult brain, including additional
species, such as gorilla, orangutan or marmoset, and further individuals of the species studied
here, would offer the possibility to dissect species-specific cell type and developmental timing





Menschen leben in kompliziert organisierten Gesellschaften und haben Technologien entwick-
elt, die es ihnen ermöglichen mit unterschiedlichen Lebensräumen und Lebensbedingungen
zurechtzukommen. Dies kann nur durch ein hohes Maß an Zusammenarbeit, Kommunikation
über Sprache und komplexe Planung erreicht werden, die eine Anpassung und Wissensver-
mittlung über mehrere Generationen hinweg ermöglicht [1]. Obwohl unsere nächsten leben-
den Verwandten, die Menschenaffen und insbesondere die Schimpansen, kognitive Fähigkeiten
höherer Ordnung wie Werkzeuggebrauch und sogar Verhaltensweisen aufweisen, die mit Tra-
dition und Kultur in Verbindung gebracht wurden [2, 3], sind moderne Menschen einzigartig
was das Ausmaß ihrer technologischen Fortschritte und die Art und Weise, wie sie die Umwelt
verändert haben, angeht. Diese kognitiven Unterschiede zwischen Mensch und Schimpanse
haben eine Grundlage in Form, Funktion und Zellzusammensetzung im Gehirn, und diese Un-
terschiede haben wahrscheinlich einen Ursprung in frühen Entwicklungsphasen. Bislang ist
jedoch wenig darüber bekannt, wie sich die Gehirnentwicklung zwischen Menschen und Men-
schenaffen unterscheidet. Zudem gestaltet es sich schwierig, die Mechanismen zu untersuchen,
die den potenziellen Unterschieden zugrunde liegen, da es kein experimentelles System gibt,
das die Entwicklung des Gehirns effektiv nachbildet.
Gehirnentwicklung und menschenspezifische Eigenschaften des
Gehirns
Frühe Phasen der Gehirnentwicklung
Das Gehirn entwickelt sich aus dem Neuroektoderm, das die Neuralplatte bildet und sich an-
schließend zum Neuralrohr faltet. Das Neuralrohr segmentiert sich folgend in drei Vesikel, das
Vorderhirn (Prosencephalon), das Mittelhirn (Mesencephalon) und das Hinterhirn (Rhomben-
cephalon) einschließlich der Großhirnrinde, die aus dem Prosencephalon entsteht, und als
Telencephalon bezeichnet wird. Das Neuralrohr besteht aus einer Einzelschicht von Zellen, die
als Neuroepithel bezeichnet wird und Stammzellen beherbergt, die entlang einer apikobasalen
Achse vom Lumen (apikale Seite) zur Außenseite (basale Seite) ausgerichtet sind. Neuroep-
ithelzellen sind die Stammzellen des sich entwickelnden Gehirns, die sich durch Teilung zu
radialen Gliazellen entwickeln. Diese wiederum weisen ein beschränktes Entwicklungspotenzial
auf und differenzieren in verschiedene Vorläuferzelltypen.
Die verschiedenen kortikalen Vorläuferzellen unterscheiden sich in ihrem Proliferations-und
Differenzierungspotenzial, der Position, an der die Mitose stattfindet, und dem Zellkontakt
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zur apikalen und basalen Membran [5]. Sie befinden sich dabei in unterschiedlichen Keim-
zonen des sich entwickelnden Kortex. Die apikalste Zone wird als ventrikuläre Zone (VZ)
bezeichnet, gefolgt von der subventrikulären Zone (SVZ), der Intermediärzone/Mantelzone,
der Rindenzone und der Marginalzone. Während der kortikalen Neurogenese entstehen aus
den Vorläuferzellen exzitatorische glutamaterge Neuronen, die entlang der radialen Gliafasern
von innen nach außen zu ihrer Position an der basalen Seite des Kortex wandern, wo sie
schließlich sechs kortikale Schichten bilden, die durch unterschiedliche Zellzusammensetzun-
gen gekennzeichnet sind [6–9]. Andere Zelltypen, wie z.B. die Mehrheit der GABAergen
inhibierenden Neuronen (Interneuronen) im Kortex entwickeln sich aus anderen Keimzonen,
den sogenannten ganglionischen Vorwölbungen, und wandern in den Neokortex, um sich in
neuronale Schaltkreise zu integrieren [10–12].
Aus den radialen Gliazellen entwickeln sich später während der Entwicklung Gliazellen wie
z.B. Astrozyten und myelinisierende Oligodendrozyten. Darüber hinaus werden neuronale
Schaltkreise durch Synapsenbildung aufgebaut und verfeinert. Die Gehirnentwicklung ist bei
der Geburt noch nicht abgeschlossen, viele Prozesse wie Hirnwachstum, die Ausbildung von
Synapsen, die Gliogenese und Myelinisierung erstrecken sich über die fetale Entwicklung hinaus
in die postnatale Phase. Die Myelinisierung zum Beispiel durchläuft sogar noch Veränderungen
im erwachsenen Gehirn [4, 13]. Das erwachsene Gehirn beherbergt schließlich rund 86 Milliar-
den Neuronen [14], von denen 10-20 Milliarden Neuronen und 15-30 Milliarden Gliazellen in
der Großhirnrinde zu finden sind [15], welche zusammen mehr als 80% der gesamten Hirnmasse
ausmacht [16].
Probleme während der kortikalen Entwicklung führen zu verschiedenen Fehlbildungen, die z.B.
durch Beeinträchtigungen des Vorläuferzellverhaltens, der neuronalen Migration und Schal-
tungsintegration verursacht werden können. Dadurch können Unterschiede in der Gehirngröße
(Mikrozephalie, Makrozephalie), der Furchung des Kortex (z.B. Lissenzephalie) und der
Fehllokalisierung von Neuronen (Heterotopie) beobachtet werden [17]. Viele dieser Erkrankun-
gen führen zu epileptischen Anfällen und kognitiven Einschränkungen. Darüber hinaus wird
vermutet, dass auch neuropsychiatrische Erkrankungen wie Autismus [18–21] und Schizophre-
nie [19] ihren Urprung in humanspezifischen Merkmalen der Gehirnentwicklung haben könnten.
Humanspezifische Merkmale im sich entwickelnden und adulten Gehirn
Eines der wichtigsten Merkmale, das das menschliche Gehirn von unseren nächsten lebenden
Verwandten, den Menschenaffen, unterscheidet, ist die Vergrößerung des Neokortex. Folglich
zeigt der Mensch eine etwa dreifache Zunahme der Hirnmasse im Vergleich zum Schimpansen
[22]. Diese Entwicklung könnte auf Unterschiede im Zellzyklus, des zeitlichen Ablaufs der
Entwicklung oder Veränderungen in den Eigenschaften neuronaler Stamm-und Vorläuferzellen
zurückzuführen sein. So dauert beispielsweise die Neurogenese beim Menschen länger als
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bei Makaken mit 100 Tagen im Vergleich zu 60 Tagen [23]. Darüber hinaus wurde diese
Vergrößerung zum Teil auf die SVZ zurückgeführt, die bei Primaten im Vergleich zu Mäusen
dicker und weiterhin in einen inneren (ISVZ) und äußeren Abschnitt unterteilt ist, der durch
eine innere Faserschicht getrennt wird [24]. Die SVZ beherbergt einen speziellen Zelltyp
namens basale radiale Gliazellen (auch äußere radiale Gliazellen genannt), die eine erhöhte
Proliferationsfähigkeit aufweisen und damit mehr Neuronen bilden, was möglicherweise zu einer
erhöhten Hirngröße beiträgt [25, 26]. Basale radiale Gliazellen sind bei Mäusen [27] fast nicht
vorhanden und weniger ausgeprägt bei Frettchen [26] und Makaken [28]. Zudem zeichnen sie
sich durch spezifische Genexpressionsprofile [29], morphologische Variabilität [30], komplexe
Entwicklungsbeziehungen [28] und die Aufrechterhaltung stammzellartiger und proliferativer
Merkmale durch die Erzeugung einer eigenen proliferativen Nische [29, 31] aus. Abgesehen
von der allgemeinen Vergrößerung des menschlichen Gehirns ist immer noch umstritten, ob
einige Hirnregionen, wie z.B. der präfrontale Kortex, zustãndig für höhere kognitive und soziale
Fähigkeiten, sowie komplexe Planung [32], beim Menschen überproportional groß sind [33–38].
Neben der oben beschriebenen Größendifferenz des Gehirns wurden weitere morphologische,
zelluläre, physiologische und molekulare Unterschiede im menschlichen Gehirn beschrieben. So
zeigten beispielsweise magnetresonanztomographische Aufnahmen von Menschen-und Schim-
pansengehirnen eine erhöhte Plastizität in der kortikalen Organisation und Morphologie beim
Menschen, was möglicherweise zu humanspezifischen Lernfähigkeiten beitragen könnte [39].
Im Frontalpol liegen die pyramidenförmigen Neuronen in Schicht III des Kortex beim Menschen
weiter auseinander als bei Menschenaffen [40] und zeigen im Allgemeinen eine komplexere Mor-
phologie [41]. Darüber hinaus zeichnet sich der Mensch durch eine Vergrößerung der oberen
kortikalen Schichten (II+III) aus, die zu Veränderungn in der Signalgebung zwischen den kor-
tikalen Regionen führen könnten [42].
Einige menschenspezifische Unterschiede im Gehirn könnten durch neue Zelltypen oder häufiger
vorkommende Zelltypen verursacht werden. Van Economo-Neuronen, ein Pyramidenzelltyp,
der bei vielen Säugetieren mit einem großen Gehirn zu finden ist, kommt beispielsweise
beim Menschen häufiger vor als bei anderen Menschenaffen und ist beim Menschen durch
einen größeren Zellkörper gekennzeichnet [43–45]. Durch Genexpressionsstudien in verschiede-
nen Regionen des Menschen-, Schimpansen-und Makakengehirns wurde zudem ein neuer
Interneuron-Subtyp identifiziert, der Dopaminsynthesemarker exprimierte [46]. Dieser Zell-
typ war im Vergleich zum Menschenaffen im menschlichen Striatum häufiger und im Neoko-
rtex ausschließlich im Menschen vorhanden [46]. Ein weiterer kürzlich identifizierter humaner
Interneuron-Zelltyp, so genannte ”Rosehip cells”, die sich in der Schicht I des Kortex befinden,
wurden auf der Grundlage von morphologischen und Genexpressionsanalysen entdeckt. Es ist
jedoch noch nicht klar, ob dieser Zelltyp ausschließlich im Menschen vorkommt, da bisher
nur Menschen und Mäuse verglichen wurden [47]. Auch die Morphologie und Funktion von
25
ZUSAMMENFASSUNG
Astrozyten weisen Unterschiede auf, z.B. so genannte variköse Projektionsastrozyten in der
Schicht V/VI, die bei Mäusen und niederen Primaten fehlen, aber beim Menschen und Schim-
pansen zu finden sind, kommen beim Schimpansen mit geringerer Größe und Komplexität vor
[48]. Darüber hinaus hat der Mensch ein erhöhtes Glia-Neuron-Verhältnis über verschiedene
Bereiche des frontalen Kortex entwickelt [49].
Vergleichende Untersuchungen zur Zusammensetzung von Metaboliten [50, 51] und Lipiden
[52, 53] im Gehirn haben zudem Aufschluss über dynamische und artspezifische Unterschiede
während der Gehirnentwicklung geliefert. So wurden beispielsweise Veränderungen im Gluta-
matstoffwechsel im präfrontalen Kortex des Menschen, aber nicht im Kleinhirn im Vergleich
zu Schimpanse und Makak [50] gefunden. Weiterhin wurden grundsätzlich mehr Veränderun-
gen der Metaboliten im präfrontalen Kortex beim Menschen im Vergleich zu Schimpansen,
Makaken und Mäusen [51] festgestellt. Ähnliche Ergebnisse wurden bei der Untersuchung
von Lipiden erzielt, bei denen mehr Veränderungen im Neokortex im Vergleich zum Kleinhirn
festgestellt wurden [52].
Im Vergleich zu Schimpansen scheint die Entwicklung des menschlichen Gehirns verlangsamt
zu sein, ein Phänomen, das auch als Neotenie bekannt ist. Es wird angenommen, dass
die verlängerten Entwicklungsphasen mehr Flexibilität und längere Lernphasen ermöglichen
könnten, um in komplexen sozialen Konstrukten zurechtzukommen [54]. Genexpressionsstu-
dien haben gezeigt, dass bestimmte Gruppen von Genen ähnliche zeitliche Verschiebungen
aufweisen, die Neotenie nahelegen, und vor allem an der Synapsenentwicklung beteiligt sind
[55–57]. Darüber hinaus dauert die Eliminerung von Synapsen und die Myelinisierung beim
Menschen länger [13, 58]. Untersuchungen in vitro legen nahe, dass ähnliche zeitliche Unter-
schiede auch bei der pränatalen Entwicklung eine Rolle spielen könnten [59], jedoch sind diese
Prozesse bisher nicht gut verstanden.
Mögliche genetische Ursachen humanspezifischer Gehirnmerkmale
Die genetischen Grundlagen der humanspezifischen Merkmale des Gehirns sind noch nicht
gut verstanden und nur einige Kandidaten wurden funktionell näher charakterisiert. So wur-
den beispielsweise humanspezifische Deletionen [60] und Genduplikationen [61] identifiziert,
die mit evolutionären Gehirnunterschieden verbunden sind. Die humanspezifische segmen-
tale Duplikation ARHGAP11B [62] erhöht nachweislich die Amplifikation der basalen radialen
Gliazellen und führt zu einer Faltung des Kortex bei Mäusen, was auf eine potenzielle Rolle
bei der Evolution der Hirngröße im Menschen hinweist. Ein weiteres bekanntes Beispiel ist
NOTCH2NL [63, 64], das in radialen Gliazellen im fetalen menschlichen Gehirn exprimiert wird,
an einer verlängerten radialen Gliaproliferation beteiligt ist und somit zu einer Vergrößerung
des Gehirns geführt haben könnte. SRGAP2C eine weitere segmentale Duplikation induziert
eine verzögerte Bildung sogenannter Dornfortsätze an Dendriten und führt zu einer höheren
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Dornfortsatzdichte im Neokortex der Maus [65, 66]. Ein weiterer Kandidat, GLUD2 [67], ein
Gen, das beim Menschen und bei Menschenaffen vorhanden ist, könnte eine Rolle bei der
Lipidbiosynthese während der postnatalen Gehirnentwicklung spielen.
Konservierte Sequenzen, die im Menschen verloren gegangen sind, können ebenfalls zu evo-
lutionären Veränderungen beitragen. Eine dieser humanspezifisch konservierten Deletionen
inaktiviert einen vermeintlichen Enhancer des Gens GADD45G und könnte aufgrund seiner
Rolle bei der Gewebeproliferation somit für eine vergrößerte Gehirngröße verantwortlich sein.
Im Allgemeinen scheinen menschliche konservierte Deletionen in der Nähe von Genen, die an
der Neurogenese des Kortex beteiligt sind, überrepräsentiert zu sein. Häufig stehen sie im
Zusammenhang mit Genen, die wahrscheinlich an einer erhöhten Proliferation beteiligt sind
[60].
Das bisher herausragendste Beispiel auf der Ebene der Unterschiede in der Proteinkodierungsse-
quenz ist FOXP2. Es ist durch zwei Aminosäureänderungen speziell im Menschen gekennze-
ichnet und führt zu Unterschieden in der Stimmbildung und beim Lernen in humanisierten
Mäusen [68, 69]. Studien an Mausembryonen, die mit der humanen FOXP2 -Variante elektro-
poriert wurden, deuteten darauf hin, dass FOXP2 auch an der frühen Entwicklung beteiligt sein
könnte, indem es das relative Verhältnis von radialen Gliazellen zu differenzierteren neuronalen
Vorläufern ändert [70].
GPR56, ein Gen, das an der Proliferation von Vorläuferzellen und der kortikalen Furchung
beteiligt ist, weist eine erhöhte Anzahl von Promotoren im Vergleich zu Mäusen auf. Die
Deletion eines dieser regulatorischen Elemente führte zudem zu regional begrenzten Faltung-
sunterschieden im menschlichen Gehirn [71].
Human Accelerated Regions (HARs) sind genomische Segmente, die einen Überschuss an Se-
quenzänderungen in der menschlichen Linie aufweisen, aber in anderen Spezies konserviert
sind [72]. Im Allgemeinen befinden sich viele dieser Regionen in nicht-kodierenden genomis-
chen Regionen und wurden mit Enhancern, die in der Gehirnentwicklung aktiv sind, assozi-
iert [73]. Das Gen, welches die meisten HARs in seiner Nähe aufweist, heißt NPAS3. Es
wurde bei Mäusen gezeigt, dass die menschliche Version einer dieser HARs, 2xHAR142, zu
einem erweiterten Aktivitätsmuster führt, das auch das Vorderhirn im Vergleich zur Maus-und
Schimpansenversion mit einschließt [74]. Ein weiteres interessantes Beispiel ist die human
accelerated region 5 (HARE5), die die Genexpression von FZD8 steuert. Bei Tests an Mäusen
führt die menschliche Version zu einem schnelleren Zellzyklus bei neuronalen Vorläufern und
einer Vergrößerung des Gehirns im Vergleich zur Schimpansensequenz [75]. HAR1 ist ein weit-
eres bekanntes Beispiel, das 18 Substitutionen auf der menschlichen Linie aufweist und sich
in einem regulatorischen RNA-Gen, einer langen nichtcodierenden RNA (lncRNA), HAR1F,
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befindet. Die regulatorische RNA wird in der Großhirnrinde während der frühen Entwick-
lung in so genannten Cajal-Retzius-Zellen exprimiert, die eine wichtige Rolle beim Aufbau
der laminaren Organisation der Großhirnrinde spielen. Somit ist HAR1F ein seltenes Beispiel
für regulatorische RNAs, die eine Rolle bei der Evolution der menschlichen Gehirnentwicklung
spielen könnten [72].
Die oben beschriebenen Studien haben somit geholfen, humanspezifische genetische Veränderun-
gen zu identifizieren, die zu evolutionären Unterschieden in der Gehirnentwicklung führen. Die
meisten der Versuche wurden jedoch bei Mäusen und nicht im humangenetischen Kontext
durchgeführt. Daher wäre es wünschenswert, Modellsysteme zu verwenden, die die men-
schliche Biologie genauer nachbilden.
Fortgeschrittene in vitro Modellsysteme zur Untersuchung der
Entwicklung
Bisherige Modelle und das Aufkommen induzierter Stammzellen
Es wird angenommen, dass viele der im menschlichen Gehirn zu beobachtenden evolutionären
Veränderungen in der frühen Entwicklung verwurzelt sind, was die Bedeutung vergleichender
Entwicklungsuntersuchungen unterstreicht. Die Erforschung der menschlichen Gehirnentwick-
lung, ihrer Fehlbildungen und Evolution beruht hauptsächlich darauf, dass entweder fetales
Gewebe [76] oder Modellorganismen wie Mäuse [8], Ratten [6], Frettchen [77] oder Makaken
[57] erforscht wurden. Die Verwendung von fetalem Gewebe ist jedoch mit ethischen Fra-
gen und technischen Einschränkungen verbunden und Gewebe von Menschenaffen kann nicht
untersucht werden. Darüber hinaus kann primäres Gewebe nicht ohne weiteres mit gentech-
nischen Methoden verändert werden, um die Wirkung ausgewählter Gene zu untersuchen.
Transgene Modellorganismen wie Mäuse hingegen konnten die beim Menschen beobachteten
Phänotypen oft nur teilweise widerspiegeln [78, 79], was höchstwahrscheinlich auf ihre phy-
logenetische Distanz zurückzuführen ist. Daher sind neue Modellsysteme erforderlich, die die
menschliche Entwicklung genauer nachbilden, um vergleichende Entwicklung und Krankheit-
sprozesse genauer zu untersuchen.
Ein wichtiger Durchbruch auf dem Weg zu diesem Ziel war die Entdeckung, dass somatis-
che Zellen aus vergleichsweise leicht zugänglichen Quellen wie Hautzellen [80] oder Blutzellen
[81] durch die Verabreichung bestimmter Faktoren [80] zu sogennanten pluripotenten Zellen
reprogrammiert werden können. Dadurch ist es möglich, Stammzellen von verschiedenen Pri-
matenarten [82–84] und patientenspezifische Stammzellen zur Untersuchung von Krankheiten
zu erzeugen [85]. Aufgrund ihrer Differenzierungskapazität können diese Zellen zu vielen ver-
schiedenen Zelltypen entwickelt werden und bieten somit das Potenzial, verschiedene Gewebe
von mehreren Individuen und Arten über mehrere Entwicklungsstufen hinweg zu untersuchen,
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um zeitlich aufgelöste Entwicklungprozesse zu entschlüsseln. Um humanspezifische Unter-
schiede in der Gehirnentwicklung zu untersuchen, wurden eine Reihe von Differenzierungspro-
tokollen in 2D entwickelt. Obwohl diese Systeme im Vergleich zum nativen Gewebekontext
nur eine begrenzte [86–88] Komplexität aufweisen, haben sie sich beispielsweise als nützlich
erwiesen, um zeitliche Unterschiede in der Entwicklung von Primaten zu identifizieren [59, 89].
Organoide als modernste 3D in vitro Modelle
In den letzten Jahren wurden so genannte Organoid-Technologien eingeführt, die es ermöglichen,
frühe Entwicklungsstadien mit adulten, embryonalen oder induzierten pluripotenten Stam-
mzellen nachzubilden, was das Feld der Stammzellforschung revolutionierte. Organoide sind
3D-Modelle, die sich zu organähnlichen Strukturen mit erhöhter Komplexität ausbilden, die
gewebespezifische Zelltypen enthalten und Funktionen des Gewebes aufweisen [90]. Organoide
können beispielsweise aus induzierten pluripotenten Stammzellen oder embryonalen Stam-
mzellen des Menschen abgeleitet werden. Bis heute wurde eine Vielzahl verschiedener Gewebe
nachgebildet, wie z.B. Darm [91], Gehirn [92–94], Leber [95], Niere [96], Lunge [97], Bauch-
speicheldrüse [98], Netzhaut [99] und Innenohr [100]. Einer der Hauptvorteile, der sich durch
die Verwendung von Organoiden aus Stammzellen gegenüber Primärgewebe ergibt, ist die
Möglichkeit Gene, z.B. mittels CRISPR/Cas9, zu verändern [101, 102]. Dies ermöglicht die Un-
tersuchung der Rolle bestimmter Gene in einem 3D-System, das Entwicklungsprozesse genauer
nachahmt.
Arten von Gehirnorganoiden
Gehirnorganoide, die aus menschlichen embryonalen Stammzellen gewonnen werden, wurden
2008 von der Sasai-Gruppe [103] vorgestellt und später von Lancaster et al. [92] und Ka-
doshima et al. [93] weiter modifiziert. Das von Lancaster et al. eingeführte System produziert
verschiedene Regionen des Gehirns in einem Organoid, was auch zu dem Begriff ”zerebrale
Organoide” für dieses System führte. Alternative Methoden wurden zudem dahingehend op-
timiert, bestimmte Regionen wie Vorderhirn [93, 104], Mittelhirn [104, 105] und Hypothala-
mus [104], Plexus choroideus und Hippocampus [106], sowie Hinterhirn [107] und Hypophyse
[108] zu bilden. Zahlreiche Modifikationen und weitere Ergänzungen dieser Protokolle wurden
eingeführt, darunter miniaturisierte Organoide, die in 3D-gedruckten Bioreaktoren gezüchtet
werden, und so genannte Assembloide, um die Interaktion zwischen verschiedenen Gehirn-
regionen zu analysieren [109–112]. Die Untersuchung gewebespezifischer Merkmale [109–
112], der Genexpression [20, 114–117], des Epigenoms [115, 116] und elektrischer Netzw-
erkaktivitäten [118] haben die Anwendbarkeit von Organoiden zur Untersuchung von Entwick-





Zerebrale Organoide wurden bisher verwendet, um entwicklungsbedingte Störungen des Gehirns
wie Mikrozephalie [92], kortikale Furchung [102, 119] oder neuronale Migrationsstörungen
[109, 120], Down-Syndrom [121], sowie Autismus [122] zu studieren. So wurden beispiel-
sweise Organoide zur Untersuchung des Miller-Dieker-Syndroms angewendet, einer Form der
Lissenzephalie, die zu einer fehlenden Furchung des Kortex und einer reduzierten Hirngröße
führt. Die Autoren fanden dabei Unterschiede in der Zellteilung äußerer radialer Gliazellen und
einen vermehrten Zelltod in neuronalen Stammzellen [119]. Darüber hinaus wurden Organoide
verwendet, um die Mechanismen der Infektion mit dem Zika-Virus (ZIKV) aufzuklären [104,
123, 124], ZIKV-Infektionshemmer zu testen [125], die Wirkung von Bisphenol A auf die
Gehrinentwicklung zu untersuchen [104] und sogar um neurodegenerative Krankheiten wie die
Alzheimer-Krankheit nachzubilden [126, 127]. Daher haben sich zerebrale Organoide bereits
als sehr nützlich erwiesen, um verschiedene Fragen im Zusammenhang mit der Entwicklung
des Gehirns und den Mechanismen von Krankheiten zu verstehen.
Die derzeitigen Nachteile von Organoiden stellen die begrenzte Reifungskapazität mit un-
vollständiger Schichtung kortikaler Regionen [104], sowie Größenbeschränkungen durch das
Fehlen externer Signale und begrenzter Nährstoffversorgung dar. Darüber hinaus ist die
Mehrheit der Protokolle durch Variabilität in der Zusammensetzung gekennzeichnet, inbeson-
dere im Bezug auf das Vorkommen bestimmter Regionen, als auch durch chargenabhängige Un-
terschiede von Differenzierung zu Differenzierung [113, 128]. So zielen die jüngsten Bemühun-
gen zur Verbesserung des Organoidsystems auf eine Erhöhung der Reproduzierbarkeit [117,
129], die Erzeugung von bestimmten Hirnregionen auf kontrollierte Art und Weise, sowie die
Einführung derzeit fehlender Zelltypen wie Oligodendrozyten [130, 131] und Mikroglia [132] ab.
Weiterhin soll die Reifung durch verlängerte Kultivierungszeiten [133], die Zugabe zusätzlicher
Wachstumsfaktoren [104, 128] oder die Einführung von Blutgefäßen [134] verbessert werden,
um die Anwendungsmöglichkeiten von Organoiden zu erweitern.
Die Erforschung der frühen Gehirnentwicklung bei Menschen und Menschenaffen stellt auf-
grund ethischer und technischer Einschränkungen eine Herausforderung dar. Zerebrale
Organoide, die aus pluripotenten Stammzellen generiert werden können, bieten jedoch die
Möglichkeit, frühe Entwicklungsunterschiede zwischen diesen Arten in kontrollierten Zellkul-
turumgebungen zu modellieren. Einige Studien [20, 59] haben das Potenzial gezeigt, Unter-
schiede, die die frühe menschliche Gehirnentwicklung betreffen, zu detektieren, wie beispiel-
sweise eine höhere Aktivierung des mTOR-Signalweges in menschlichen radialen Gliazellen im





Mensch und Schimpanse haben 98,8% ihrer DNA-Sequenz gemein, jedoch sind trotz dieser
hohen Ähnlichkeit eindeutige phänotypische Unterschiede erkennbar [135]. Es wurde da-
her vermutet, dass viele Merkmale, die den Menschen vom Schimpansen unterscheiden, auf
nicht-kodierende regulatorische Sequenzunterschiede und Veränderungen in der Genexpression
zurückzuführen sind und nicht auf Sequenzunterschiede in proteinkodierenden Genen [136,
137]. Damit stellen die Untersuchung genomweiter Muster der Genexpression und regula-
torischer Signaturen vielversprechende Ansätze dar, um globale Veränderungen während der
Gehirnentwicklung und im erwachsenen Gehirn zu analysieren, die den Menschen von den
Menschenaffen unterscheiden.
Transkriptom-Sequenzierungsstudien des menschlichen Gehirns haben Veränderungen während
der pränatalen [76, 138] und postnatalen Gehirnentwicklung [138] aufgedeckt und dynamische
Genexpressionsänderungen mit einem Überschuss an Unterschieden in der pränatalen Entwick-
lung beschrieben [138]. In Studien, die postnatale Stadien der Gehirnentwicklung untersuchten,
schienen die menschlichen Entwicklungsmuster vor allem im präfrontalen Kortex [139] größere
Unterschiede aufzuweisen. Weiterhin war die Genexpression von Synapsen beim Menschen
im Vergleich zu Schimpanse und Makake durch eine zeitliche Verschiebung zu späteren En-
twicklungszeitpunkten gekennzeichnet [56]. Ebenso zeigte die Untersuchung des pränatalen
und postnatalen Makakengehirns im Vergleich zum Menschen [57] eine längere Reifung im
menschlichen Gehirn, die mit Genen verbunden war, die eine Rolle bei der Myelinisierung und
Synaptogenese spielen [140].
Die Untersuchung schichtaufgelöster Genexpressionsmuster im präfrontalen Kortex von Men-
sch, Schimpanse und Makake lieferte Hinweise darauf, dass beim Menschen häufiger Unter-
schiede auftraten, die auf eine Reorganisation der Schichtexpressionsmuster hinweisen [141].
Die Erstellung von Genkoexpressionsnetzwerken, die eine integrierte Sicht auf Genbeziehun-
gen liefern [142–145], zeigte, dass bestimmte Klassen von Transkriptionsfaktoren wie Krüppel
assoziierte-Box Zink-Fingerproteine (KRAB ZNFs) bei Genexpressionunterschieden im
präfrontalen Kortex zwischen Mensch und Schimpanse angereichert sind [143]. Zudem halfen
diese Methoden humanspezifische Genexpressionsmodule im Frontalpol [144] zu identifizieren.
In einem größeren Kontext ist es jedoch noch nicht vollständig geklärt, ob das menschliche
Gehirn einer beschleunigten Evolution unterlag, die auf einen Überschuss an Veränderungen
in der menschlichen Linie hinweist, oder ob sich die Veränderungen linear über die evolu-
tionäre Divergenzzeit anhäuften [146–150]. Darüber hinaus ist noch nicht bekannt, inwiefern
bestimmte Zelltypen einer eventuell beschleunigten Evolution unterliegen könnten.
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Unterschiede in der Genregulation
Eine Reihe von Studien untersuchte evolutionäre Veränderungen in der Genregulation wie
z.B. DNA-Methylierung, Histonmodifikationen oder der Expression regulatorischer RNAs wie
Mikro-RNAs und lncRNAs. Ein Vergleich der Histonmodifikationen zwischen Mensch, Makake
und Maus im pränatalen Gehirn ergab zum Beispiel, dass menschenspezifische Regionen mit
höherer Aktivität unter anderem mit der Zellproliferation und der extrazellulären Matrix as-
soziiert waren [151]. Eine ähnliche Studie, die im erwachsenen Gehirn von Mensch, Schim-
panse und Makake durchgeführt wurde, beschrieb einen kleinen Satz von humanspezifischen
aktiven Regionen, wobei 139 Regionen an Aktivität hinzugewannen und 45 Aktivität beim
Menschen verloren hatten [152]. Vergleichbare Ergebnisse wurden erzielt, indem aktive Tran-
skriptionsstartstellen in Neuronen des präfrontalen Kortex untersucht wurden, wobei 410 Loci
hinzugewonnen wurden und 61 Loci ihre Aktivität speziell im Menschen verloren hatten [153].
Eine kürzlich durchgeführte Studie zeigte zudem die Verwendung von iPS-Zellen von Mensch
und Schimpanse um diese zu Zellen der Neurralleiste zu differenzieren. Die Untersuchung
von epigenomischen Mustern dieser Zellen könnte Unterschiede in Schädel-und Gesichtsform
erklären, und unterstrich zudem die Anwendbarkeit von Stammzellmodellen zur Untersuchung
evolutionärer Unterschiede [154]. Regulatorische RNAs wie microRNAs [46, 139, 155] oder
lncRNAs [156] wurden bisher erst wenig im Zusammenhang mit humanspezifischen Gehirnun-
terschieden erforscht. Weiterhin könnte auch DNA-Methylierung eine Rolle bei Genexpression-
sunterschieden spielen, wie durch den Vergleich der präfrontalen Hirnrinde von Mensch und
Schimpanse untersucht wurde, die höhere Methylierung im Schimpansen zeigte [157].
Obwohl die oben genannten Studien wertvolle Ressourcen darstellen, um humanspezifische
Genexpressionsunterschiede und ihre potenziell zugrunde liegende regulatorische Logik zu
analysieren, basiert die Mehrheit auf Gesamtmessungen heterogener Gewebe. Auf diese Weise
könnten einige der beobachteten Veränderungen auf unterschiedliche Zusammensetzungen
im Gewebe zurückzuführen sein, sodass subtilere zelltypspezifische Veränderungen verdeckt
werden.
Die Bandbreite von Einzelzellmethoden
Technologische Fortschritte der letzten Jahre haben es ermöglicht, die Genexpressionsprofile
von Einzelzellen zu untersuchen [158]. Die Einzelzellanalyse ist aufgrund ihrer Fähigkeit,
komplexe Gewebezusammensetzungen aufzulösen, seltene Zelltypen zu erkennen und orthologe
Zelltypen zwischen verschiedenen Arten zu vergleichen [159] zu einer weit verbreiteten Methode
geworden.
Die ersten Einzelzell-Transkriptommethoden basierten auf der manuellen Zellisolierung und der
Generierung von Sequenzierbibliotheken in Reaktionsgefäßen mit geringem Durchsatz [158].
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Eine Erhöhung des Durchsatzes wurde durch ventilbasierte Mikrofluidikgeräte, die auf die
Trennung und Isolierung von Zellen ausgerichtet sind (Fluidigm C1-System) [160–162], durch
Zellsortierung und automatische Verarbeitung kleiner Volumina (MARS-Seq, massive parallele
RNA-Einzelzellsequenzierung) [163], sowie die Verwendung von mikrostrukturierten Platten
mit Nanowells zur Zellisolation erreicht [164]. Die Einführung von tröpfchenbasierten mikroflu-
idischen Techniken, die darauf beruhen, Tropfen als separate Reaktionsgefäße zu verwenden,
hat jedoch den Durchsatz von Einzelzellstudien erheblich verbessert, so dass es möglich wurde,
Tausende von Zellen in einem Experiment zu untersuchen [165, 166]. Zusätzliche Neuerungen,
so genannte ”Split-und-Pool”-Ansätze, haben die Anzahl der parallel untersuchbaren Zellen
noch weiter erhöht und ermöglichen z.B. die Entdeckung seltener Zelltypen [167].
Diese Einzelzell-Transkriptomtechniken hatten somit bereits einen wesentlichen Einfluss auf
die Untersuchung der Differenzierungsdynamik [161, 168], der Zellzustandsübergänge [169],
der zellulären Zusammensetzung von Geweben [170–173], zellulärer Verwandschaftsbeziehun-
gen [174, 175], sowie der Störung von zellulären Vorgängen [176, 177]. Jüngste gemeinsame
Anstrengungen haben zudem damit begonnen mittels Einzelzell-Transkriptomik, Zellen aus
allen wichtigen Organen von Mäusen [178] sowie von Menschen [179] zu untersuchen, um
Referenzkarten von Zelltypen in gesunden [163, 169, 180–184] und pathologischen Zuständen
[184–188] zu erstellen. Weiterhin wurden Zellreferenzen von häufig [189–192] und weniger
häufig verwendeten Modellorganismen erstellt [168, 193]. Darüber hinaus hat sich die Einzelzel-
lanalyse von der Untersuchung von Transkriptomen [194, 195] auf Genome, Epigenome [197,
198], Proteome, Chromosomen-Komformation [200, 201] und verschiedene Kombinationen
selbiger [202–207] ausgeweitet, was eine integrierte Sicht auf Einzelzellzustände ermöglicht.
Einzelzellaufgelöste Untersuchungen des Gehirns
In den Neurowissenschaften hat sich die Einzelzell-Transkriptomanalyse zu einer Methode von
unschätzbarem Wert entwickelt, um die Vielfalt der Gehirnzelltypen in der Maus [208–211] zu
analysieren. Darüber hinaus wurden die Methoden erweitert, um die Einzelzellsequenzierung
mit zusätzlichen Eigenschaften wie Zellmorphologie und elektrophysiologischen Eigenschaften
zu kombinieren [212, 213], sowie Genexpressionsmuster aus gefrorenem und archiviertem
Gewebe zu untersuchen [214–216]. Weiterhin wurde die Einzelzellanalyse angewendet, um
die Mechanismen des sich entwickelnden [114, 217–220] und erwachsenen [215, 218, 221] men-
schlichen Gehirns zu beleuchten, einschließlich der Charakterisierung von 3D-Zellkulturmodellen
sowohl von Menschen [20, 114, 117, 128], als auch Primaten [20, 222]. Zudem ergab ein Ver-




Zielstellung der Dissertation und Überblick
Die Verfügbarkeit von Methoden zur Modellierung der menschlichen Gehirnentwicklung in kon-
trollierten Zellkultursystemem kombiniert mit Technologien zur Untersuchung von Geweben
mittels Einzelzell-Transkriptomik, ermöglichen es, die Mechanismen zu verstehen, die der Evo-
lution und Krankheitsenstehung des menschlichen Gehirns zugrunde liegen. In dieser Ar-
beit werden von Stammzellen abgeleitete zerebrale Organoide und Einzelzell-Transkriptomik
genutzt, um humanspezifische Merkmale der Entwicklung des Kortex, sowie der Zelldiversität
im adulten präfrontalen Kortex zu erforschen. Weiterhin werden Einzelzell-Transkriptomanalysen
eingesetzt, um Zellpopulationen im Rahmen einer kortikalen Fehlbildung zu untersuchen.
Die ersten beiden Kapitel konzentrieren sich auf die Verwendung zerebraler Organoide, um die
humanspezifische Gehirnentwicklung zu verstehen. In Kapitel 1 werden zerebrale Organoide,
die aus induzierten pluripotenten Stammzellen von Mensch und Schimpanse erzeugt werden,
verwendet, um frühe Entwicklungsänderungen im Menschen nachzubilden. Hierzu werden
Einzelzell-Transkriptomanalysen verwendet, um zelltypspezifische Unterschiede zu entschlüsseln,
die möglicherweise zu menschenspezifischen Zellmerkmalen beitragen.
Kapitel 2 erweitert das in Kapitel 1 beschriebene Projekt durch die Analyse von Einzelzell-
Transkriptomen einer größeren Anzahl von Individuen, Arten, Zeitpunkten und Zellen. Dadurch
werden dynamische Unterschiede untersucht, die während der frühen Gehirnentwicklung auftreten.
Die beobachteten Genexpressionsänderungen werden weiterhin mit Unterschieden regulatorischer
Signaturen mittels Chromatinzugänglichkeit integriert und ihre Konsistenz anhand von Anal-
ysen von Einzelzellkern-Transkriptomdaten von adultem Hirngewebe von Menschen, Schim-
pansen/Bonobos und Makaken getestet.
In Kapitel 3 werden zerebrale Organoide genutzt, um veränderte Zellzustände, die während
einer kortikalen Fehlbildung, auftreten, zu verstehen. Zerebrale Organoide werden hierbei
aus patientenabgeleiteten iPS-Zellen generiert und genutzt um periventrikuläre Heterotopie
(PH) zu modellieren, die durch Mutationen im Cadherin-Rezeptor-Ligandenpaar DCHS1-
FAT4 verursacht werden. Einzelzell-RNA-Sequenzierung wird hierbei angewendent, um anor-
male Genexpressionsprogramme auf der Ebene spezifischer Zelltypen in Organoiden sowie 2D-




Unterschiede und Gemeinsamkeiten zwischen neuronalen
Vorläuferzellen von Menschen und Schimpansen während der
Entwicklung der Großhirnrinde
Der menschliche Neokortex veränderte sich während der Evolution stark, was vor allem in
einer Größenzunahme zu beobachten ist, auf die höhere kognitive Fähigkeiten beim Men-
schen zurückzuführen sind [223]. Frühe Entwicklungsunterschiede zwischen den Arten tra-
gen wahrscheinlich zu den Unterschieden bei, die zwischen Menschen und unseren nächsten
lebenden Verwandten, den Schimpansen, beobachtet werden können. In dieser Studie wur-
den zerebrale Organoide eingesetzt, um die frühe Entwicklung zwischen Mensch und Schim-
panse unter Verwendung histologischer Methoden, zeitaufgelöster Bildgebung (durchgeführt
von Mitgliedern der Gruppe von Wieland Huttner) und der Einzelzell-RNA-Sequenzierung zu
untersuchen, um zelluläre und molekulare Veränderungen zu identifizieren, die möglicherweise
zu evolutionären Unterschieden beitragen.
Um molekulare Unterschiede zwischen den Spezies auf der Ebene von Zelltypen zu entschlüsseln,
wurden menschliche und Schimpansen-Organoide mit Hilfe von Einzelzell-RNA-Sequenzierung
untersucht. Einzelzell-Transkriptomanalysen von Schimpansen-Organoiden zeigten Gruppen
kortikaler neuronaler Voläuferzellen und Neurone, die entlanger einer Pseudozeitache angeord-
net werden konnten, in ähnlicher Weise wie bei Einzellzelltranskriptomen von menschlichen
fetalen und Organoidzellen [114]. Dies deutete darauf hin, dass die Differenzierung von neu-
ronalen Vorläuferzellen zu Neuronen zwischen den Spezies konserviert ist und in Organoiden
nachgebildet werden kann.
Differentielle Genexpressionsanalyse zeigte, dass die meisten zelltypspezifischen Gene zwischen
den Arten nicht unterschiedlich exprimiert waren, was wiederum bestätigt, dass die meisten
Merkmale konserviert sind. Durch den direkten Vergleich von apikalen Vorläuferzellen und
Neuronen zwischen Mensch und Schimpanse wurden für beide Gruppen ähnlich viele unter-
schiedlich hochexprimierte Gene detektiert. Funktionelle Kategorien für diese Gene umfassten
Membran-und interzelluläre Signaltransduktion. Interessante Gene mit höherer Expression im
Menschen waren Integrin beta 8 (ITGB8) in Vorläuferzellen und der Insulinrezeptor (INSR) in
Neuronen.
Darüber hinaus ergab die Untersuchung der Histologie in menschlichen und Schimpansen-
Organoiden eine sehr ähnliche Organisation von Keimzonen, die an den sich entwickelnden
fetalen Kortex erinnerten, mit einer sehr ähnlichen Anzahl von Zelltypen und proliferierenden
Zellen. Darüber hinaus zeigten zeitlich aufgelöste Messungen des Zellzyklus eine interessante
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Verlängerung der Metaphase beim Menschen während der Mitose, insbesondere bei apikalen
Vorläuferzellen in frühen Stadien (Tag 30) der Organoid-Entwicklung.
Diese Arbeit unterstreicht somit die Anwendbarkeit von zerebralen Organoiden als nützliches
in vitro Modell zur Untersuchung der vergleichenden Gehirnentwicklung und ergänzt damit
frühere 2D-Studien zum Vergleich von Arten [59].
Kapitel 2
Einzelzell-Genomik-Atlas von Organoiden zeigt humanspezifische
Merkmale der Gehirnentwicklung auf
Frühere Studien, in denen zerebrale Organoide zur Untersuchung der evolutionären Entwick-
lung verwendet wurden, verwendeten Einzelzell-Transkriptomik zur Entschlüsselung zelltyp-
spezifischer Veränderungen, jedoch mit geringerem Durchsatz und mit weniger Zeitpunkten,
um stadienspezifische Genexpressionveränderungen zu untersuchen [20, 222]. Darüber hinaus
fokussierten sich aktuelle vergleichende Studien zur frühen Entwicklung auf Messungen der
Genexpression, sodass die zugrunde liegenden Regulationsmechanismen noch immer unklar
sind.
In dieser Studie wurden Tausende von Zellen unter Verwendung tröpfchenbasierter Mikrofluidik
aus zerebralen Organoiden untersucht, die aus iPS-Zellen und embryonalen Stammzellen von
Menschen, Schimpansen und Makaken generiert wurden [224]. Durch die Analyse der Entwick-
lung von menschlichen und Schimpansenzellen vom Stadium der Pluripotenz bis zu 4 Monate
alten Organoiden konnte eine Trajektorie rekonstruiert werden, in der Zellen verschiedene Sta-
dien wie Neuroektoderm, Neuroepithelium und neuronale Vorläuferzustände durchlaufen, bis
sie sich in verschiedene regionale Identitäten wie dorsales und ventrales Vorderhirn, Mittel-
hirn und Hinterhirn diversifizieren. Durch die Erweiterung des Datensatzes 2 Monate alter
menschlicher Organoide auf 7 Zelllinien konnten unterschiedliche Tendenzen dieser Linien zur
Ausbildung regionaler Identitäten aufgedeckt werden, was ein ähnliches Ergebnis zu früheren
Untersuchungen darstellt [113]. Genexpressionsmuster von Zellen aus der gleichen Region
wiesen eine hohe Korrelation auf, was darauf hindeutete, dass Genexpressionsprogramme in-
nerhalb einer Region reproduzierbar waren.
Die Rekonstruktion der gleichen Trajektorie anhand von Signaturen zugänglichen Chromatins
[197] zeigte zeitlich dynamische Veränderungen in regulatorischen Mustern. Um artspezifische
Unterschiede aufzudecken, wurden pseudozeitbasierte Trajektorien [225] der Genexpression
von Mensch und Schimpanse aneinander ausgerichtet. Diese Analyse identifizierte Zellen im
Schimpansen, die aufgrund höherer Reife nicht zu einem menschlichen Äquivalent passten,
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was auf zeitliche Unterschiede in der Entwicklung zwischen den Arten hinweist [55, 59, 222].
Während sich bei Schimpansen bereits Neuronen der oberen Schichten gebildet hatten, wurden
nur sehr wenige dieser Zellen bei menschlichen Organoiden zu den entsprechenden Zeitpunkten
beobachtet. Darüber hinaus schienen Schimpansen-und Makakenneuronen basierend auf Gen-
expressionsmustern im Zusammenhang mit der Neuronenreifung reifer zu sein als menschliche
Neuronen.
Durch die Anordnung von Zellen auf einem Pseudozeitpfad [225] und die Ausrichtung der Tra-
jektorien von 2 Monate alten Organoiden, die aus menschlichen, Schimpansen-und Makaken-
zellen erzeugt wurden, konnten zelltypspezifische Muster der differentiellen Genexpression iden-
tifiziert und mit Signaturen unterschiedlicher Chromatinzugänglichkeit integriert werden. Dies
ergab, dass Cadherin 7 (CDH7), sowie eine nahegelegene regulatorische Region, interessante
Kandidaten für Folgeuntersuchungen darstellen. Die regulatorische Region überschnitt sich
zudem mit einer im Menschen beschleunigt evolvierten Region und einzelnen, im Menschen
fixierten Nukleotidänderungen, was deren evolutionäre Relevanz unterstreicht.
Um zu analysieren, welche artspezifischen Genexpressionsänderungen im erwachsenen Gehirn
bestehen bleiben, wurden einzelne Zellkerne aus gefrorenem präfrontalem Kortexgewebe von
Menschen, Schimpansen/Bonobos und Makaken untersucht. Das Gewebe wurde dabei von
apikalen zu basalen Positionen geschnitten und ermöglichte so eine räumlich aufgelöste Rekon-
struktion der Genexpressionssignaturen. Im Allgemeinen zeigten Gliazellen, insbesondere As-
trozyten, den höchsten Grad an Genexpressionsänderungen und eine geringere Konservierung
im Vergleich zu Neuronen. Einige Unterschiede in der Genexpression, wie beispielsweise das
Gen COL6A1, wurden in Organoiden und im erwachsenen Gehirn gefunden, was die Relevanz
von Organoiden für die Untersuchung von Veränderungen unterstreicht, die möglicherweise
noch spätere Entwicklungsphasen beeinflussen. Andere Gene jedoch waren ausschließlich im
sich entwickelnden oder adulten Gehirn unterschiedlich exprimiert, was die Vorteile komple-
mentärer Ansätze unter Anwendung von Organoiden und adultem Gewebe zur Analyse von
Gehirnunterschieden hervorhebt.
Zusammenfassend stellt diese Studie einen vergleichenden zeitlich ausgelösten Atlas von Genex-
pressions-und Chromatinzugänglichkeitsunterschieden während der frühen Gehirnentwicklung
von Mensch, Schimpanse und Makake dar. Zudem verknüpft sie Unterschiede im Organoid mit
Artenunterschieden im erwachsenen Gehirn und stellt somit eine wertvolle Ressource für andere
Neurowissenschaftler dar. Die Studie erweitert und ergänzt neuere Untersuchungen mit Schw-
erpunkt auf dem menschlichen Gehirn [116, 215, 219–221] und vergleichende Einzelzellstudien
mit geringem Durchsatz under Anwendung von Organoiden [20, 222]. Die zukünftige funk-
tionelle Untersuchung der hier identifizierten Kandidaten hat hohes Potenzial, die multidimen-




Verändertes neuronales Migrationsverhalten in menschlichen
zerebralen Organoiden von Individuen mit neuronaler Heterotopie
Die Gehirnentwicklung ist ein fein orchestrierter Prozess, bei dem Abweichungen zu unter-
schiedlichen Phänotypen und Erkrankungen führen. So kann beispielsweise ein fehlerhaftes
Verhalten neuronaler Vorläuferzellen oder Neuronen zu verschiedenen Missbildungen des Kor-
tex führen, einschließlich Anomalien in der Hirngröße, Kortexfaltung und Fehllokalisierung von
Neuronen [17]. Periventrikuläre neuronale Heterotopie (PH) ist eine kortikale Fehlbildung,
die durch atypische Positionen von Neuronen entlang der Ventrikel im Gehirn gekennzeichnet
ist und entweder Ansammlungen oder Schichten von falsch platzierten Neuronen bildet. Der
anormale Phänotyp beschränkt sich jedoch nur auf eine Untergruppe von Neuronen, die an
den Ventrikeln verbleiben und sich nicht richtig in den Kortex integrieren, die Mehrheit der
Neuronen hingegen verhält sich normal. Patienten, die diese Pathologie aufweisen, leiden oft
an Epilepsie und geistigen Einschränkungen [79, 226].
Untersuchungen der genetischen Grundlagen von PH durch Sequenzierung von betroffenen In-
dividuen identifizierte DCHS1 und FAT4, ein Cadherin-Rezeptor-Ligandenpaar als krankheit-
sauslösende Gene. Der Effekt dieser Gene wurde in Mäusen untersucht, um Licht in die
molekularen Mechanismen der Krankheitenstehung zu bringen [79, 227]. Mäuse waren je-
doch nicht in der Lage den beim Menschen beobachteten Phänotyp vollständig abzubilden,
möglicherweise aufgrund der Unterschiede im genetischen Hintergrund im Vergleich zum Men-
schen und aufgrund der Tatsache, dass Mäuse mit ihrem glatten Kortex ein unzureichendes
Modell für den menschlichen gefalteten Kortex darstellen.
Die Verfügbarkeit von iPS-Zellen, die aus Blutzellen oder Hautzellen umprogrammiert wurden,
öffnete die Tür zur Rekapitulation von Krankheitsmechanismen unter Verwendung patienten-
spezifischer Zellen [80, 81]. Neue Werkzeuge zur Modifikation des Genoms wie CRIPSR/Cas9
ermöglichen zudem das Einbringen patientenspezifischer Mutationen in Zelllinien mit dem
gleichen genetischen Hintergrund (isogen). Um PH zu untersuchen, wurden iPS-Zellen aus
Patientenhautzellen, die die Krankheitsmutationen tragen mittels Reprogrammierung, sowie
isogene FAT4 und DCHS1 Knock-Out und Kontrollstammzellen mit CRISPR/Cas9 Genomedi-
tierung erzeugt. Diese Zellen wurden zur Kultivierung zerebraler Organoide verwendet, welche
sich bereits bei der Untersuchung von Entwicklungserkrankungen des Gehirns wie Mikrozephalie
und Lissenzephalie als nützlich erwiesen haben [92, 119].
Die histologische und zelluläre Charakterisierung von Organoiden, die aus patientenabgeleiteten
und isogenen Knock-Out-iPS-Linien hergestellt wurden (durchgeführt von Kooperationspart-
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nern in der Gruppe von Silvia Cappello), zeigte tatsächlich Phänotypen, die an die Erkrankung
erinnern. Beispielsweise sammelten sich Neuronen an den Ventrikeln an. Außerdem wiesen die
Keimzonen eine gestörte Organisation auf. Diese Beobachtungen wurden durch morphologis-
che Veränderungen neuronaler Vorläuferzellen in den Organoiden und vorzeitiges Ablösen von
der apikalen Membran, was zu differenzierteren Neuronen führte, weiter bestätigt. Darüber
hinaus wurde das dynamische Migrationsverhalten von Neuronen in Organoiden verfolgt, bei
denen DCHS1 und FAT4 heruntergeregelt wurde, sowe in 2D-Kulturen von patientenabgeleit-
eten Zellen. Dabei wurde eine Untergruppe von Neuronen identifiziert, die einen veränderten
migratorischen Phänotyp aufwies.
Um die molekularen Mechanismen und Genregulationsnetzwerke, die den oben beschriebenen
Beobachtungen zugrunde liegen könnten, zu analysieren, wurden Einzelzell-RNA-Sequenzier-
ungen von zerebralen Organoiden von Patienten und Kontrollen durchgeführt. Obwohl die
Hauptmerkmale neuronaler Vorläuferzellen und Neuronen von Kontroll-und Patienten-Organoiden
ähnlich waren, zeigten mutierte Zellen einen spezifischen Satz dysregulierter Gene, darunter
RND3, dessen Rolle bei der Neurogenese und neuronalen Migration bereits zuvor [228] beschrieben
wurde. Die computergestützte Rekonstruktion des Differenzierungsverlaufs zeigte zudem eine
Untergruppe von Neuronen in den mutierten Organoiden mit hochregulierten Genexpression-
smustern. Diese waren mit der Orientierung von Axonen, neuronaler Migration und Muster-
bildung verknüft. Zudem exprimierten sie Gene wie ROBO3 und CNTN2, die spezifisch für
diese Untergruppe waren. Im Gegensatz dazu waren in dieser Subpopulation beispielsweise
Gene herunterreguliert, die mit Synapsenbildung und Zytoskelett assoziiert waren. Interessan-
terweise wurde eine ähnliche Untergruppe, die viele mutierte Neurone aufweist, in Neuronen
gefunden, die in einem 2D-Kultursystem differenziert wurden. Dies bestätigte Ergebnisse der
histologischen und zellulären Analysen, die eine Untergruppe von Zellen mit verändertem Mi-
grationsverhalten zeigten.
Warum nur eine Untergruppe von Neuronen unterschiedliche Migrationsphänotypen zeigt, ob-
wohl sie die gleichen Mutationen aufweiset, muss noch in weiterführenden Studien untersucht
werden. Dennoch birgt die Kombination von zerebralen Organoiden und Einzelzell-RNA-
Sequenzierung großes Potenzial, die Mechanismen von Entwicklungsstörungen wie Heterotopie
zu entschlüsseln. Die Erkenntnisse aus diesen Studien könnten letztendlich zu zielgerichteten
Behandlungsstrategien für fehlorganisierte neuronale Schaltkreise führen.
Schlussfolgerungen und Ausblick
Einzelzell-Sequenzierungstechnologien und zerebrale Organoide stellen einflussreiche technol-
ogische Innovationen der letzten Jahre dar und wurden in dieser Arbeit verwendet, um Auf-
schluss über humanspezifische zelltypaufgelöste Unterschiede zu geben. Durch den Vergleich
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dieser Unterschiede mit Einzelzellkerndaten aus gefrorenem adultem Gewebe gelang es, Merk-
male zu definieren, die spezifisch für das sich entwickelnde Gehirn sind, sowie Veränderungen,
die noch im erwachsenen Gehirn fortbestehen. Darüber hinaus wurde die Einzelzell-RNA-
Sequenzierung bei patientenabgeleiteten zerebralen Organoiden angewendet, um die Genex-
pressionsprogramme der neuronalen Heterotopie, einer kortikalen Fehlbildung, zu analysieren.
Deren Phänotyp war bisher nicht vollständig im Mausmodell nachstellbar [79]. Diese Stu-
dien unterstreichen somit die Relevanz der Verwendung von Organoiden zur Untersuchung der
vergleichenden und anormalen Gehirnentwicklung, integriert mit dem Nutzen der Einzelzellse-
quenzierung zur Analyse von Genexpressionsprogrammen mit hoher Auflösung.
Die Untersuchung von Primatenorganoiden über einen Zeitraum von pluripotenten Stam-
mzellen bis zu 4 Monaten hat zeitliche Unterschiede in der Neuronenreifung aufgezeigt. Die
Analyse älterer Organoide könnte über zusätzliche Unterschiede in der Neuronenreifung sowie
dem Zeitpunkt der Gliogenese aufklären, da Astrozyten erst im Spätstadium der Organoiden-
twicklung beobachtet wurden. Ständige Optimierungen der Organoid-Kultivierungsprotokolle,
die zu einer verbesserten Reifung führen, könnten bei der Untersuchung dieser späteren En-
twicklungsstadien helfen und wären zudem nützlich, um pathogene Prozesse reiferer Zelltypen
beim Studium kortikaler Fehlbildungen zu identifizieren.
Neuere Studien haben zudem elektrische Aktivität in Organoiden gemessen [118, 128] und
der Vergleich dieser Merkmale zwischen verschiedenen Primaten und während längerer Kul-
tivierungsperioden könnte zu Erkenntnissen über elektrophysiologische Unterschiede während
der frühen Gehirnentwicklung, sowie über mögliche zeitliche Unterschiede im Aufbau neu-
ronaler Netzwerke informieren. Da kortikale Fehlbildungen oft von epileptischen Anfällen be-
gleitet werden, was auf eine veränderte elektrische Aktivität in neuronalen Subpopulationen
hindeutet, stellt die Messung der elektrischen Aktivität in patientenabgeleiteten Organoiden
eine sinnvolle Ergänzung dar, um zu untersuchen, wie gut sich Krankheitsbilder in vitro nach-
bilden lassen [118, 128].
Die Untersuchung der Transkriptome, sowie der Chromatinzugänglichkeit in Primatenorganoiden
hat eine Reihe von zelltypspezifischen Kandidatengenen und regulatorischen Regionen ergeben,
die wahrscheinlich eine Rolle bei der menschenspezifischen Entwicklungsdivergenz im Vergleich
zum Schimpansen spielen und einige dieser Unterschiede bestehen sogar bis ins Erwachsenenal-
ter. Gene mit Expressionsänderungen könnten in Organoiden weiter analysiert werden, indem
Einzelzell-Knock-Out-Screens mit hohem Durchsatz verwendet werden, um die Funktion der
Gene in genregulatorischen Netzwerken zu analysieren [177]. Dies würde es ermöglichen,
Genexpressionsänderungen zu identifizieren, die eine Rolle in der Entwicklung spielen und
Kandidaten einzugrenzen, die durch Knock-Outs mittels CRISPR/Cas9 Genomveränderung,
oder Überexpression einzelner Gene, genauer untersucht werden könnten. Darüber hinaus
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überschneiden sich einige Gene mit artspezifischen Expressionsunterschieden und regulatorischen
Unterschieden mit interessanten evolutionären Signaturen wie Einzelnukleotidvarianten oder
beschleunigt evolvierenden Regionen im Menschen. Fortschritte bei Einzelzell-Assays ermöglichen
es, Gruppen von regulatorischen Elementen im hohen Durchsatz auf Einzelzellebene [229]
in Organoiden zu testen. Darüber hinaus würde die Genomeditierung auch die Änderung
humanspezifischer Einzelnukleotidvarianten zurück in den Schimpansenzustand ermöglichen,
was ein interessanter Ansatz für CDH7 sein könnte, das humanspezifische Einzelnukleotidvari-
anten in seiner regulatorischen Region zeigt. Darüber hinaus ist es in menschlichen Neuronen
im Vergleich zu Schimpansen höher exprimiert und spielt somit möglicherweise eine Rolle bei
den beobachteten Unterschieden in der Neuronenreifung.
Zellen durchlaufen während der Entwicklung komplexe Entwicklungstrajektorien, die durch
die Verwendung von Methoden zur Abstammung dieser Zellen, sogenanntes lineage tracing
mit Einzelzellauflösung [174, 175, 230, 231] untersucht werden könnten. Der Vergleich von
menschlichen und Schimpansen-Organoiden mit dieser Methode bietet z.B. die Möglichkeit,
Unterschiede in den Abstammungslinien aufzudecken, die Vorläuferzellen durchlaufen, um zu
Neuronen und Gliazellen zu werden. Dies ist besonders interessant, da zeitliche Unterschiede
in der neuronalen Entwicklung zwischen Mensch und Schimpanse in Organoiden gefunden
wurden. Darüber hinaus wurden beim Vergleich von patientenabgeleiteten und gesunden
Organoiden zur Untersuchung der periventrikulären Heterotopie veränderte Gruppen neu-
ronaler Vorläuferzellen und Neuronen identifiziert, jedoch durch computergestützte Rekon-
struktion der Differenzierung der Zellen. Lineage tracing würde es ermölichen die Verwand-
schaftsbeziehungen der Zellen auf direkterem Wege zu rekonstruieren. Dadurch könnte der
Zusammenhang von Zellen, die sich anders verhalten und denen, die einen normalen Phänotyp
trotz gleicher genetischer Ausstattung aufzeigen, näher beleuchtet werden, um die Mechanis-
men der Erkrankung besser zu verstehen.
Weiterhin können neue Erweiterungen von Einzelzellsequenzierungsmethoden zur Analyse zu-
sätzlicher Modalitäten wie lncRNAs, microRNAs [232], Chromosomenkonformation und Methy-
lierung [207] zu einem vielschichtigen Blick auf Zelltypeigenschaften und deren Vielfalt [205,
206] sowohl im erwachsenen Gehirn als auch in Organoiden verschiedener Spezies oder von
Patienten abgeleiteten Organoiden beitragen. Dies würde eine detaillierte Sicht auf die regu-
latorische Mechanismen von zelltypspezifischen Unterschieden im Kontext von Evolution und
Erkrankungen liefern.
Die Einzelzell-Transkriptomik liefert eine hochaufgelöste Beschreibung von Zellzuständen und
Zelltypen, allerdings geht der räumliche Zusammenhang bei der Dissoziation von Gewebe
für diese Experimente verloren. Die Validierung dieser Expressionsmuster im Gewebe unter
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Verwendung quantitativer räumlich aufgelöster FISH-Methoden (Fluoreszenz in situ Hybri-
disierung) wie z.B. mittels Einzelmolekül-FISH stellt eine interessante Erweiterung dar [233].
Darüber hinaus wurden in den letzten Jahren räumlich aufgelöste Transkriptommethoden
eingesetzt, die eine quantitative Visualisierung von Hunderten bis Tausenden von Transkripten
in einzelnen Zellen ermöglichen [171, 173, 234]. Dies würde die Integration von Morphologie,
sowie von zelltypspezifischen Hochdurchsatz-Genexpressionsprofilen ermöglichen.
In den hier vorgestellten Studien wurden hauptsächlich Menschen, Schimpansen, Bonobos und
Makaken studiert, um Artenunterschiede auf der Transkriptomebene zu identifizieren. Die
Untersuchung zusätzlicher Arten wie Gorilla, Orang-Utan oder Krallenäffchen, und weiterer
Individuen der hier untersuchten Arten würde die Möglichkeit bieten, artspezifische Zelltypun-
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Felipe Mora-Bermúdez1†, Farhath Badsha1†, Sabina Kanton2†, J Gray Camp2†, Benjamin
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Human neocortex expansion likely contributed to the remarkable cognitive abilities of humans.
This expansion is thought to primarily reflect differences in proliferation versus differentiation
of neural progenitors during cortical development. Here, we have searched for such differences
by analysing cerebral organoids from human and chimpanzees using immunohistofluorescence,
live imaging, and single-cell transcriptomics. We find that the cytoarchitecture, cell type com-
position, and neurogenic gene expression programs of humans and chimpanzees are remarkably
similar. Notably, however, live imaging of apical progenitor mitosis uncovered a lengthening of
prometaphase-metaphase in humans compared to chimpanzees that is specific to proliferating
progenitors and not observed in non-neural cells. Consistent with this, the small set of genes
more highly expressed in human apical progenitors points to increased proliferative capacity,
and the proportion of neurogenic basal progenitors is lower in humans. These subtle differences
in cortical progenitors between humans and chimpanzees may have consequences for human
neocortex evolution.
Introduction
The expansion of the neocortex during primate evolution is thought to contribute to the
higher cognitive capacity of humans compared to our closest living relatives, the great apes,
and notably the chimpanzees [23, 235, 236]. Neocortex expansion in humans relative to
chimpanzees involves an increase in the number of cortical neurons generated during fetal
development [237–240]. This reflects primarily a greater and prolonged proliferative capacity
of human neural stem and progenitor cells (NSPCs) within the germinal zones of the developing
neocortex [241]. Unravelling differences between human and chimpanzee NSPC behaviour is
therefore a key issue, yet very little is known about such differences.
The neocortex develops from two principal germinal zones, the ventricular zone (VZ) and the
subventricular zone (SVZ) [242]. In primates developing a folded (gyrencephalic) neocortex,
and notably in humans, an inner SVZ (iSVZ) and an outer (oSVZ) can be distinguished [24,
243]. Correspondingly, the VZ and SVZ harbour the cell bodies of two principal classes of
NSPCs, called apical progenitors (APs) and basal progenitors (BPs), respectively, each of
which comprise several distinct NSPC types [5, 237, 240, 244]. APs (neuroepithelial cells,
apical radial glia, and apical intermediate progenitors) divide at the ventricular surface, keep
ventricular contact and exhibit apical cell polarity, whereas BPs (basal (or outer) radial glia
and basal intermediate progenitors) lack this contact and type of cell polarity [5].
Studies dissecting the switch between NSPC proliferation and differentiation have demon-
strated that a central aspect of the cell division process, the orientation of the mitotic spindle,
has a pivotal role, particularly in the case of APs [245–248]. The orientation of the spindle
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relative to the apical-basal axis of cell polarity in mitotic apical radial glia, the major cortical
neural stem cells [244, 249], can determine whether their division is symmetric or asymmetric,
and whether it is proliferative or neurogenic, with regard to their progeny [245–248]. Com-
paring spindle orientation in mitotic APs may therefore provide insight into the cell biological
basis underlying the differences between humans and chimpanzees in NSPC proliferation versus
differentiation during neocortex development.
Protocols to generate structured cerebral tissue (cerebral organoids) from pluripotent stem
cells in vitro constitute a major advance for studying neocortex development, in particular
with regard to humans and non-human primates where fetal brain tissue is hard or impossible
to obtain and manipulate [92, 93, 104, 122, 250]. Human cerebral organoids form a variety
of tissues that resemble specific brain regions, including the cerebral cortex, ventral forebrain,
midbrain-hindbrain boundary, hippocampus, and retina. Moreover, their cerebral cortex-like
regions exhibit distinct germinal zones, that is, a VZ containing APs and an SVZ contain-
ing BPs, as well as basal-most neuronal layers. Cerebral organoid APs include apical radial
glia-like NSPCs that contact a ventricle-like lumen, express radial glia marker genes, undergo
interkinetic nuclear migration, and divide at the apical surface, similar to their in vivo coun-
terparts, and cerebral organoid BPs comprise both basal radial glia-like and basal intermediate
progenitor-like NSPCs [92]. Finally, we have previously shown by single-cell RNA sequenc-
ing that the gene expression programs controlling neocortex development in human cerebral
organoids are remarkably similar to those in the developing fetal tissue [114]. Together, these
findings suggest that cerebral organoids constitute a valid system to explore potential differ-
ences in NSPC proliferation versus differentiation between humans and chimpanzees [59], in
particular with regard to spindle orientation in mitotic APs.
Here, we have generated cerebral organoids from chimpanzee-derived induced pluripotent stem
cells (iPSCs), and used single-cell transcriptomics, immunohistofluorescence and live imaging
to compare relevant features of chimpanzee NSPCs to human NSPCs in cerebral organoids and
fetal neocortex. While most NSPC characteristics are found to be similar, we show that the
prometaphase-metaphase in mitotic APs is longer in humans than in chimpanzees, indicating
that a fundamental difference exists in the regulation of mitosis during neocortex development
between the two species. Our data also provide a resource for further studies on human
and chimpanzee differences in cortical development, and demonstrate the usability of cerebral




Chimpanzee cerebral organoids recapitulate cortex development
We generated cerebral organoids from iPSCs derived from chimpanzee fibroblasts and lympho-
cytes (Figure 1A left, Figure 1—figure supplement 1). These chimpanzee cerebral organoids
formed complex tissue structures that resembled the developing primate brain (Figure 1A
right), as reported previously for human cerebral organoids [92]. Similar to human iPSC-
derived cerebral organoids ([114], Figure 1B,C right), within the chimpanzee organoids grown
for 52 days (D52), we observed cortex-like regions (Figure 1A right) with PAX6-positive APs
(such as radial glia) residing predominantly in the apical-most zone facing a ventricular lumen
(Figure 1B left), similar to the ventricular zone (VZ) of developing primate neocortex at an
early-mid stage of neurogenesis. Consistent with this, cells immunoreactive for the deep-layer
neuron marker CTIP2 were observed in the basal region of the developing cortical wall (Figure
1B left), corresponding to an early cortical plate. TBR2 (also known as EOMES) positive
BPs (presumably mostly basal intermediate progenitors) were concentrated in a zone between
the PAX6+ progenitors and the CTIP2+ neurons, corresponding to the subventricular zone
(SVZ). In the context of the time-lapse live imaging of apical mitoses described below, we
observed apically directed nuclear migration prior to, and basally directed nuclear migration
after, mitosis, consistent with the existence of interkinetic nuclear migration. Our results sug-
gest that chimpanzee cerebral organoids recapitulate important aspects of fetal chimpanzee
brain development and allow comparisons with cerebral cortex development in human cerebral
organoids and fetal neocortex.
We next compared the proportion of various NSPC types, as revealed by expression of PAX6
and/or TBR2, and neurons at a very early (D28) and a mid-neurogenic (D52-D54) stage
between human and chimpanzee cerebral organoid cortices (Figure 2). In both species, we
observed a decrease in PAX6+TBR2– apically located NSPCs (presumably proliferating APs)
from D28 to D52, concomitant with an increase in PAX6+TBR2+ and PAX6–TBR2+ basally
located NSPCs (presumably neurogenic BPs) (Figure 2A,B). Notably, whereas no significant
differences were observed at D28, at D52-D54, the proportion of PAX6+TBR2+ NSPCs in
the chimpanzee organoids was nearly twice that in the human organoids, and the proportion of
PAX6+TBR2– NSPCs was correspondingly lower, whereas no significant difference between
human and chimpanzee was observed for PAX6–TBR2+ NSPCs (Figure 2B). In line with
what would be expected with regard to neuron production, the proportion of PAX6–TBR2–
cells, located in the basal-most zones of the developing cortical wall, was very low at D28 but
increased by D52-D54 to about a third of the total cells for both, human and chimpanzee
cerebral organoids (Figure 2B). Immunostaining for CTIP2 corroborated the neuronal identity
of these cells (data not shown).
47
CHAPTER 1
Consistent with the observation that the total proportion of NSPCs relative to neurons was
virtu- ally identical in human and chimpanzee organoids (Figure 2B), the abundance of cycling
cells, as revealed by KI67 immunostaining, was essentially similar (Figure 2C,D). We conclude
that at the two stages studied, there are – with the exception of the PAX6+TBR2+ NSPCs
– no major differences between human and chimpanzee cerebral cortex developing in organoid
culture with regard to the types of NSPCs and their abundance, or neuron output.
Cell composition and lineage relationships in chimpanzee cerebral organoids
To survey the cellular composition and cell type-specific transcriptomes of the chimpanzee
organoids, we analysed 344 single cell transcriptomes from 7 organoids ranging in age from
45 to 80 days (Figure 1D, Figure 1—source data 1). We combined all transcriptomes and
identified the genes most informative for defining cell populations by principal component
analysis (PCA) (Figure 1—source data 2). Using these genes, we used tSNE analysis to
cluster cells into transcriptionally distinct groups representing cerebral cortex, hindbrain, ventral
midbrain and peripheral mesenchyme (Figure 1—figure supplement 2). These groups are
similar to those identified in human cerebral organoids [114]. We identified 178 cortex-like
cells based on strong expression of canonical NSPC and neuron marker genes (i.e., NSPCs and
neurons: FOXG1, NFIA, NFIB; NSPCs: PAX6, SOX2, GLI3; neurons: NEUROD6) and the
lack of expression of the ventral and medial telencephalic markers OTX2 and RSPO2 (Figure
1—figure supplement 2).
We sub-classified the 178 cerebral cortex-like cells based on the correlation between their
transcriptomes and the bulk transcriptomes of laser-capture microdissected VZ, iSVZ, oSVZ,
and cortical plate of fetal human neocortex (GSE38805, [31]). We found that groups of cells
correlated best with one of the four zones, suggesting that the range of cell types present in
the human fetal and organoid cerebral cortex are represented in our chimpanzee data (Figure
1E). Consistent with this, each chimpanzee cell represents a cell state on a continuum from
NPSCs to neurons based on gene expression signatures extracted from fetal human cerebral
cortex transcriptomes (Figure 1F, Figure 1—figure supplement 3) [114].
We next classified the chimpanzee cerebral cortex cells by determining the fetal cell type
with which each cell most strongly correlates, resulting in 73 APs, 25 BPs, and 80 neurons.
Analysis of known cell type markers revealed expression patterns consistent with what has
been observed in human organoid and fetal cerebral cortex (Figure 1G) [114]. Though this
classification is convenient to describe the cell types present in the chimpanzee organoid, we
note that many of the cells can be described as intermediates between APs, BPs, and different
stages of neuron maturation. We inferred lineage relationships among the chimpanzee cerebral
cortex in an adjacency network based on pairwise correlations between cells (Figure 1H),
revealing a structured topology where VZ-APs connect to cortical plate neurons through SVZ-
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Figure 1: Chimpanzee cerebral organoids recapitulate cortex development. (A) Bright-field
image showing a representative chimpanzee organoid (Sandra A, left) and a cryosection from a chim-
panzee organoid (PR818-5) immunostained for PAX6 (magenta) and Ctip2 (green) combined with
DAPI staining (blue) (right) at day 52. Scale bars, 200 µm. (B, C) Cryosections of cortical regions
from chimpanzee (Sandra A) and human (SC102A-1) organoids at day 52 immunostained for PAX6
(magenta), Ctip2 (B, green) and TBR2 (C, green), without (B) and with (C) DAPI staining (blue).
Asterisks, ventricular lumen; scale bars, 50 µm. (D) Cartoon showing NSPC types (APs, BPs) and
neurons enriched in zones within the neocortex at mid-neurogenesis. CP, cortical plate; N, neuron.
(E) Heatmap showing normalized correlation (Z-score) of single-cell transcriptomes from chimpanzee
cerebral organoid cortex with bulk RNA-seq data from laser-microdissected zones [31] from 13 wpc
human neocortex. CP, cortical plate. (F) Scatterplot showing NSPC and neuronal signature scores
derived from analysis of fetal cerebral cortex single-cell transcriptomes (Figure 1—figure supplement
1) calculated for each chimpanzee cerebral organoid cortical cell. (G) Heatmap showing expression
of AP, BP, and neuron (N) marker genes. Each column represents a single cell, each row a gene.
Cell type and maximum correlation to bulk RNA-seq data from cortical zones are shown in the top
sidebar. APs and BPs were sub-classified based on G1 (light grey) or S-G2-M (dark grey) phases
of the cell cycle. (H) Lineage network based on pairwise correlations between chimpanzee cerebral
organoid cortical cells reveals a structured topology where VZ-APs connect to cortical plate (CP)
neurons (N) through SVZ-BPs. Cells are coloured based on cortical zone (top left) or cell type
assignment (bottom left). APs, BPs, and neurons were classified based on maximum correlation
with single-cell transcriptomes from the human fetal neocortex. Expression of markers PAX6, TBR2,
and MYT1L are shown to the right.
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Figure 2: Changes in the proportion of cortical NSPC subtypes and neurons during human
and chimpanzee cerebral organoid development. (A) Cryosections of cortical regions from
human and chimpanzee organoids at day 28 and day 52 immunostained for PAX6 (magenta) and
TBR2 (green) combined with DAPI staining. Scale bars; D28, 10 µm; D52, 20 µm. Insets in the D52
merge images show selected areas with PAX6+TBR2+ double-positive nuclei (arrowheads) at higher
magnification. (B) Quantification of the percentage of PAX6+TBR2-, PAX6+TBR2+, PAX6-TBR2+
and PAX6-TBR2- cortical cells in human (light grey) and chimpanzee (dark grey) organoids at D28
(n = 5 organoids, 50 µm wide field) and D52-D54 (n = 17 organoids, 100 µm wide field). Error
bars, SEM; *p<0.05, **p<0.01. (C) Cryosections of cortical regions from human and chimpanzee
organoids at D53 immunostained for KI67 (yellow) combined with DAPI staining (blue). Scale bars,
20 µm. (D) Quantification of KI67+ cells in a 100 µm wide field in human and chimpanzee organoids
at D52-D53 (n = 7). Error bars, SEM
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BPs. These lineage relationships were corroborated using a minimal spanning tree algorithm
(Figure 1—figure supplement 3G) [251]. Together, these data allowed reconstruction of the
chimpanzee organoid cerebral cortex from single-cell transcriptomes.
Chimpanzee and human gene expression in the developing cerebral cortex
To further explore transcriptome similarities and differences between chimpanzee and human
cerebral cortex cells, we compared them to the single-cell transcriptomes of 220 fetal hu-
man cortex cells (12–13 weeks post-conception (wpc), published in [114], GSE75140) and
207 cortex-like cells from human cerebral organoids (40–80 days, 155 single-cell transcrip-
tomes published in [114], GSE75140; 52 single-cell transcriptomes acquired as part of this
study) (Figure 3—source data 1). In a PCA, the first principal component (PC1) separated
NSPCs and neurons, whereas PC2 separated species (Figure 3A). Hierarchical clustering of
organoid and fetal cells showed that human and chimpanzee organoid and human fetal cells
were distributed together within the two main sub-clusters representing NSPCs and neurons
(not shown), and showed highly correlated expression of marker gene patterns (Figure 3B).
We constructed an intercellular correlation network, which revealed a VZ sub-network of human
and chimpanzees APs that link through BPs expressing iSVZ and oSVZ markers to cortical
plate neurons. Generally, APs, BPs, and neurons from human and chimpanzee intermixed,
confirming that cells in the chimpanzee organoid cortices have a zonal organization consistent
with what is observed histologically (Figure 3C,D). In conclusion, the major proportion of the
variation in these data is not between in vitro and in vivo tissues or between species, but among
cell states during neurogenesis, confirming that the major features of the genetic programs
regulating the NSPC-to-neuron lineage are conserved between human and chimpanzees, and
are recapitulated in cerebral organoids.
To identify genes differentially expressed between chimpanzee and human cortex-like cells,
we remapped all single-cell transcriptome reads to a consensus human-chimpanzee genome
and used human annotations to identify 1-to-1 orthologous genes. We then used a Bayesian
approach to identify differentially expressed genes by comparing cerebral organoid APs and neu-
rons between species (ignoring BPs due to the low number of BPs identified). We identified
297 and 279 genes that were more highly expressed in human APs and neurons, respectively,
and 283 and 314 genes that were more highly expressed in chimpanzee APs and neurons,
respectively (Figure 3E, Figure 3-source data 2). In addition to the between-species com-
parisons, we identified genes differentially expressed between human or chimpanzee APs and
neurons to identify cell-type specific genes (for human: 1328 AP-specific, 1132 neuron-specific;
for chimpanzee: 1501 AP-specific, 1166 neuron-specific). The vast majority (94%) of genes
that are AP-specific and neuron-specific in humans are not differential between human and
chimpanzee (Figure 3E, Figure 3—figure supplement 1). Of the differentially expressed genes
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Figure 3: Comparing human and chimpanzee cerebral cortex gene expression. (A) PC1 and
PC2 from PCA separated NSPCs and neurons, and human and chimpanzee, respectively. PCA was
performed on all single-cell transcriptomes using genes expressed in more than two cells and with a
non-zero variance. (B) Quasibinomial fit line of representative marker gene expression across cells
ordered by correlation with PC1. (C) Lineage network based on pairwise correlations between human
fetal, human organoid, and chimpanzee organoid cells reveals a differentiation topology from VZ APs
through BPs in iSVZ and oSVZ, to cortical plate (CP) neurons, with inter-species mixing in all stages.
(D) Lineage network (see (C)) coloured by scaled expression level of marker genes. (E) Scatterplots
showing z-scored significance estimates from single-cell differential expression (SCDE) analysis based
on Bayesian probabilistic models. Reads from human and chimpanzee were mapped to a consensus
genome, and human gene annotations were used for expression counting. The x-axis represents
SCDE between human organoid APs vs. human organoid neurons. The y-axes on the left and right
plots represent SCDE between human and chimpanzee APs and neurons (N), respectively. Genes
coloured as white triangles represent marker genes from Figure 1 and are generally not differentially
expressed between human and chimpanzee, but do vary between APs and neurons, validating the
SCDE analysis. Yellow and purple circles represent genes upregulated specifically in human APs
and neurons, respectively. Circles are sized based on differential expression between human APs
and neurons. Figure 3—figure supplement 1 shows a similar plot from the chimpanzee perspective.
(F) Gene ontology enrichments (-log10 P-value) for differentially expressed gene groups shown in
panel E. Left, human APs (yellow) and neurons (N, purple) that are not differential between human
and chimpanzee. Center, upregulated in human APs (top) or neurons (N, bottom) compared to
chimpanzee. Right, upregulated in chimpanzee APs (top) or neurons (N, bottom) from Figure
3—figure supplement 1. (G) Left, expression profiles of ITGB8 and INSR are shown from human
organoid, chimpanzee organoid, and human fetal cells ordered by correlation with PC1. Right, bulk
RNA-seq data from sorted aRG, bRG, and neurons (N) from human and mouse developing neocortex
[62] confirms enriched expression of ITGB8 and INSR in human APs and neurons, respectively. (H)
The same bulk RNA-seq data was used to confirm and estimate the origin of differential gene
expression in APs versus neurons from single-cell organoid data. Pie chart shows the proportion of
AP-enriched (yellow) or neuron-enriched (N, purple) genes that are observed in human, chimpanzee,
and mouse. Pie charts also show the proportion of genes differential between APs and neurons
that are observed only in human and chimpanzee, but not mouse (human-chimp ancestor), or genes
specific to human or chimpanzee.
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between species, we identified 93 genes that are strongly upregulated in human organoid APs
and 72 genes upregulated in human organoid neurons. Gene ontology enrichments suggest
that the proteins encoded by some of these genes are integral to cell membranes and involved
in intercellular signalling (Figure 3F, Figure 3—source data 2), for example integrin beta 8
(ITGB8) in APs and insulin receptor (INSR) in human neurons. This upregulation of ITGB8
specific to human APs and INSR specific to human neurons is also observed in comparisons
between human and mouse [62] (Figure 3G).
When comparing these results to bulk RNA-seq data from mouse APs and neurons [62], we find
that 75% of the genes with expression specific to APs or neurons in humans are also specific
to each cell type in the mouse, suggesting that these gene expression programs were already
established and likely present in the common ancestor of mouse, human and chimpanzee some
90 million years ago (Figure 3F). Notably, a similar proportion of AP- and neuron-specific genes
were gained on the chimpanzee and human branch subsequent to their separation, suggesting
that our analysis did not have a strong human bias. About 12% of these genes specific to AP
or neurons in both human and chimpanzee were not specific to these cell types in the mouse
[62], suggesting that they may be involved in developmental processes specific to the primate
cerebral cortex.
Live imaging of NSPC mitoses in human fetal neocortex and cerebral organoids
We used an established live imaging method [247] to compare dividing cortical APs, i.e. cells
undergoing mitosis at the ventricular surface (presumably mostly aRG), in slice cultures of both
11–13 wpc human fetal neocortex and human D30 cerebral organoids. We did not observe signs
of strong perturbation during live image acquisition in either system, such as mitotic arrest
(Figure 4A,C,E; see also Figure 5A–C and Video 1) or lack of nuclear movements and cell
death. Chromosome dynamics and spindle orientation of APs, as revealed by the orientation
of the metaphase plate, were similar in human developing neocortex and human organoids,
both before anaphase (Figure 4A–D,G) and during anaphase (Figure 4A–D,H,I), when cell
cleavage initiates. This strongly suggests that cerebral organoids are a suitable model to study
live NSPC division and spindle orientation dynamics.
Spindle orientation dynamics are similar in human and chimpanzee NSPCs
Spindle orientation can determine symmetric vs. asymmetric NSPC division [245–248] and
is therefore a major candidate mechanism to explain the approximately 3-fold expansion of
the neocortex in humans compared to great apes. We compared spindle orientation dynamics
between human and chimpanzee APs in cerebral organoids. However, our data revealed no
clear differences in spindle orientation, either during metaphase (Figure 4C–G) or shortly after
anaphase onset (Figure 4C–F, I–J). As deduced from the orientation of the chromosome
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Video 1: Differences in prometaphase-metaphase length between APs of human and chim-
panzee cerebral organoids. Related to Figure 5B and C Live tissue imaging of mitotic phases, as
reported by chromosomes, in organotypic slice culture of cerebral organoids. Time-lapse is ∼1.1 min.
Datasets are the same as in Figure 5B and C. Left side: APs in a slice of a D30 human cerebral
organoid from iPSC line SC102A-1. Right side: APs in a slice of a D30 chimpanzee cerebral organoid
from iPSC line Sandra A. Growing colour bars at the bottom indicate time progression of the respec-
tive dividing AP and are synchronized to the beginning of prometaphase (in green). Metaphase plate
time is in yellow and anaphase time is in red. Note the slower progression of the dividing human AP
on the left. DOI: 10.7554/eLife.18683.021.
plates, most APs in both human and chimpanzee divided with a cleavage orientation largely
perpendicular to the apical, ventricular surface, showing deviations of fewer than 30◦ from a
perfect orthogonal cleavage. Oblique and near-horizontal orientations were also observed, but
at a much lower abundance and at similar frequencies in chimpanzee and human organoids
(Figure 4H–J). This shows that the frequency of asymmetric cell division caused by oblique
spindle orientation is most likely not a major difference between human and chimpanzee APs.
Longer prometaphase-metaphase in human than great ape APs
We noticed, however, unexpected differences between human and chimpanzee APs in their
progression through mitosis. Specifically, measurement of the length of the various phases of
mitosis (for details, see Materials and methods) revealed that APs in 11–13 wpc fetal human
neocortex and D30 cerebral organoids remained approximately 5 min longer in prometaphase-
metaphase than APs in chimpanzee organoids (Figure 5A–C,E; Video 1). By comparison,
prometaphase-metaphase of APs in slice culture of mouse neocortex, a well-characterized
model system for neurogenesis, lasted for only approximately half the amount of time than
human APs (Figure 5D,E; Figure 5—source data 1).
To trace the specific phase of mitosis when this difference arises, we used chromosome mor-
phology and dynamics to determine the time chromosomes spent congressing toward the equa-
torial plane of the cell (defined here as ’prometaphase’) and the time they spent tightly aligned
as a metaphase plate (defined here as ’metaphase’). Remarkably, the longer prometaphase-
metaphase of human than chimpanzee APs was specifically due to a 40-60% lengthening
of metaphase (Figure 5A–C,G), whereas prometaphase was not significantly different (Figure
5A–C,F; Video 1). By contrast, in mouse APs, both prometaphase and metaphase were found
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Figure 4: Spindle orientation variability is similar between APs of human developing neocor-
tex, human organoids and chimpanzee organoids. Live tissue imaging of spindle orientation, as
reported by chromosome plate orientation, in organotypic slice culture of developing neocortex and
cerebral organoids. Measurements were started after all chromosomes had formed a tight metaphase
plate. 0 min is anaphase onset. Time-lapse is ∼ 1.1 min. (A, C, E) APs in a coronal slice of 13 wpc
human frontal neocortex (A), in a slice of a D30 human cerebral organoid from iPSC line SC102A1
(C), and in a slice of a D30 chimpanzee cerebral organoid from iPSC line Sandra A (E). The time
indicated on each image is when that image was taken, relative to anaphase onset (0 min). White
dashed lines, ventricular surface. Yellow dashed lines indicate the two metaphase plate orientations
with the greatest difference to each other. Scale bar, 5 µm. (B, D, F) Quantification of all orienta-
tions of the chromosome plates from the beginning of the metaphase plate stage to anaphase, for
APs in the three respective tissues described in (A, C, E). To facilitate tracing, individual tracks are
colour-coded acaccording to the initial range of the track, and the 90◦-0◦ range is depicted twice
(green and yellow, 90◦-75◦; cyan and red, 75◦-60◦; blue and dark red, 60◦-0◦; 90◦ indicates perfectly
vertical chromosome plates). (G) Maximal range of chromosome plate orientations for APs, from
the beginning of the metaphase plate stage to anaphase onset, as determined in the measurements
shown in (B, D, F). Data are the mean ± SEM of 34 ≥ APs from 3 independent experiments each.
(H, I, J) Orientation of chromosome plates at 2.2 min after anaphase onset, which indicates the
predicted plane of cleavage, as determined in the measurements shown in (B, D, F). 90◦ indicates
a perfectly vertical cleavage plane.
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Figure 5: Differences in prometaphase-metaphase length between APs of human develop-
ing neocortex, human organoids, chimpanzee organoids and mouse developing neocortex.
Live tissue imaging of mitotic phases, as reported by chromosomes, in organotypic slice culture of
developing neocortex and cerebral organoids. 0 min is anaphase onset. Time-lapse is ∼1.1 min.
(A–D) APs in a coronal slice of 13 wpc human frontal neocortex (A), in a slice of a D30 human
cerebral organoid from iPSC line SC102A-1 (B), in a slice of a D30 chimpanzee cerebral organoid
from iPSC line Sandra A (C), and in a coronal slice of E14.5 mouse neocortex. The time indicated
on each image is when that image was taken, relative to anaphase onset (0 min). White dashed lines,
ventricular surface. Scale bar, 5 µm. (E–G) Time between the start of chromosome congression and
anaphase onset (referred to as ’prometaphase + metaphase’) (E), between the start of chromosome
congression and the formation of a metaphase plate (referred to as ’prometaphase’) (F), and be-
tween the formation of a metaphase plate and anaphase onset (referred to as ’metaphase’) (G), for
APs in the four tissues described in (A–D). Data include APs from 11–13 wpc human neocortex,
organoids from the human iPSC lines SC102A-1 and 409b2, and chimpanzee iPSC lines Sandra A
and PR818-5, and are the mean ± SEM of ≥60 APs from 4 independent experiments each. Bracket
with **<0.01; brackets with ***p<0.001; ***p<0.001 (mouse vs. all primate tissues).
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to be significantly shorter than the respective mitotic phases in human and chimpanzee APs
(Figure 5D,F,G; Figure 5—source data 1).
None of the other mitotic phases (prophase, anaphase, telophase) differed in length be-
tweenAPs in human fetal neocortex and human cerebral organoids vs. chimpanzee organoids.
However, anaphase of mouse APs was found to be significantly shorter than that of human and
chimpanzee APs (Figure 5—figure supplement 1A; Figure 5—source data 1). These differ-
ences between species in the individual mitotic phases were reflected in the cumulative length
of total mitosis, which was significantly shorter in mouse APs than human and chimpanzee
APs (Figure 5—figure supplement 1B).
To search for potential functional implications of these observations, we next quantified
and compared the length of prometaphase-metaphase in human and chimpanzee APs of
day 52 (D52) cerebral organoids, and compared the results with those of D30 organoids.
Prometaphase-metaphase (Figure 5—figure supplement 2A) and metaphase alone (Figure
5—figure supplement 2C; Figure 5—source data 1) were shorter in D52 than in D30 human
APs, and not anymore statistically significantly different in length from D52 chimpanzee APs.
The longer metaphase of human than chimpanzee organoid APs may therefore characterise
early phases of cortical development, when proliferative AP divisions are predominant.
We also generated cerebral organoids from an orangutan iPSC line and determined the length
of AP prometaphase-metaphase. This revealed that the length of prometaphase-metaphase in
orangutan D30 organoid APs was similar to that of chimpanzee APs and significantly shorter
than that of human organoid APs (Figure 5—figure supplement 3A,B). As was the case for the
human-chimpanzee AP comparison, the shorter prometaphase-metaphase of orangutan than
human APs was due to a shorter metaphase (Figure 5—figure supplement 3A,D) rather than
prometaphase (Figure 5—figure supplement 3A,C; Figure 5—source data 1). Together, these
data indicate that human APs specifically lengthen prometaphase-metaphase as compared to
great ape APs.
In light of these differences in the duration of mitotic phases, it was of interest to compare
the length of the total cell cycle of human and chimpanzee organoid APs. Using cumulative
EdU labelling of D52-D54 cerebral organoids (Figure 5—figure supplement 4A), we found a
relatively minor ( 6%) difference in total cell cycle length, with human APs (PAX6+TBR2–
cells) exhibiting a 2.7 hr longer cell cycle (46.5 h) than chimpanzee APs (43.8 h) (Figure
5—figure supplement 4B). However, a notable difference between the two species was the
length of S-phase, which was nearly 5 hr longer in human (17.5 h) than chimpanzee (12.8 h)
organoid APs (Figure 5—figure supplement 4B).
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The prometaphase-metaphase lengthening in humans occurs upon neural
differentiation
To investigate the origin of the longer metaphase in human than chimpanzee APs, we measured
mitotic phase lengths in the original iPSCs used to grow the cerebral organoids. This revealed
that both the human and chimpanzee organoid APs had a longer prometaphase-metaphase
than their respective iPSCs of origin, showing that this general lengthening was due to the
transition between iPSCs and the organoids of both species (Figure 6A,B,E). In human APs,
however, the lengthening was greater than in chimpanzee APs. In contrast to APs, human
and chimpanzee iPSCs had similar prometaphase-metaphase lengths (Figure 6A,B,E; Figure
5—source data 1).
Further dissection into individual phases revealed that, whereas both human and chimpanzee
APs had a longer prometaphase than their iPSCs of origin (Figure 6A,B,F), only human
APs had a longer metaphase when compared to the iPSCs of origin (Figure 6A,B,G; Figure
5—source data 1).This shows that prometaphase-metaphase lengthened in both species as
APs were generated during cerebral organoid formation with the accompanying neural differ-
entiation. However, the lengthening characteristics were species-specific. The lengthening was
greater in humans than chimpanzees because the metaphase plate stage became longer only
in human APs.
To determine whether prometaphase-metaphase length may differ between chimpanzees and
humans also in another cell type, we measured mitotic phases in human and chimpanzee
B cells. In contrast to fetal tissue, these cells can be obtained not only from humans but
also chimpanzees by collecting blood, that is, without major invasive procedures. The length
of prometaphase-metaphase in B cells, as well as prometaphase and metaphase measured
individually, were similar to that in iPSCs (Figure 6 C–G), and hence significantly shorter than
in human or chimpanzee APs. By contrast, the other mitotic phases were similar among
organoid APs, iPSCs and B cells in both species (Figure 6—figure supplement 1; Figure
5—source data 1). This raises the intriguing possibility that lengthening of prometaphase-
metaphase could be specific to ape and human NSPCs and, furthermore, that lengthening of
the metaphase plate time could be specific to human NSPCs.
Longer prometaphase-metaphase in proliferative than neurogenic mouse APs
To investigate potential functions of prometaphase-metaphase lengthening, we asked whether
mitotic phases were different between proliferating and neurogenic APs. To this end, we
measured mitotic phase lengths in a transgenic mouse line where EGFP is expressed under
the promoter of the pan-neurogenic marker Tis21 in neurogenic but not proliferative NSPCs
[8, 252]. This revealed that prometaphase-metaphase was longer in proliferative AP divisions
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Figure 6: Human and chimpanzee organoid APs exhibit longer prometaphase, and human
organoid APs longer metaphase, than their iPSC lines of origin or B cells. Live imaging of
mitotic phases, as reported by chromosomes, in human and chimpanzee iPSCs and B cells. 0 min
is anaphase onset. Time-lapse is ∼1.1 min. (A–D) Human iPSC (SC102A-1) (A), chimpanzee
iPSC (Sandra A) (B), human B cell (A158) (C), and chimpanzee B cell (Dorien) (D). The time
indicated on each image is when that image was taken, relative to anaphase onset (0 min). Scale
bar, 5 µm. (E–G) Time between the start of chromosome congression and anaphase onset (referred
to as ’prometaphase + metaphase’) (E), between the start of chromosome congression and the
formation of a metaphase plate (referred to as ’prometaphase’) (F), and between the formation of a
metaphase plate and anaphase onset (referred to as ’metaphase’) (G). Data include cells from each
of the following iPSC lines: human, SC102A-1 and 409b2; chimpanzee, Sandra A and PR818-5; and
from the following B cell lines: human, A144, A156 and A158; chimpanzee, Jahaga, Ulla and Dorien.
For comparison, the relevant mitotic phase lengths of human and chimpanzee cerebral organoid APs
from Figure 5 are shown (columns with dashed line). Data are the mean ± SEM of ≥30 cells from
≥ independent experiments each. **p<0.01; ***p<0.001.
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Figure 7: Prometaphase-metaphase is longer in proliferative than neurogenic mouse APs.
Live tissue imaging of mitotic phases, as reported by chromosomes, in organotypic slice culture
of E14.5 mouse neocortex. 0 min is anaphase onset. Time-lapse is ∼1.1 min. Data is from the
same mouse dataset shown in Figure 5, but distinguishes between Tis21::GFP– (proliferative) and
Tis21::GFP (neurogenic) APs. (A,B) APs in a coronal slice of mouse E14.5 dorsolateral telen-
cephalon, either negative (A) or positive (B) for expression of Tis21::GFP. The time indicated on
each image is when that image was taken, relative to anaphase onset (0 min). White dashed lines,
ventricular surface. Scale bar, 5 µm. Image panels in (B) are the same as in Figure 5D, but the
Tis21::GFP fluorescence (green) is included in the prophase image (merge). The GFP channel is also
merged in the prophase image of (A), and the other panels are DNA staining only. (C,D) Length
of prometaphase and/or metaphase in proliferative vs. neurogenic APs. Data are the mean ± SEM
of 41 Tis21::GFP– and 37 Tis21::GFP APs from 4 independent experiments. *p<0.05. (C) Time
between the start of chromosome congression and anaphase onset (referred to as ’prometaphase
+ metaphase’). (D) Time between the start of chromosome congression and the formation of a
metaphase plate (referred to as ’prometaphase’, left), and time between the formation of a metaphase
plate and anaphase onset (referred to as ’metaphase’, right).
(Tis21–) than in neurogenic AP divisions (Tis21+), whereas the separate phases were not
significantly different (Figure 7; Figure 5—source data 1). These results suggest that a
lengthening of prometaphase-metaphase may be characteristic of proliferating NSPCs.
Gene expression in human and chimpanzee mitotic APs
We used the single-cell RNA-seq data to identify organoid APs in different phases of the cell
cycle (Figure 8A, Figure 8—figure supplement 1) and searched for genes that might be involved
in human-specific lengthening of the metaphase. We compared human organoid APs in G1
with APs in G2-M and identified 395 genes with enriched expression in G2-M (Figure 8B). We
next compared human APs in G2-M with human iPSCs (TkDA3-4) and an endothelial cell line
(HUVEC; both single-cell RNA-seq data sets in GSE81252) to understand the specificity of
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G2-M regulation in APs. We found that nearly all genes upregulated in human APs in G2-M
compared with human APs in G1 were also upregulated during G2-M in iPSCs and endothelial
cells (Figure 8C). Therefore, the expression level of these genes is unlikely to contribute to the
specificity of mitotic control of human APs in G2-M. However, we identified many genes that
were highly expressed throughout the human AP cell cycle and were specific to APs. Genes with
the highest specificity score encoded canonical cerebral cortex patterning transcription factors
such as PAX6, ID4, and GLI3, as well as proteins involved in cell adhesion and ECM signalling
(CDH4, EFNB1/2, COL4A2). Notably, no genes associated with cell cycle, kinetochore, or
spindle terms were specific to human APs (Figure 8C, inset). Of genes specific to APs, a
subset were also differentially expressed between human and chimpanzee cerebral organoids
(APOLD1, BICC1, EFNB1, GSTM1, IFI44L, ITGB8, SDK2, SEMA5A, SLC35F1, ZNF516),
which makes them candidates for the unique regulation of AP proliferation in humans (Figure
8D).
Discussion
We have characterized cerebral organoids generated from chimpanzee iPSCs, including a newly
generated iPSC line, and shown that their cytoarchitecture, cell type composition, and neu-
rogenic gene expression programs are remarkably similar to human cerebral organoids and to
human fetal neocortex. This extends a very recent study [59] and establishes cerebral organoids
as a valid system to compare human and chimpanzee NSPC behaviour. Using this system,
we have shown that human and chimpanzee APs differ in that prometaphase-metaphase is
longer in humans than in chimpanzees. This difference was also observed between human and
orangutan and reflects a greater extent of prometaphase-metaphase lengthening that occurs
as human APs are generated during cerebral organoid development from IPSCs. There are
two intriguing implications as to the biological significance of this prometaphase-metaphase
lengthening in human APs.
One is related to the fate of the progeny arising from AP division. Mouse Tis21::GFP-negative
APs, which are known to undergo proliferative divisions to generate more APs, have a longer
prometaphase-metaphase than Tis21::GFP-positive APs, which are known to undergo neu-
rogenic divisions to generate BPs [8]. The longer prometaphase-metaphase in human than
chimpanzee APs would therefore be consistent with a greater tendency for proliferative than
neurogenic divisions. In this respect, other changes in progeny fate have also been recently
observed in a different context, upon an experimentally induced and considerable prolongation
of AP mitosis in embryonic mouse neocortex [253].
Another set of observations are consistent with the notion that the longer prometaphase-
metaphase in human than chimpanzee APs may indicate a greater tendency for proliferative
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Figure 8: Differential gene expression during AP mitotic phases. (A) G1 (dark green) and
G2-M (light green) cell cycle phases were assigned to cells by performing PCA using genes involved
in cell cycle regulation. PC1 and PC2 described cell cycle phases, and the top 50 correlating and
anticorrelating genes were used to infer an intercellular correlation network for human and chimp
APs, human iPSCs, and a human endothelial cell line. Networks are coloured based on the expression
level of MKI67. (B) Scatterplot shows z-scored significance estimates from single-cell differential
expression (SCDE) analysis between human organoid APs vs. neurons (N, x-axis) and APs in G2-
M vs. APs in G1 (y-axis). Genes coloured as white circles represent marker genes and green
circles represent genes upregulated specifically in APs in G2-M. Circles are sized based on differential
expression between human APs and neurons. (C) iPSC and endothelial cell (EC) expression was used
to assign a specificity score for genes enriched in human organoid APs compared to neurons (higher
in AP genes from panel B). The specificity score is plotted against the differential expression between
APs in G2-M and APs in G1. Cells with high AP specificity scores are in yellow in the main scatter
plot. This shows that nearly all genes enriched in G2-M phase of the AP cell cycle are not specific
to APs, but also enriched in G2-M of mitotic iPSCs and endothelial cells. (D) Heatmap shows the
differential expression score between human and chimpanzee APs (z-score) and AP specificity score
(Log2 normalized) of the same genes that are specific to APs relative to endothelial cells and iPSCs.
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than differentiative divisions. The human vs. chimpanzee prometaphase-metaphase difference
decreased in the course of organoid cortical development from D30 to D52, when one would
expect proliferative AP divisions to decrease and differentiative AP divisions to increase.
Further support for this notion was obtained by analysis of the interphase of the cell cycle,
specifically S-phase. Mouse Tis21::GFP-negative (proliferative) APs have previously been
shown to have a longer S-phase than Tis21::GFP-positive (differentiative) APs [254]. The
substantially longer S-phase of human than chimpanzee APs observed here is therefore also in
line with human APs having a greater tendency for proliferative divisions.
Finally, the changes in the abundance of NSPC types in the course of cerebral organoid
develop- ment yielded data supporting a greater AP proliferation in human than chimpanzee.
Specifically, the proportion of PAX6+TBR2– NSPCs, located in the VZ and thus constituting
proliferating APs, decreased in both human and chimpanzee cerebral organoids, but the value
reached in human organoids was slightly higher than that in chimpanzee organoids (Figure
2B). Conversely, the proportion of PAX6+TBR2+ NSPCs, located in the basal VZ and SVZ
and constituting BPs with neurogenic potential, showed a greater increase in chimpanzee than
human cerebral organoids. In sum, two independent lines of evidence, the detailed analysis of
AP mitosis phase lengths and the determination of the proportions of the various NSPC types,
support the concept that a longer neurogenic period [255], which in turn implies a longer phase
of NSPC proliferation [59], contributes to the greater expansion of the neocortex in humans
than the great apes.
The second implication as to the biological significance of the longer prometaphase-metaphase
in human than chimpanzee APs concerns the fact that these are the phases of mitosis when
chromosomes prepare for segregation, to ensure that only one copy of each chromosome is dis-
tributed to each nascent daughter cell [256]. The longer duration of prometaphase-metaphase
in human than chimpanzee APs, in particular of the metaphase plate stage (Figure 5B), may
therefore reflect some difference between the two species with regard to the preparation for
chromosome segregation.
If the longer prometaphase-metaphase in human than chimpanzee APs reflects a greater ten-
dency for proliferative than neurogenic divisions in the human NSPCs, why did we not detect
significant differences between human and chimpanzee APs in spindle orientation, a parameter
previously shown to affect the mode of AP division [245–248] This may be due to spindle
orientation variability between individual APs being greater than potential inter-species dif-
ferences. This suggests that, in the cell types and stages analysed, spindle orientation may
not play a key role in human vs. chimpanzee neurogenesis. Alternatively, this may reflect
the fact that differences in proliferative versus neurogenic AP divisions can occur without a
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change in spindle orientation [246, 257, 258]. In this context, differences between human and
chimpanzee NSPCs of relevance for neocortex expansion are likely to be small. Consistent
with this view, our single-cell transcriptome analyses revealed only few differences between
human and chimpanzee, and the differences in the proportions of organoid NSPC populations
were in the range of a few percentage points. Furthermore, the 5 min longer prometaphase-
metaphase in human than chimpanzee APs constituted only a fraction of the total duration
of their mitosis. These small differences nevertheless provide a set of clues as to which NSPC
features may underlie the differential extent of neocortex expansion in humans versus apes,
and are consistent with a scenario in which the accumulation of such small differences during
evolution may have resulted in the distinct chimpanzee and human neocortices.
Materials and methods
Neocortex tissue
Human fetal brain tissue (11–13 weeks post conception (wpc)) was obtained with informed
written maternal consent followed by elective pregnancy termination, and neocortex was dis-
sected at room temperature, as described previously [62]. Research involving human fetal brain
was approved by the Ethical Review Committee of the Universitätsklinikum Carl Gustav Carus
of the Technische Universität Dresden (reference number EK100052004). In addition, research
was approved by the Institutional Review Board of the Max Planck Institute of Molecular Cell
Biology and Genetics.
Mice were kept pathogen-free at the Biomedical Services Facility of the MPI-CBG. All mouse
embryos were heterozygotes of the Tis21::GFP knock-in line [8]. Imaging was performed in
the dorsolateral telencephalon of E14.5 embryos, at a medial position along the rostro-caudal
axis. Embryonic day (E) 0.5 was defined as noon of the day of vaginal plug identification. All
experiments using mice were performed according to the German Animal Welfare Legislation.
Cell lines and organoid culturing
Two human iPSC lines (409b2, SC102A-1), two chimpanzee iPSC lines (PR818-5, Sandra A),
and one orangutan iPSC line (Toba) were used to generate cerebral organoids in this study.
409b2 was purchased from the RIKEN BRC cell bank and SC102A-1 was purchased from Sys-
tem Biosciences. PR818-5 (0818) was obtained as a kind gift from F. Gage [82] from the Salk
Institute for Biological Studies (La Jolla, CA). Sandra A and Toba were generated in collabo-
ration with Shinya Yamanaka following a nonviral transfection method [81]. Briefly, blood was
collected from a chimpanzee and an orangutan, both housed at the Leipzig Zoo, and leuko-
cytes were isolated by Ficoll gradient centrifugation, which were then used for reprogramming
to iPSCs. DNA sequencing revealed no chromosome aberrations, and RNA-seq and immuno-
histochemistry confirmed pluripotent gene and protein expression signatures. Primate blood
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samples used to generate iPSCs were obtained by certified veterinarians during annual medical
examinations or other necessary medical interventions, meaning that no invasive procedures
were performed on primates for the sole purpose of our research project. The Max Planck In-
stitute for Evolutionary Anthropology has an institutional permit for the transport of biological
material derived from endangered species (DE216-08, see http://cites.org/common/reg/si/e-
si-beg.shtml). Human iPSC line TkDA3-4 [95] was used to generate iPSC single-cell tran-
scriptomes. iPSC lines were cultured under standard iPSC culturing methods on matrigel (BD
Biosciences) using mTeSR1 (Stemcell Technologies). Human endothelial cells. (HUVECs,
Lonza, Basel, Switzerland) were maintained in endothelial growth medium (EGM) (Lonza)
at 37◦C in a humidified 5% CO2 incubator. Single cell transcriptome analysis confirmed the
identity of human and chimpanzee iPSCs and human endothelial cells, and showed no con-
tamination with other cell lines. B-cell lines were generated from blood obtained from three
human (A144, A156, A158) and three chimpanzee (Dorien, Jahaga, Ulla) individuals. With-
drawal and processing of blood samples was performed according to approved protocols, and
was performed for chimpanzee during necessary veterinary interventions. Lymphocytes were
isolated from blood using a Ficoll gradient centrifugation. Immortalization was performed by
adding Epstein Barr virus (EBV) supernatant to the lymphocytes and further cultivation of
the cells until colonies of immortalized B-lymphocytes were established [259]. B-cells were
maintained in RPMI with 10% FBS, 1% Glutamax and 2% penicillin/streptomycin. Cell lines
were regularly tested for mycoplasma using a PCR-based test (Minerva Biolabs) and found to
be negative.
Human and chimpanzee cerebral organoids were generated from the above iPSCs and cul-
tured for the indicated times as described previously for human cerebral organoids [92, 250],
with minor modifications [114].
Single-cell RNA-seq experiments
Preparation of single-cell suspensions from cerebral organoids To generate single-
cell suspensions, cerebral organoids were either dissociated as a whole or first sliced using a
vibratome to dissect cortical regions. Whole organoids were washed three times in PBS and
incubated at 37◦C in 2 ml Accutase (Sigma) plus 2 U/ml DNAse I (New England Biolabs)
for ∼45 min. For dissections, organoids were washed using PBS and embedded into 4%
low-melting agarose (Sigma) and sliced into 150 µm sections using a vibrating microtome (Ci
7000 smz, Camden Instruments). Slices were kept in differentiation plus vitamin A (Diff
+VA) medium [92] and inspected under a stereomicroscope (Leica) to dissect cortical regions.
Selected regions were washed three times with PBS and incubated in ∼200 µL Accutase with
DNAse I at 37◦C for ∼45 min. Additional mechanical dissociation was performed by triturating
the tissue. Subsequently, cells were filtered through a 30 µm cell filter (Miltenyi Biotec),
washed with Diff +VA medium and spun down at 300 g for 5 min. The resulting pellet was
resuspended in 30-50 µL (for cortical slices) or 250500 µL (for whole organoids) of Diff +VA
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medium. In case of excessive debris being present, cells were cleaned using a Percoll (Sigma)
gradient centrifugation and the resulting pellet was resuspended in 30-50 µL Diff +VA medium.
Counting of cells was performed using a Countess automated cell counter (Invitrogen) and by
staining with Trypan blue. For single-cell experiments, cell suspensions were diluted to a final
concentration of 450–600 cells/µL.
Single-cell cDNA generation These steps were performed as described [114, 161]. De-
pending on the size distribution of the cells, cells were loaded at a concentration of 250–500
cells per ml onto small (5–10 µm) or medium (10–17 µm) integrated fluidic circuits (IFCs,
Fluidigm). Lysis, reverse transcription and amplification were performed on the Fluidigm C1
platform using the SMARTer Ultra Low RNA Kit for the Fluidigm C1 system. External RNA
Control Consortium (ERCC) spike-ins (Ambion) were added to the lysis mix at a dilution of
1:80,000. Resulting cDNA was quantified and checked for its size distribution using a cap-
illary gel electrophoresis system (Fragment Analyzer, Advanced Analytical, 1–6000 bps High
Sensitivity).
RNA-Seq library preparation and sequencing Each cell’s cDNA was diluted and libraries
were prepared using Nextera XT DNA library preparation kits (Illumina). Up to 96 single-
cell libraries were pooled and cleaned up using solid phase reversible immobilization (SPRI)
beads (Thermo Scientific). Quantification and library size distribution was assessed on a
Bioanalyzer (Agilent) platform using High Sensitivity DNA chips. Up to 192 cells were pooled
and sequenced in 100-bp paired-end mode on one lane of an Illumina HiSeq 2500 platform
(rapid mode).
Read processing, mapping and gene quantification Base-calling, adaptor trimming and
demultiplexing of reads was performed using a custom pipeline based on freeIbis [260], leeHom
[261] and deML [262]. Demultiplexed reads were mapped using TopHat v2.0.14, and FPKM
(Fragments Per Kilobase of transcript per Million mapped reads) values per gene were quan-
tified using Cufflinks v.2.2.1 [263]. Human reads were mapped to the hg38 reference genome
(release 77) and chimpanzee reads were mapped to panTro4 (release 80). The raw FPKM data
of all single cells were combined into one master table and transformed to log2 (FPKM +1).
(RStudio Team, 2015) was used to run [264], scripts to perform principal component analysis
(PCA, FactoMineR package), hierarchical clustering (stats package), differential expression
analysis (SCDE package), and to construct heatmaps, scatter and line plots, dendrograms,
bar graphs, pie charts and histograms. Generally, ggplot2 and gplots packages were used to vi-
sualize the data. Gene ontology enrichment analyses were performed using DAVID informatics
Resources 6.7 of the National Institute of Allergy and Infectious Diseases [265].
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Analysis of chimpanzee single-cell RNA-seq data The Seurat package [166] imple-
mented in R was used to identify cell populations present in chimpanzee organoids (Figure
1—figure supplement 2). T-distributed stochastic neighbour embedding (tSNE) was per-
formed on all chimpanzee organoid cells using the most significant genes (p-value <10–3, with
a maximum of 200 genes per principal component) that define the first 6 principal components
of a PCA analysis on the data set. In Figure 1E we calculated for each chimpanzee organoid
cortex cell the Spearman correlation of its transcriptome (all genes) with bulk transcriptome
data from each of 4 microdissected human cortical zones (VZ, iSVZ, oSVZ, CP, mean ex-
pression value of each gene across 4 replicates from 13 weeks post conception, data published
in ([31] GSE38805). We hierarchically clustered (Pearson’s correlation distance metric) cells
based on their correlation coefficient with germinal zones and visualized the clustering in a
heatmap showing correlation coefficients scaled across zones (mean-centering and dividing by
standard deviation). The scaling enables a better comparison between cells, since the max-
imum and minimum correlation for each cell is color-coded in the same way after scaling.
We used this analysis to identify the zone with which each individual cell had a maximum
correlation.
NSPC and neuron signatures (Figure 1—figure supplement 3, Figure 1F) were defined by
the top 100 genes correlating or anti-correlating with PC1 from PCA of human fetal neocortex,
respectively. Each fetal, human organoid, and chimpanzee organoid cortex cell was scored for
the NSPC or neuron signature by summing the number of genes from each signature that
have an expression greater than log2 FPKM of 5, and normalizing by the number of all genes
expressed above log2 FPKM of 5 for each cell. Lineage network analysis and visualizations
were done using igraph implemented in R (http://igraph.sf.net). To construct the chimpanzee
cellular network, we computed a pairwise correlation matrix for all chimpanzee cerebral cortex
cells and using genes discovered in PCA of fetal neocortex single cell transcriptomes [114].These
same genes had been used to infer lineage relationships in the fetal neocortex. We then
generated a weighted adjacency network graph using the graph.adjacency() command and
visualized cells as vertices connected to other cells via edges if the pairwise correlation between
two cells was higher than 0.4. The fruchterman reingold layout was used to plot the network
graph. The combined species network was con- structed in a similar way using the same genes
and a correlation threshold of 0.4, and was based on FPKM quantification of alignments to
each respective species’ reference genome. Monocle [251] was used to establish pseudotime
estimates and corroborate lineage relationships of chimpanzee cerebral cortex cells using the
same genes as in the network analysis.
Human-chimpanzee consensus genome construction We re-aligned reads from each cell
to a human-chimpanzee consensus genome to account for mapping bias originating from the
different genome qualities of the human and chimpanzee genome. The consensus genome was
generated as previously described [156]. In brief, the consensus genome was constructed based
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on the chained and netted pairwise alignment of human (hg38) and chimpanzee (panTro4)
obtained from UCSC. Discordant sites and indels including 6 bp upstream and downsteam of
the indel position were masked (replacing the base with N). STAR v2.5.1a [266] was used to
map all sequences to the consensus genome requiring a minimal fraction of 85% of mapped
bases per read. For quantification, HTSeq [267] v0.6.1.p1 was used applying the human GEN-
CODE v.24 annotation. Resulting count files were combined into one master table containing
all cells and genes.
Differential gene expression analysis To identify differentially expressed genes between
human and chimpanzee, cells were first annotated as AP, BP or neuron based on the fetal cortex
cell type with which each cell maximally correlated. After cell type assignment, SCDE (Single
Cell Differential Expression) [268], a Bayesian approach for finding differentially expressed
genes accounting for noise inherent to single-cell data, was used to compare the orthologous
cell type between human and chimpanzee. AP or neuronal specificity was defined as one
standard deviation from the mean of z-scores from SCDE of APs and Neurons (Z.x). A more
stringent threshold of twice the standard deviation of the z-score was used to define differential
expression between human and chimpanzee (Z.y). For the differential gene expression analysis
during mitotic phases, we aimed to identify relatively homogeneous clusters of human organoid
APs, chimpanzee organoid APs, endothelial cells (ECs), or iPSCs in G2M or G1 phases. We
hierarchically clustered cells (Pearson correlation) using expression of genes that correlated with
PC1 from PCA on human fetal cortex progenitor cells [114] and which are able to distinguish
between cells in G2M and G1 phases. We selected the clusters with high or no expression and
assigned them as G2/M or G1, respectively, and ignored the intermediate cells for SCDE. For
the organoid APs, this assignment was consistent with an independent assignment using the
method published by [269].
Immunohistofluorescence
Cerebral organoids were fixed with 1% PFA in 120 mM phosphate buffer pH 7.4 for 20 min
at room temperature and subjected to cryosectioning (14 µm) and immunofluorescence as
described [114]. The following primary antibodies were used: rabbit anti-PAX6 (PRB-278P;
Covance), sheep anti-TBR2 (AF6166; R+D systems), rat anti-CTIP2 (ab18465; Abcam), rab-
bit anti-KI67 (ab15580; Abcam). The secondary antibodies, used in combination with DAPI
staining, were all donkey-derived and conjugated with Alexa 488, 555 or 647 (Life Technolo-
gies). Images were acquired with a Zeiss LSM 880 Airy inverted microscope, using 10X (0.45
NA) and 20X (0.8 NA) Plan-Apochromat objectives, and analysed using Fiji. Quantifications
were carried out in cortical regions of D28 and D52-54 cerebral organoids by counting, from
the ventricular to the pial surface, either all PAX6 and TBR2 positive and negative nuclei
stained by DAPI in 50 µm and 100 µm wide fields, respectively, or all KI67-positive cells in
100 µm wide fields. An average of 350 cells per sample were counted. Statistical significance
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was calculated using the Mann–Whitney U-test.
Cumulative EdU labeling
EdU was added to 52 day old cerebral organoids at a final concentration of 1 mg/ml (added
from a 1 µg/ml EdU stock in PBS). The organoids were supplied with fresh medium containing
EdU every six hours for up to 48 hr. Organoids were then collected in triplicates at the indicated
time points (1, 2, 6, 24, 30/36, 48 hr) and processed as described above. For EdU detection,
the Click-iT EdU Alexa Fluor 647 Imaging Kit (Invitrogen C10340) was used according to
the manufacturer’s instructions. Cell cycle parameters were determined using linear regression
based on a model described previously [270].
Live imaging
Live tissue imaging was performed as described previously [247]. In short, cerebral organoids
or freshly dissected developing neocortex tissue were embedded in agarose (Sigma, Germany),
sectioned with a vibratome (∼200 µm, Leica, Germany), embedded in type Ia collagen (Cell-
matrix, Japan), mounted in glass bottom microwell dishes (MatTek, Germany), and incubated
with Hoechst 33342 (Sigma) as vital DNA dye. Tissue slices in the dish were further cultured
for observation in a microscope stage incubation chamber (Pecon, Germany) kept at 37◦C.
iPSCs and B cells were likewise mounted in glass bottom microwell dishes previously coated for
1h with matrigel (BD Biosciecne) and poly-D-lysine (Sigma, Germany) respectively, and im-
aged under their respective standard culturing conditions (see above). Potential phototoxicity
was stringently controlled as previously described [271].
Image analysis Images were viewed and prepared with ImageJ (http://imagej.nih.gov/ij/).
Brightness and contrast of images were recorded and adjusted linearly. Spindle orientation
analysis was performed as described [247]. In short, the degree values given in Figure 4 are
deviations from a perfect orthogonality with the local apical surface plane, as seen from a
coronal perspective (Figure 4A–F). For Figure 4G, the maximal range of orientations per every
mitotic AP was calculated from the formation of a metaphase plate to anaphase onset.
Mitotic phase length determination To measure the duration of mitotic phases, the start
of each different phase was defined as follows, based on morphology, dynamics and conden-
sation of chromosomes as reported by vital DNA staining (Figures 5 and 6). Prophase: the
beginning of mitotic chromosome condensation; prometaphase + metaphase: the beginning
of chromosome congression and alignment; anaphase: the beginning of chromosome segre-
gation toward the mitotic poles of the dividing cell; telophase: the beginning of chromosome
decondensation after maximal chromosome condensation in late anaphase and until a level
indistinguishable from interphase was achieved. The total duration of mitosis was the sum
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of these phases. We note that our measurements of mitotic phases are limited by the use
of chromosomes as markers. Nevertheless, the use of a single fluorescence channel allowed
a very high time resolution (∼1.1 min) for close monitoring of key chromosomal dynamics
to delimit mitotic phases. Towards distinguishing between prometaphase and metaphase, we
subdivided prometaphase + metaphase into ’prometaphase’, defined here as the time in which
chromosomes are congressing and aligning toward the formation of a metaphase plate, and
’metaphase’, defined here as the time after every chromosome has been incorporated into a
tight metaphase plate at the equatorial plane of the cell, and until anaphase onset.
Statistical analysis Data were tabulated with Excel (Microsoft, Redmond, WA) and anal-
ysed with GraphPad Prism (La Jolla, CA). Statistical tests: for two groups of observations,
the Mann–Whitney U-test was used. For three or more groups, the Kruskal–Wallis ANOVA in
conjunction with Dunn’s Multiple Comparison test for pair-wise comparisons was used. Results
were interpreted as statistically significant when p<0.05.
Additional information
Acknowledgements
We thank the Services and Facilities of the Max Planck Institute of Molecular Cell Biology and
Genetics for outstanding support, notably Jussi Helppi and his team of the Animal Facility,
and Jan Peychl and his team of the Light Microscopy Facility. We thank David Andrijevic
and Anne Weigert for help with maintenance and characterization of iPSC lines. We thank
Marta Florio for assistance with human tissue dissection. We thank Andrea Musacchio and
members of the Huttner, Treutlein and Pääbo labs for helpful discussions. We thank Fred Gage
and Rick Livesey for kindly donating the PR818-5 iPSC line. SK was supported by a PhD
fellowship of the Boehringer Ingelheim Fonds. SP was supported by the Paul G. Allen Family
Foundation. WBH was supported by grants from the Deutsche Forschungsgemeinschaft (DFG,
SFB 655, A2) and the European Research Council (ERC, 250197), by the DFG-funded Center
for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie. SP, BT and
WBH were supported by the Max Planck Society.
Author contributions
FM-B, Conceived the study, Designed the experiments, Performed and analysed live imaging
experiments, Wrote the paper; FB, Conceived the study, Designed the experiments, Grew
cerebral organoids, Performed and analysed organoid immunohistochemistry and cumulative
EdU labelling, Wrote the paper; SK, Conceived the study, Designed the experiments, Grew
cerebral organoids, Performed single-cell RNA-seq experiments, Analysed single-cell RNA-seq
data, Wrote the paper; JGC, Conceived the study, Designed the experiments, Performed
single-cell RNA-seq experiments, Analysed single-cell RNA-seq data, Wrote the paper; BVe,
70
CHAPTER 1
Analysed single-cell RNA-seq data, Provided information relevant for the interpretation of the
data; KK, BVo, KO, TM, Prepared chimpanzee iPSC line Sandra A and orangutan iPSC
line Toba, Provided information relevant for the interpretation of the data; ZH, Constructed
human-chimpanzee consensus genome ; RL, Provided human fetal tissue, Provided informa-
tion relevant for the interpretation of the data; SP, WBH, Conceived the study, Designed the
experiments, Provided intellectual guidance in the interpretation of the data, Wrote the pa-
per; BT, Conceived the study, Designed the experiments, Analysed single-cell RNA-seq data,
Provided intellectual guidance in the interpretation of the data, Wrote the paper.
Ethics
Human subjects: Human fetal brain tissue (11-13 weeks post conception (wpc)) was ob-
tained with informed written maternal consent followed by elective pregnancy termination.
Research involving human tissue was approved by the Ethical Review Committee of the Univer-
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Figure 1-figure supplement 1: Characterization of chimpanzee iPSCs. (A) Chimpanzee iPSC
line Sandra A stained for pluripotency markers SSEA5 (red) and NANOG (Green). Nuclei are stained
with DAPI. (B) PCA on bulk RNA-seq data from human iPSCs, chimpanzee and bonobo iPSCs,
and human fibroblasts was used to describe the variation between cell types. RNA-seq data on
chimp iPSC line Sandra A and human iPSC line 409b2 was generated in this study. Data from
the other human, chimpanzee and bonobo, and fibroblast lines were previously published [82, 272].
(C) Dendrogram showing hierarchical clustering of human IPSC, chimpanzee and bonobo IPSC, and
human fibroblast lines based on the Pearson correlation of the expression of 12,221 genes.
Figure 1-figure supplement 2: Deconstructing cell type composition in chimpanzee cerebral
organoids using single-cell RNA-seq. (A) scRNA-seq was performed on chimpanzee organoids
dissociated at 45, 50, 51, 55, 62, and 80 days (d) after embryoid body (EB) culture. PCA and
unbiased clustering using tSNE reveals cell populations from hindbrain, midbrain, mesenchyme, and
cerebral cortex (shaded in grey) within organoids. Different symbols indicate different experiments.
(B) Marker genes are shown for each cluster with cells coloured based on gene expression level.
Cerebral cortex cells have high expression of FOXG1 and NEUROD6, and low expression of OTX2
and RSPO2. Progenitors express marker SPAG5. Cells are coloured based on expression level.
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Figure 1-figure supplement 3: Fetal human progenitor and neuronal neocortical signatures
are recapitulated in chimpanzee cerebral organoids. (A) PCA of human fetal neocortex was used
to identify genes describing cortical cell populations. Each dot represents a cell that is color-coded
in shades of blue representing three different experiments. The genes correlating and anticorrelat-
ing with PC1 were used to define the NSPC and neuron signature, respectively. (B) Hierarchical
clustering and heatmap visualization showing the expression of genes that have highest correlation
(NSPC signature) and anti-correlation (Neuron signature) with PC1. Cells are shown in rows, genes
in columns. (C,D) Fetal cortical cells were classified as APs in G2-M (AP1), APs in G1-S (AP2),
BPs in G2-M (BP1), BPs in G1-S (BP2), or migrating (N1, N2) and cortical plate (N3) neurons.
Each cell was scored for the NSPC (top) or neuron (bottom) signature and plotted in the order of
pseudotemporal point on the neurogenic lineage (C) or plotted for each cell type (D). (E) Scatterplot
showing NSPC and neuronal signature scores for each human fetal, human organoid and chimpanzee
organoid cortical cell. The signatures were derived from PCA of fetal cerebral cortex single-cell tran-
scriptomes. (F) Heatmap showing gene expression of top NSPC and neuron signature genes across
human fetal, human organoid (hOrg), and chimpanzee organoid (cOrg) cells. (G) Monocle reveals a
NSPC-to-neuron lineage in the chimpanzee organoid that correlates with the zones of the developing
fetal primate neocortex. Cells (circles, coloured by maximum correlation with cortical zones; CP,
cortical plate) are arranged in the 2-D independent component space based on genes identified using
PCA. The minimal spanning tree (grey lines) connects cells, with the black line indicating the longest
path. (H) Each chimpanzee cerebral organoid cortical cells scored for the NSPC (top) or neuron (N,
bottom) signature and plotted in the order of pseudotemporal position on the neurogenic lineage.
Cells are coloured by maximum correlation with cortical zones (left) or cell type (right).
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Figure 3-figure supplement 1: Differential expression analysis between chimpanzee and hu-
man cerebral cortex cells from the chimpanzee perspective. (A) Scatterplots showing z-scored
significance estimates from single-cell differential expression (SCDE) analysis based on Bayesian
probabilistic models. Reads from human and chimpanzee were mapped to a consensus genome,
and human gene annotations were used for expression counting. The x-axis represents SCDE be-
tween chimpanzee organoid APs vs. chimpanzee organoid neurons (N). The y-axes on the left and
right plots represents SCDE between human and chimpanzee APs and neurons, respectively. Genes
coloured as white circles represent marker genes from Figure 1 and are generally not differentially
expressed between human and chimpanzee, but do vary between chimpanzee APs and neurons,
validating the SCDE analysis. Yellow and purple circles represent genes upregulated specifically in
chimpanzee APs and neurons, respectively. Circles are sized based on differential expression between
chimpanzee APs and neurons. (B) Plot showing the number of differentially expressed genes between
human and chimpanzee cells as a function of standard deviations above the mean z-score from the
Bayesian differential gene expression analysis.
Figure 5-figure supplement 1: The length of the mitotic phases other than prometaphase-
metaphase is similar between human and chimpanzee APs. Length of prophase, anaphase and
telophase (A), and of total mitosis (B, sum of all mitotic phases described here and in Figure 5)
between APs of human developing neocortex, humanand chimpanzee cerebral organoids and mouse
developing neocortex, determined from the experiments described in Figure 5. Data are the mean
± SEM of ≥60 APs from ≥4 independent experiments each. *p<0.05; ***p <0.001.
74
CHAPTER 1
Figure 5-figure supplement 2: Differences in prometaphase-metaphase length between APs
of D30 and D52 human and chimpanzee cerebral organoids. Mitotic phase measurements
similar to those in Figure 5E–G, but for APs in D52 organoids. Time between the start of chromosome
congression and anaphase onset (referred to as ’prometaphase + metaphase’) (A), between the start
of chromosome congression and the formation of a metaphase plate (referred to as ’prometaphase’)
(B), and between the formation of a metaphase plate and anaphase onset (referred to as ’metaphase’)
(C). Data include APs from organoids from the human iPSC line SC102A-1 and chimpanzee iPSC
line Sandra A, and are the mean ± SEM of 30 APs from 2 independent experiments each. For
comparison, the relevant data for human and chimpanzee D30 cerebral organoid APs from Figure 5
are shown (dashed lines). *p<0.05; **p<0.01; ***p<0.001; n.s., not significant.
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Figure 5-figure supplement 3: Prometaphase-metaphase in orangutan organoid APs is sim-
ilar to chimpanzee organoid APs. Live tissue imaging of mitotic phases, as reported by chro-
mosomes, in organotypic slice culture of orangutan cerebral organoid. 0 min is anaphase onset.
Time-lapse is ∼ 3.5 min. (A) AP in a slice of orangutan D30 cerebral organoid (Toba). The time
indicated on each image is when that image was taken, relative to anaphase onset (0 min). White
dashed line, ventricular surface. Scale bar, 5 µm. (B–D) Time between the start of chromosome
congression and anaphase onset (referred to as ’prometaphase + metaphase’) (B), between the start
of chromosome congression and the formation of a metaphase plate (referred to as ’prometaphase’)
(C), and between the formation of a metaphase plate and anaphase onset (referred to as ’metaphase’)
(D). For comparison, the relevant mitotic phase lengths of human and chimpanzee cerebral organoid
APs from Figure 5 are shown (columns with dashed line). Data for orangutan are the mean ± SEM
of 16 cells from 2 different cortex regions of an organoid. ***p<0.001.
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Figure 5-figure supplement 4: Determination of cell cycle parameters of human and chim-
panzee organoid APs using cumulative EdU labeling. (A) Schematic representation of the
cumulative EdU labeling experiment. (B) Linear regression curves of human (r2 = 0.984) and chim-
panzee (r2 = 0.998) PAX6+TBR2– cells after cumulative EdU labeling over 48 hr. The total cell
cycle length minus the S-phase length (Tc-Ts) was obtained directly from the graph (vertical dashed
lines). The S-phase length (Ts) was determined from the x-axis and y-axis intercepts of the linear
regression curves, and the total cell cycle length (Tc) was calculated therefrom. The growth fraction
(GF, solid horizontal line) is indicated by orange arrowheads.
Figure 6-figure supplement 1: The length of prophase, anaphase and telophase is similar in
human and chimpanzee iPSCs, B cells and organoid APs. Length of prophase, anaphase and
telophase (A), and of total mitosis (B, sum of all mitotic phases described here and in Figure 6)
in human and chimpanzee iPSCs and B cells, determined from the experiments described in Figure
6. For comparison, the relevant mitotic phase lengths of human and chimpanzee cerebral organoid
APs from Figure 5–figure supplement 1 are shown (columns with dashed line). Data are the mean
± SEM of ≥30 cells from ≥3 independent experiments each.
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Figure 8-figure supplement 1: Cell cycle assignment for differential gene expression analysis.
(A) Hierarchical clustering was used to identify human organoid APs that most strongly expressed
genes enriched in G2M phase of the cell cycle (red). The genes were identified from PCA on
fetal cortex progenitor cells (top 100 correlating genes) [114]. The cluster with weakest expression
of these G2M associated genes was assigned as G1 phase (blue). Intermediate cells (grey) were
discarded from differential gene expression analysis. (B) A previously published method was used to
computationally assign cell-cycle stage based on a machine-learning approach [269]. This method
was generally consistent with our assignment based on the hierarchical clustering presented in panel
A. (C–F) The same approach was used to identify the chimpanzee organoid APs, endothelial cells
(ECs), and iPSCs that most highly express G2M markers. Note that all iPSCs analyzed highly




Source data can be found in the online version of the article (doi: 10.7554/eLife.18683)
Figure 1—source data 1
Processed single-cell RNA-seq data for chimpanzee cells.
*.txt file containing processed chimpanzee single-cell RNA-seq data (344 single cells) in
log2(FPKM) with genes in columns and cells in rows. The first 7 columns contain metadata
for each cell: cortex: assignment of cell to cortex (1) or to other regions within organoid(0);
tSNE 1: tSNE1 loading for each cell; tSNE 2: tSNE2 loading for each cell; PC1: PC1 loading
for each cell; PC2: PC2 loading for each cell; species: species of origin for each cell; cell id:
unique ID for each cell, with information about the experiment and the age of the organoid of
origin for each cell.
https://doi.org/10.7554/eLife.18683.004
Figure 1—source data 2
Genes describing cell populations in the chimpanzee organoids.
List of genes identified by PCA on all chimpanzee organoid single-cell transcriptomes as being
most informative for defining cell populations.
https://doi.org/10.7554/eLife.18683.005
Figure 3—source data 1
Processed single-cell RNA-seq data for human cells.
*.txt file containing processed human single-cell RNA-seq data (207 single cells) in log2(FPKM)
with metadata in first 4 columns for each cell: cell id: unique ID for each cell; experiment:
the experiment during which each cell was isolated; species: species of origin for each cell;
cortex: assignment of cell to cortex (1) or to other regions within organoid (0).
https://doi.org/10.7554/eLife.18683.011
Figure 3—source data 2
Results of differential gene expression analyses.
Excel file (*.xlsx) with multiple sheets containing results of all differential expression analyses
presented in the manuscript as well as GO enrichment analysis for the differentially expressed
(DE) genes: Sheet 1: Genes specific to APs, not DE between chimpanzee and human; Sheet
2: GO enrichment analysis for genes of sheet 1; Sheet 3: Genes specific to Neurons, not DE
between chimpanzee and human; Sheet 4: GO enrichment analysis for genes of sheet 3; Sheet
5: Genes specific to APs and upregulated to human compared to chimpanzee; Sheet 6: GO
enrichment analysis for genes of sheet 6; Sheet 7: Genes specific to Neurons and upregulated
to human compared to chimpanzee; Sheet 8: GO enrichment analysis for genes of sheet 7;
Sheet 9: Genes specific to APs and upregulated to chimpanzee compared to human; Sheet
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10: GO enrichment analysis for genes of sheet 6; Sheet 11: Genes specific to Neurons and
upregulated to chimpanzee compared to human; Sheet 12: GO enrichment analysis for genes
of sheet 11; Sheet 13: GO enrichment data used to generate Figure 3F.
https://doi.org/10.7554/eLife.18683.012
Figure 5—source data 1
Durations of all mitotic phases.
Numerical values in minutes for the duration of all mitotic phases ±SEM used in the graphs
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The human brain has undergone substantial change since humans diverged from chimpanzees
and the other great apes [223, 273]. However, the genetic and developmental programs un-
derlying this divergence are not fully understood. Here we have analysed stem cell-derived
cerebral organoids using single-cell transcriptomics and accessible chromatin profiling to inves-
tigate gene-regulatory changes that are specific to humans. We first analysed cell composition
and reconstructed differentiation trajectories over the entire course of human cerebral organoid
development from pluripotency, through neuroectoderm and neuroepithelial stages, followed
by divergence into neuronal fates within the dorsal and ventral forebrain, midbrain and hind-
brain regions. Brain-region composition varied in organoids from different iPSC lines, but
regional gene expression patterns remained largely reproducible across individuals. We anal-
ysed chimpanzee and macaque cerebral organoids and found that human neuronal development
occurs at a slower pace relative to the other two primates. Using pseudotemporal alignment
of differentiation paths, we found that human-specific gene expression resolved to distinct cell
states along progenitor-to-neuron lineages in the cortex. Chromatin accessibility was dynamic
during cortex development, and we identified divergence in accessibility between human and
chimpanzee that correlated with human-specific gene expression and genetic change. Finally,
we mapped human-specific expression in adult prefrontal cortex using single-nucleus RNA se-
quencing analysis and identified developmental differences that persist into adulthood, as well
as cell-state-specific changes that occur exclusively in the adult brain. Our data provide a tem-
poral cell atlas of great ape forebrain development, and illuminate dynamic gene-regulatory
features that are unique to humans.
Main text
Bulk genomic measurements in primary brain tissue from adult humans, chimpanzees and
other apes [46, 55, 141, 144], as well as from developing rhesus macaque [140, 151], have
identified molecular features that appear to be specific to the human brain. These studies
have largely been limited by ensemble averaging and it has been difficult to perform similar
experiments in developing great apes owing to the lack of available tissue. Cerebral organoids
[92] grown from great ape induced pluripotent stem cells (iPSCs) [82] offer the potential to
study the evolution of human brain development in controlled culture environments. Previous
single-cell sequencing studies have shown that human organoids can recapitulate many aspects
of in vivo cortex development [114, 116, 117, 128], and comparisons with other primate
organoids can be used to identify human-specific gene expression [20, 222]. However, the
gene-regulatory mechanisms that distinguish humans from the other primates are unclear. Here
we use single-cell RNA sequencing (scRNA-seq) together with accessible chromatin profiling
to understand human cerebral organoid development and explore how human cortical gene
expression programs have diverged from chimpanzee. We further analysed adult prefrontal
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cortex tissue using single-nucleus RNA-seq (snRNA-seq) to reveal the potential and limits of
cerebral organoids to study human-specific expression patterns.
We first used scRNA-seq (10x Genomics) to profile cell composition across a time course of
human organoid development from pluripotency to four months using embryonic stem cells
(H9) and an iPSC (409b2) line (Fig. 1a, Extended Data Fig. 1; 43,498 cells). We constructed
a force-directed k-nearest neighbour graph [274] based on pseudocells to visualize the temporal
progression (Fig. 1b). We tracked a progression through stem cell states during the first 15
days, and by 1 month, cells diversified into neural progenitor cells (NPCs) of multiple brain
regions including the forebrain (dorsal and ventral telencephalon and diencephalon), midbrain
(mesencephalon), hindbrain (rhombencephalon) and retina. By two months, excitatory and
inhibitory neuronal fates had differentiated, and by four months, astrocytes had emerged.
These observations were based on inspection of marker genes, comparisons to transcriptomes
from regions and cells from the developing human brain [76, 219], and analysis of spliced and
unspliced transcripts [275] (Fig. 1c,d, Extended Data Fig. 2).
We next analysed the reproducibility of gene expression patterns across pluripotent stem cell
(PSC) lines from different human individuals in two-month-old organoids (Fig. 1e, Extended
Data Fig. 3). We identified cells on the neuronal lineage (49,153 cells), classified distinct cell
types from different brain regions, analysed differentiation trajectories and ordered ventral and
dorsal telencephalic cells along pseudotimes (Fig. 1e–g, Extended Data Fig. 3). Consistent
with previous studies [113, 128], we found that each inducible PSC (iPSC) line contributed
cells to multiple differentiation trajectories; however, the proportions of cells in each trajectory
varied across organoid and line (Fig. 1f, Extended Data Fig. 3). Nevertheless, gene-expression
patterns of each trajectory across the lines were highly correlated and cells representing each
region clustered together (Fig. 1h, i, Extended Data Fig. 3). These data provide a temporally
and pseudotemporally resolved gene-expression atlas of the earliest stages of human brain
development and provide a baseline for identifying human-specific gene expression.
We next generated a gene-expression atlas of chimpanzee organoid development to dissect
features that differ from that of the human (Fig. 2a, Extended Data Fig. 4; 36,884 cells).
We identified dorsal and ventral telencephalon trajectories, as well as rhombencephalic cell
populations in chimpanzee organoids (Fig. 2b). We used time warping to align human and
chimpanzee cortical pseudotimes and observed that the latest pseudotime points in chimpanzee
failed to map to a human counterpart (Fig. 2c). We found that chimpanzee neurons express
higher levels of neuron maturation-related genes (Fig. 2d) and confirmed differences in matu-
ration using scRNA-seq data from additional human and chimpanzee individuals [20, 222], as
well as from macaque (Extended Data Figs. 5, 6). In addition, more astrocytes were observed
in chimpanzee organoids compared to humans at four months (Fig. 2e). We observed more
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Fig. 1: Reconstructing human cerebral organoid differentiation from pluripotency. a, scRNA-
seq was performed on iPSC- and embryonic stem cell (ESC)-derived cells (43,498) at different time
points during cerebral organoid differentiation from pluripotency. EB, embryoid body; N. ect., neu-
roectoderm; N. epi., neuroepithelium. b, All time points were combined, pseudocells (11,427) were
constructed and the differentiation trajectory was reconstructed using SPRING [274]. Pseudocells
are coloured by time point (main image) or cell line (top left). Org., organoid; RGC, radial glial cell.
c, RNA velocity analysis [275] supports differentiation of NPCs into distinct regions of the developing
human brain. d, Left, SPRING plot coloured (magenta) by reference similarity spectrum (RSS) to
bulk RNA-seq data generated from diverse brain regions at different time points (Allen Brain Atlas)
[76]. Shown are the tissues and time points with maximum correlation. CB, cerebellum. Right,
SPRING plot coloured (cyan) by marker gene expression. PCW, post-conception weeks. e, SPRING
reconstruction based on the RSS of organoid scRNAseq data from six iPSC lines and one ESC (H9)
line (49,153 cells), with clusters coloured by cell type. CGE, caudal ganglionic eminence; MGE,
medial ganglionic eminence; LGE, lateral ganglionic eminence; IN, inhibitory neuron; EN, excitatory
neuron. IP, intermediate progenitors; GE, ganglionic eminence. f, Proportion of cells per organoid
that are in the dorsal or ventral telencephalon or diencephalon, mesencephalon and rhombencephalon
(D/M/R) neuronal branches. g, Box plots (outliers removed) showing relative expression of marker
genes for major neuron populations that emerge in the human cerebral organoids. Boxes represent
interquartile range (IQR) and whiskers represent minimum and maximum with outliers removed.
UMI, unique molecular identifier. h, Dendrogram based on pairwise correlations between cells from
different lines, branches or stages based on pseudotime-dependent gene expression patterns. i, Pseu-
dotemporal expression patterns of neuronal differentiation markers for the dorsal (top) and ventral
(bottom) telencephalon trajectories for each line.
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pronounced upper- and deep-layer cortical neuronspecification in chimpanzee and macaque
organoids relative to human organoids at the same time point on the basis of expression, but
this was not consistent across lines, organoids and protocols (Extended Data Fig. 6). Our data
suggest that delayed maturation of the human brain [55, 57, 276] is observed in organoids and
can be traced back to early stages of development, consistent with previous reports comparing
human and macaque brain development in vivo [140] and in in vitro 2D cultures [59, 89].
We next aimed to detect human-specific changes in gene expression in the developing cortex.
We first inspected the expression of duplicated or rearranged genes (Supplementary Table 7)
and detected 23 of 24 genes included in the annotation, 4 of them specific to G2M phase
progenitors of the telencephalon (ARHGAP11B, FAM72B, FAM72C and FAM72D) [61]. We
next aligned all human, chimpanzee and macaque reads to a consensus genome and aligned
dorsal telencephalic trajectories between the species (Fig. 2f, Extended Data Fig. 7). We
then searched for genes that were differentially expressed specifically on the human branch, and
found that most of the observed human-specific deviations from chimpanzee and macaque were
expression gains (Fig. 2g); this was also observed for chimpanzee-specific changes (Extended
Data Fig. 7). We propose that this is because it is more deleterious to lose a highly conserved
gene expression pattern than it is to gain the expression of a new gene. Of the 98 identified
differentially expressed genes, 96 clustered into 7 pseudotemporal patterns (Fig. 2h–j), with
clusters 1, 2 and 3 specifically enriched in human radial glia, intermediate progenitors and
neurons, respectively (Fig. 2h). Genes with human-specific expression gain are associated with
diverse biological processes including proliferation of radial glia, neuron migration and neurite
formation, and are localized to different clusters of maturing neurons (Fig. 2i, j, Extended Data
Fig. 7). When comparing our results to previously published data on human and great ape
organoids and fetal brains [20, 222], we find strong overlap between datasets (Extended Data
Fig. 7). Using cells of ventral telencephalon identity, we find 92 genes differentially expressed
between human and chimp - 17% of them distinct from those differentially expressed in the
cortex (Extended Data Fig. 7). In sum, this analysis identifies human-specific gene expression
changes that may be specific to certain cell states within the developing human forebrain.
To identify potential regulatory mechanisms, we performed bulk and single-cell accessible chro-
matin profiling (scATAC-seq; Fluidigm C1) along the organoid-differentiation time course in
human and chimpanzee, including that of microdissected cortical regions (Fig. 3a–c, Extended
data Fig. 8). We analysed cell heterogeneity, ordered cells in pseudotime and dynamically mon-
itored transcription factor binding motifs and chromatin accessibility over the differentiation
path (Fig. 3d, Extended Data Fig. 8). We searched for differential accessibility between
human and chimpanzee cortical NPCs and neurons, and found that 7% and 9% of acces-
sible peaks showed increased and decreased accessibility in humans, respectively (Fig. 3e),
with many differential accessibility peaks being specific to either NPCs (53.8%) or neurons
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Fig. 2: Comparing human and chimpanzee organoids reveals human-specific features of cor-
tex development. a, scRNA-seq was performed on chimpanzee iPSC-derived cells at different time
points during cerebral organoid differentiation from pluripotency. b, The differentiation trajectory
was reconstructed using SPRING. Pseudocells (9,647) coloured on the basis of time point (main
image) or by trajectory pseudotimes (top left, alongside human data). c, Alignment of human and
chimpanzee pseudotimes after combining pseudocells from the early stages and the dorsal forebrain
lineage. d, Box plots (outliers removed) showing cumulative expression of neuron projection-related
genes in human and chimpanzee along unaligned cortical pseudotimes. Boxes represent IQR and
whiskers represent minimum and maximum with outliers removed. e, Astrocytes identified by scRNA-
seq in organoids at different time points, normalized by the corresponding number of radial glia. f,
Schematic of pseudotime alignment from cortical NPC to deeper layer neurons in human, chimpanzee
and macaque. g, Number of differentially expressed genes in human versus chimpanzee and macaque
comparison grouped by gain or loss of expression in humans. h, Average human–chimpanzee dif-
ferential expression (DE) patterns along the trajectory from pluripotent cells to cortical neurons
shown for the seven clusters of differentially expressed genes. NE, neuroepithelium; IPC, interme-
diate progenitor cell; Norm. FC, normalized fold-expression change. i, j, Distinct humanspecific
pseudotemporal expression patterns (i, cluster number with number of genes in parenthesis) and
exemplary genes (j) for each of the seven clusters.
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(33.8%). Differential accessibility peaks are enriched for distinct biological processes (Fig.
3f), and many differential accessibility peaks are accessible specifically in organoids (Fig. 3g)
and drive reporter expression in the mouse developing forebrain [277] (Extended Data Fig. 9).
Most differential accessibility peaks were located in non-protein-coding regions distal to the
promoter (Fig. 3h). The majority of genes that were differentially expressed between human
and chimpanzee along the dorsal telencephalon trajectory have one or more differential acces-
sibility peaks nearby (Fig. 3h), and are more likely to be near a differential accessibility region
than non-differentially expressed genes (Extended Data Fig. 9). Differential accessibility peaks
are also significantly enriched for single nucleotide changes (SNCs) that are fixed in humans
and distinct from other primates (Fig. 3i), some of which are predicted to generate new
or disrupt existing binding sites for organoid-expressed transcription factors (Extended Data
Fig. 9). We annotated differential accessibility peaks and identified organoid-specific poten-
tial regulatory regions near differentially expressed genes that have human-fixed SNCs, have
undergone accelerated evolution in humans (human accelerated regions (HARs)) or overlap
conserved regions that have been deleted in humans (hCONDELs) (Fig. 3j, Supplementary
Table 11). This analysis identified many regions specific to NPCs and neurons (Extended Data
Fig. 9), and we found 62 HARs that overlap differential accessibility peaks, one of which is
near cadherin 7 (CDH7), a gene with human-specific expression in neurons (Fig. 3k).
Finally, we wanted to know whether the human-specific gene expression patterns observed
in the developing cortex persist into adulthood. We generated snRNA-seq data from post-
mortem prefrontal cortex tissues of three humans, two chimpanzees, one bonobo and three
macaques by isolating nuclei from sequential sections from basal to apical positions [141]
(Fig. 4a). Nuclei clustered into different populations of neurons, astrocytes, oligodendrocytes,
microglia and endothelial cells (Fig. 4a, b, Extended Data Fig. 10). Genes specifically
expressed in neurons showed higher sequence conservation than genes specific to other cell
types (Fig. 4c), astrocytes had the largest number of human-specific differentially expressed
genes (Fig. 4d), and some genes with human-specific differential expression in excitatory
neurons showed layer specificity (Fig. 4e). A substantial fraction of the genes expressed in
excitatory or inhibitory neurons in the adult cortex were also detected in their counterparts in
the organoid telencephalon (Fig. 4f, Extended Data Fig. 10). Notably, relatively few genes
were commonly detected as differentially expressed (human versus chimp) in organoid and
adult excitatory (53 of 354) or inhibitory (13 of 217) neurons (Fig. 4g), and differentially
expressed genes detected ubiquitously in the organoid cortex show stronger consistency with
adult neurons compared with organoid NPC- or neuron-specific genes (Extended Data Fig.
10). Examples of human-specific differentially expressed genes in adult cell classes (Fig. 4h)
include differentially expressed genes detected in developing neurons, such as COL6A1, which
has been shown to have a protective role in ageing neurons [279]. These results suggest that,
with some exceptions, transcriptome differences between human and chimpanzee cortical cells
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Fig. 3: scATAC-seq reveals chromatin accessibility dynamics during cortex development and
evolution. a, scATAC-seq was performed at different time points of human and chimpanzee cere-
bral organoid development from pluripotency to four-month-old organoids (microdissected cortical
regions). b, Bulk, single-cell and aggregated (Agg.) single-cell ATAC-seq profiles from two-to-four
month-old organoids at a representative locus. c, ChromVAR [278]-based t-stochastic neighbour
embedding (t-SNE) of human (left, 518 cells) and chimpanzee (right, 908 cells) with cells coloured
by time point or cell state. d, Heat maps showing binding-motif enrichment for selected transcription
factors in cells ordered in pseudotime. e, Differentially accessible (DA) peaks detected between hu-
man and chimpanzee NPCs and neurons. f, Enrichment of selected biological-process gene ontology
(GO) terms associated with differentially accessible peaks in NPCs (gold) or neurons (light red) rela-
tive to all accessible organoid peaks. Grey dots indicate significantly enriched terms (hypergeometric
test, FDR <0.05 and twofold region-based enrichment). Cont., containing; comp., compound; reg.,
regulation; pos., positive. g, Top, percentage of differentially accessible peaks that are accessible
only in organoids (organoid specific) or also at earlier stages (not specific). Bottom, percentage
of human cells from each cell state accessible at differentially accessible peaks. h, A differentially
accessible peak was linked to the nearest expressed gene within 1 Mb of that gene’s transcription
start site. Top, number of differentially accessible peaks located in exonic (Ex), promoter (Pr),
intronic (In) or intergenic (Intergen) regions. Middle, percentage of differentially expressed genes
linked with differentially accessible peaks. Bottom, proportion of differentially expressed genes with a
differentially accessible peak at the promoter region (Prom. DA), distal region (Distal DA), both, or
no linked differentially accessible peak. i, Numbers of SNCs derived and fixed in humans overlapping
differentially accessible peaks and non-differentially accessible peaks (randomly sampled 2,000 times
to match the number and average accessibility of differentially accessible peaks). DE, differentially
expressed. j, Differentially accessible peak annotation noting overlap with selective sweeps (sel. sw.)
or HARs. k, A differentially accessible peak close to the differentially expressed gene CDH7 overlaps
fixed SNCs and a HAR. Bottom right, a gene correlation network with CDH7 highlighted. Expr.,
expression; Acc., accessibility; sc Agg., single-cell aggregated; cons., conservation.
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Fig. 4: Adult cortex snRNA-seq reveals shared and distinct patterns of gene expression
change compared to organoids. a, snRNA-seq was performed on sliced tissue cubes dissected
from adult human, chimpanzee or bonobo, and macaque frozen prefrontal cortex tissue. Projection
of integrated data shows different clusters of major cell classes in the different species (50,035 human,
33,847 chimpanzee or bonobo, and 50,403 macaque nuclei). Astro, astrocyte; Olig, oligodendrocyte;
OPC, oligodendrocyte precursor cell; Mic, microglia; End, endothelial cell. b, Average cluster
expression separated by species reveals similar patterns of marker gene expression for seven cell
classes. As, astrocyte; Ol, oligodendrocyte; OP, oligodendrocyte precursor; Mi, microglia; En,
endothelial cell. c, Genomic conservation (average phastCon scores) of markers for seven cell classes
(***P < 0.0001, two-sided Wilcoxon’s rank-sum test). Boxes represent IQR and whiskers represent
1.5 x IQR. d, Number of human-specific differentially expressed genes in each of the four major cell
classes. e, Predicted laminar expression patterns of three layer (L) markers (left) and six human-
specific differentially expressed genes (right) in adult excitatory neurons with size and shade of dots
above the expression pattern plot showing detection rates and average expression levels, respectively,
in the three species. f, log2(fold change) between excitatory and inhibitory neurons shows consistency
between organoid dorsal and ventral forebrain and adult tissue. g, Overlap of human–chimpanzee
differentially expressed genes detected in adult neurons and organoid trajectories. h, Dot plot
showing expression patterns and detection rates across adult and organoid cell classes for human-
specific differentially expressed genes in adult cell classes.
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are linked to developmental stages.
In sum, our data illuminate expression and regulatory features of cell states that are uniquely
human and provide an extensive resource to guide exploration into the gene regulatory mech-
anisms that distinguish the developing human and chimpanzee brains, some of which persist
into adulthood.
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Methods
No statistical methods were used to predetermine sample size. The experiments were not
randomized. The investigators were not blinded to allocation during experiments and outcome
assessment.
Pluripotent stem cell lines and organoid culture. We acquired 6 human induced pluripo-
tent stem cell (iPSC) lines (Sojd3, Hoik1, Kucg2, Wibj2 from the HipSci resource [280]; h409b2
from the RIKEN BRC cell bank [114]; Sc102a1 from System Biosciences), one human ES cell
line (H9, WiCell) [281], three chimpanzee iPSC lines (SandraA15; PR818-515, originally gener-
ated by the Gage laboratory and kindly provided to us by the R. Livesey group; JoC, generated
in this study), one bonobo iPSC line (Bokela, generated in this study), one ES macaque
cell line (MN1 [59], kindly provided through the R. Livesey group from E. Curnow) and one
orangutan cell line (Toba [222]). The iPSC line JoC (chimpanzee, Tchimpounga Sanctuary)
was reprogrammed from blood cells (primary lymphocytes) using plasmid based reprogram-
ming [81] and Bokela (bonobo, Zoo Leipzig) was reprogrammed from fibroblasts using the
StemMACS mRNA transfection kit (Miltenyi Biotec). Cell lines were validated for pluripo-
tency markers by immunhohistochemical stainings using the Human Pluripotent Stem Cell
3-Colour Immunohistochemistry Kit (R&D Systems, SC021) and were differentiated into the
three different germ layers using the Human Pluripotent Stem Cell Functional Identification kit
(R&D Systems) and StemMACS Trilineage Differentiation Kit (Miltenyi Biotec). Karyotyping
was carried out using Giemsa banding at the Stem Cell Engineering facility, a core facility of
CMCB at Technische Universität Dresden, and karyotypes were found to be normal. Cell lines
were cultivated using standard feeder-free conditions in mTeSR1 (StemCell Technologies) or
StemMACS iPS-Brew XF (Myltenyi Biotec) on matrigel-coated plates and differentiated into
cerebral organoids using a whole organoid differentiation protocol [250] (Supplementary Table
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1). Toba orangutan iPS cells were maintained on feeder cells and cultivated in ReproMix
(1:1 mix Primate ES medium (Reprocell) and TeSR2 (StemCell Technologies), 8 µg/ml bFGF
(Sigma), 50 U/ml Penicillin/Streptomycin (ThermoFisher)). Colonies were picked from feeder
cells to collect cells for generating EBs. Cell lines were regularly tested for mycoplasma us-
ing PCR validation (Venor GeM Classic, Minerva Biolabs) and found to be negative. Per-
mission to work with human and non-human primate iPSC lines was obtained through the
Sächsisches Staatsministerium fur Umwelt und Landwirtschaft (Az.: 55- 8811.72/26, Az.: 55-
8811.72/26/382, Az.: 55-8811.72/26/393, 54-8452/26/7). The utilization of hESCs for the
generation of cerebral organoids was approved by the ethics committee of the Robert Koch
Institut (https://www.rki.de/DE/Content/Gesund/Stammzellen/Register/reg-20161027-
Paeaebo.html) as well as by the Ethics committee of northwest and central Switzerland (2019-
01016) and the Swiss federal office of public health.
Single-cell RNA-seq data generation. A summary of all single-cell experiments can be
found in Supplementary Table 1. For organoid experiments (1 month, 2 months, 3 months, 4
months), whole organoids were dissociated for generating single cell gene expression libraries. In
brief, organoids were transferred to HBSS (without Ca2+ and Mg2+,-/-) and cut into two pieces
to clear away debris from the centre of the organoid (2–3 washes in total). Organoid pieces were
then dissociated using Neural dissociation kit (P) using Papain-based dissociation (Miltenyi
Biotec). Organoid pieces were incubated in Papain at 37 ◦C (enzyme mix 1) for an initial 15
min, followed by addition of Enzyme A (enzyme mix 2) to the Papain mix. Organoid pieces
were then triturated using wide bore 1,000-ml tips and incubated for additional intervals of 5-
10 min with triturations between the incubation steps, amounting to a total Papain incubation
time of approximately 45 min. Cells were filtered through a 30 µm strainer and washed,
centrifuged for 5 min at 300 g and washed 3 times with HBSS (-/-). Cells were then analysed
using Trypan Blue assay, counted using the automated cell counter Countess (Thermo Fisher),
and diluted for an appropriate concentration to obtain approximately 6,000 cells per lane of
a 10x microfluidic chip device. Typically, cells from one organoid were loaded per lane in the
microfluidic device, and in some cases organoids from different lines were pooled onto the same
lane and demultiplexed based on single-nucleotide polymorphisms. For 1 month organoids,
three pooled 409b2 and one H9 organoid were dissociated and cells from the two cell lines
were mixed at equal ratios to be loaded on the chip. For a set of 2 month HipSci organoid data,
organoids were dissociated for all four HipSci cell lines and pooled at equal ratios to be loaded
on one lane of the microfluidic device aiming for 10k cells. Fluidigm C1 data (Supplementary
Table 1) were generated as previously described [222] and cells from chimpanzee SandraA 75d
organoids were microdissected regions from vibratome slices for which single cell suspensions
were generated as described above. Single cells were then sorted into 96-well plates using a
FACS Aria III sorter and further processed using the SmartSeq2 protocol [195] to generate
cDNA and the NexteraXT kit (Illumina) to generate sequencing libraries. All libraries (10x
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and Fluidigm C1/SmartSeq2) were sequenced on Illumina’s Hiseq2500 platform in paired-end
mode (100 bp Fluidigm C1/SmartSeq2; 26+8 bp, 100 bp 10x).
Early stages of organoid differentiation (iPS cells to neuroepithelium). For iPSC/ESC
single-cell experiments, cells were detached from cell culture dishes using TrypLExpress (Thermo
Fisher) incubation for 5 min followed by addition of mTeSR1. Cells were centrifuged for 5
min at 200g and resuspended in mTeSR1, filtered through a 20 µm strainer and washed with
mTeSR1. Cells were then centrifuged again for 5 min at 200g and resuspended in mTeSR1,
counted, diluted to the same concentration and mixed at equal ratios for the three cell lines
to be loaded on the 10x microfluidic chip aiming for 10,000 cells. Thirty embryoid bodies
(EBs), 7–15 neuroectoderms, and 1–3 neuroepithelium of each cell line were pooled for each
dissociation, respectively. Cells were obtained by papain dissociation as described above for
organoid dissociation, with slightly shorter incubation times in enzyme mix 1 (approximately
30 min.). For 10x experiments, cells from the three different cell lines were diluted and mixed
at equal ratios to be loaded on the microfluidic chip device.
Single-cell experiments were conducted using the 10x Chromium Single Cell 3’ v2 Kit follow-
ing the manufacturer’s instructions. In brief, cells were mixed with reverse transcription mix,
gel beads and oil were loaded on the chip device to be coencapsulated into droplets, which
underwent first strand cDNA synthesis thereby tagging mRNAs with a UMI and a unique cell
barcode. All following steps were conducted in bulk by breaking the droplets and cleaning up
and amplifying the cDNA. Single-cell libraries were then constructed by fragmentation, end
repair and adaptor ligation and amplification using library specific index sequences as provided
by 10x Genomics. Quantification and quality control of libraries was performed using High
Sensitivity DNA assays for Agilent’s Bioanalyzer and sequenced on a HiSeq2500 in Rapid or
HighOutput sequencing mode. Typically, one 10x library was sequenced on one lane of a se-
quencing flow cell, with the exception of the HipSci organoids for which three pooled libraries
(each library contained pooled cells from four dissociated HipSci organoids from different cell
lines) were sequenced on two lanes of a flow cell. See Supplementary Table 1 for more details.
Immunohistochemistry Organoids were washed in PBS before fixing in 4% PFA for 2–4 h.
The excess of fixative was removed with three PBS washes and organoids were then transferred
to a 30% sucrose solution for 24–48 h for cryoprotection. Finally, organoids were transferred
to plastic cryomolds (Tissue Tek) and embedded in OCT compound 4583 (Tissue Tek) for
snap-freezing on dry ice. For immunohistochemical stainings, organoids were sectioned in slices
of 20 µm thickness using a Leica CM3050 S cryostat and Microm HM 560 (Thermo Fisher
Scientific) at -15 to -20 ◦C. Organoid sections were quickly washed in PBS to remove any resid-
ual OCT. Then, sections were incubated in antigen retrieval solution (HistoVT One, Nacalai
Tesque) at 70 ◦C for 20 min. Excess solution was washed away with PBS and the tissue was in-
cubated in blocking-permeabilizing solution (0.3% Triton, 0.2% Tween-20 and 5% normal goat
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serum in PBS) for 1h at room temperature. Afterwards, sections were incubated overnight
at 4◦C in blocking-permeabilizing solution containing antibodies anti-PAX6 (mouse, 1:1,000,
Thermo Fisher Scientific, MA1-109; rabbit, 1:300, Covance, PRB-278P)and anti-CTIP2 (rat,
1:1,000, Abcam, AB18465), anti-SATB2 (rabbit, 1:500, Abcam, Ab92446; mouse, 1:500, Ab-
cam, Ab51502), anti-Tbr2 (mouse, 1:500, MPI-CBG Antibody Facility [61]). On the next
day, sections were rinsed three times in PBS before incubation for 1 h at room tempera-
ture in secondary antibody solution, which contained blocking-permeabilizing solution, DAPI
(1:3000), Alexa Fluor 488-conjugated anti-rabbit antibody (goat, 1:1,000, Thermo Fisher,
A11008), Alexa Fluor 546-conjugated anti-mouse antibody (goat, 1:500, Thermo Fisher Sci-
entific, A-21123), Alexa Fluor 647-conjugated anti-rat antibody (goat, 1:500, Thermo Fisher
Scientific, A-21247) and Alexa Fluor 488-conjugated anti-mouse (A21202) and anti-rat an-
tibody (A21208), Alexa Fluor 555-conjugated anti-rabbit antibody (A31572), Alexa Flour
647-conjugated anti-mouse antibody (A31571) (all donkey-derived, 1:500, Molecular Probes).
Finally, remainders of secondary antibody solution were washed off with PBS before covering
with ProLong Gold Antifade Mountant medium (Thermo Fisher Scientific). Stained organoid
cryosections were imaged using a confocal laser scanning Olympus Fluoview FV1200 micro-
scope and Zeiss LSM 880 Airy upright microscope. Whole-section tilescans composed of 3
different z-plane images (z-step = 5-8 µm) were acquired using a 10x magnification objective,
Plan-Apochromat 10x/0.45 M27 and Plan-Apochromat 20x/0.8 M27 objectives. Images were
then stitched, stacked and further processed using the Olympus Fluoview 4.2b software and
ImageJ (Fiji).
Single-cell RNA-seq data preprocessing. We used Cell Ranger, the set of analysis pipelines
suggested by 10x Genomics, to demultiplex raw base call files to FASTQ files and align reads
to the human genome and transcriptome (hg38, provided by 10x Genomics) with the default
alignment parameters. Pooled samples, including samples from different species or human
lines, were then demultiplexed using a two-step procedure based on the read mapping results.
In the first step, the genome alignment between human (hg38) and chimpanzee (panTro5)
was downloaded from UCSC Genome Browser. Sites with diverged bases between human
and chimpanzee were obtained based on the genome alignment. Reads covering the species-
diverged sites were collected for each reported cell, with the number of bases matching each
species counted. Cells with more than 80% reads covering the species-diverged sites matching
with one species were assigned as cells from the species. For those samples with human cells
from different lines pooled, a second step of demultiplexing was done using demuxlet [282],
based on the genotyping information of lines downloaded from HipSci websites (Kucg2, Wibj2,
Hoik1, Sojd3) or called using bcftools based on the unpooled scRNA-seq data (H9, 409b2).
Cells with the best singlet likelihood no less than 50 higher than the second best singlet likeli-
hood and estimated mixture ratio less than 30% were labelled as their bestmatched lines. All




Seurat [283] was then applied for further data processing. Cells with more than 6,000
or less than 200 detected genes, as well as those with mitochondrial transcripts proportion
higher than 5% were excluded. After the log-normalization, confounding factors including the
number of detected genes and proportions of mitochondrial transcripts were also regressed
out. Highly variable genes were then obtained as genes with dispersion higher than 0.5 and
normalized expression level between 0.0125 and 3, followed by principal component analysis
(PCA) based on the z-transformed expression levels of the identified highly variable genes
(Supplementary Table 2). The top-20 principal components (PCs) were used to do clustering
(with a resolution of 0.6) using Seurat. Additional quality controls of the measured cells
were based on primary cell type predictions by using public human fetal brain scRNA-seq data
(Nowakowski dataset)[219]. In brief, a Lasso logistic regression model was built, using gene
expression ranks of the Nowakowski dataset as the training set, to predict the primary cell type
identity of each single cell in two-month-old and four-month old organoids. Cells which were
predicted to be of ’glycolysis’ identity were excluded, so as cells in the Seurat clusters where
more than 80% of cells were predicted as of ‘glycolysis’ identity. Heterogeneity analysis of
human (Extended Data Fig. 2, Supplementary Tables 3, 4) and chimpanzee (Extended Data
Fig. 4, Supplementary Tables 5, 6) full lineage data was performed using t-SNE based on the
top PCs identified (top 20 PCs for human, top 15 PCs for chimpanzee). Cluster identities
were assigned based on cluster gene markers (Supplementary Tables 4, 6) as determined by
FindAllMarkers function in Seurat (min percentage of cells expressed = 0.25 and log fold
change threshold = 0.25) and gene expression of known marker genes. For human data,
cells from 409b2 and H9 and were integrated using canonical correlation analysis (CCA) as
implemented in Seurat (v.3). In brief, data were normalized and the top 2,000 highly variable
genes for 409b2 and H9 cells were determined using the vst method. The datasets were
integrated based on the top 20 CCs using the Seurat method by identifying anchors and
integrating the datasets. The resulting integrated data were scaled and PCA was performed.
Clustering was performed based on the top 20 PCs and using a resolution of 0.6. Feature plots
show non-integrated expression values. Cluster markers were determined using Wilcoxon test
considering only genes that show a minimum log fold expression change of 0.25 in at least a
fraction of 0.25 of cells in the clusters using the non-integrated expression values.
RSS and construction of pseudocell transcriptomes. RSS of one cell to the Human
Developing Brain atlas (BrainSpan) was defined as the normalized similarity between gene
expression levels of the cell and gene expression levels of each of the 237 fetal samples with
RNA-seq data in the BrainSpan database in Allen Brain Atlas. To increase discrimination
of different reference samples, only the highly variable genes of the BrainSpan dataset (see
Supplementary Table 2), defined based on expression variation-mean comparison of the refer-
ence dataset, were used for the RSS calculation. Between each cell and each sample in the
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BrainSpan dataset, Pearson correlation coefficient (PCC) was calculated across the BrainSpan-
highly variable genes. z-Transformation was then applied to PCCs between each cell to the 237
fetal BrainSpan samples to get the normalized similarities. To construct pseudocells, single
cells were first grouped based on their sample sources and Seurat clusters. Within each group
of cells, that is, those cells from the same sample and in the same Seurat cluster, cells were
selected randomly with a selection probability of 20%. The selected cells were called pseudo-
cell seeds or territory capitals. The ten nearest neighbours of each seed, based on Euclidean
distances of the top-20 PCs, were then assigned to the seed, forming a pseudocell territory.
If one cell was assigned to multiple pseudocell territories, one territory was chosen randomly.
The expression level of one gene in each pseudocell was then calculated as the average gene
expression level across cells in the pseudocell territory.
Visualization, lineage identification and pseudotime estimation of pseudocells for re-
constructing human cerebral organoid differentiation from pluripotency. First, PCA
was applied to a pseudocell expression matrix using the z-transformed expression levels of the
highly variable genes as input. Euclidean distance between the top 10 PCs of each pair of
pseudocells was calculated and a k-nearest neighbour (kNN) network (k = 100) was then cal-
culated with the constraint to only consider pseudocells from the same or nearby stages when
screening for nearest neighbours. The kNN network was visualized using SPRING [274]. To
construct the pseudotime course of human cerebral organoid differentation from pluripotency,
the Walktrap community identification algorithm (implemented in the R package igraph) was
applied to the above kNN network to identify network communities. The resulting communi-
ties were manually aggregated into four groups to minimize branches in each group. A diffusion
map algorithm (implemented in R package destiny [225]) was applied to pseudocells in each
of the four groups, with the expression levels of the highly variable genes of pseudocells as the
input. The ranks in DC1 were used as the pseudotimes. We used an F -test based ANOVA
analysis to identify genes with pseudotime-dependent expression patterns. In brief, we estab-
lished a natural splined linear regression model (ns function in the R package splines) with
six degrees of freedom (df), with expression levels as the response variable and pseudotimes
as the independent variable, for each of the highly variable genes. An F -test was applied, to
compare variation explained by the splined linear model with that of the residuals normalized
by degrees of freedom. Bonferroni correction was performed across tested genes, with a cor-
rected P value threshold 0.01 to identify genes with pseudotime-dependent expression. The
analysis was applied to the four groups of pseudocells separately.
Visualization, lineage identification, pseudotime estimation of cells in human two–
month-old cerebral organoids from different individuals. Pseudocells were constructed
for the human two-month-old organoids as above with constraint on samples and based on
cells with predicted primary cell types as one of radial glia, intermediate progenitor, excitatory
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neuron, and inhibitory neuron. RSS to the BrainSpan fetal samples was calculated for each
pseudocell, with distance between two pseudocells defined as the correlation distance between
RSS of the two pseudocells. The kNN network (k = 20) was then constructed and SPRING
was used to determine coordinates of pseudocells for visualization. To further discriminate
pseudocells representing different neuronal lineages, a Walktrap algorithm for network com-
munity identification was applied to the RSS-based kNN (k = 100). Communities that were
significantly connected and showing concordant marker expression or similarity spectrum were
aggregated, which resulted in three progenitor-to-neuron trajectories. Based on gene expres-
sion level ranks of cells in the three defined trajectories, two Lasso logistic regression models
were trained, one for classification of cortical and ventral lineage, while the other one for
classification of all the three trajectories. The first model was applied to pseudocells in the
community C6 which was significantly connected to cortical and ventral trajectories, while
the second model was applied to pseudocells in the community C4, which was significantly
connected with both the non-telencephalon pseudocells and community C4. With a unique
lineage label defined for each pseudocell, a 1 x 500 self-organizing-map (SOM) model was
trained for each of the three trajectories, using RSS of pseudocells within the lineage as the
training data. The index of neuron that one pseudocell was assigned to was used as its pseu-
dotime. Diffusion map analysis was also applied to pseudocells at each trajectory, with highly
variable gene expression as the input, with ranks of DC1 defined as alternative pseudotime
of pseudocells. Pseudotimes obtained by the two methods are highly correlated (Spearman
correlation is 0.91 and 0.92 for the dorsal and ventral telencephalon trajectories, respectively).
To project the single-cell data to the cell embedding space that was defined for pseudocells,
two support vector regression (SVR) models (implemented in the R package e1071), each
of which was for one dimension of the embedding, were trained using RSS of pseudocells as
the training set. The trained models were applied to RSS of single cells for their predicted
coordinates. Such coordinates were further refined by pushing each cell to its nearest pseudocell
with smallest correlation distance of RSS to be 70% closer. Similarly, a support vector machine
(SVM) model was trained (implemented in the R package e1071) using RSS of pseudocells
for the three trajectories, and applied to RSS of single cells for their trajectory identity. After
that, the corresponding SOM model for pseudotime estimation was applied to RSS of each
single cell for its estimated pseudotime.
Dynamic time warping-based alignment of pseudotime courses. We used a dynamic
time warping (DTW) algorithm to align different pseudotime courses. In brief, each pseudotime
course was evenly broke into 50 blocks. Average gene expression levels of pseudocells or cells
within each block was calculated. Pairwise distances between blocks from the two courses
were calculated as the Pearson correlation distance, that is, 1 - PCC, across the highly variable
genes in cells of both pseudotime courses. Suppose di,j represents the distance between the i-th
block in the reference pseudotime course and the j-th block in the query pseudotime course.
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We defined D as the alignment distance matrix, where
Di,j = min(Di-1,j ,Di,j-1,Di-1.j-1) + di,j
A trace-back procedure was then performed to get the alignment. Three modes of alignment
were implemented. In the first mode, the fixed-end alignment, the initialization of D was done
as:
Di,j =
di,1 if j = 1D1,j-1 + d1,j if i = 1
In the other two modes, the fixed-start and end-to-end alignments, D was initialized as:
Di,j =

d1,1 if i = 1 and j = 1
D1,j-1 + d1,j if i = 1
Di-1,1 + di,1 if j = 1
In the trace-back step, a fixed-end and end-to-end alignment was started from DM,N , where M
and N are the numbers of blocks at the reference and query pseudotime courses, respectively.
On the other hand, the trace-back step was started from Dm,N , where m = argmini(Di,N). In
our study, the fixed-end alignment was used to align the cortical and ventral lineage pseudotime
course of human organoid cells; the fixed-start alignment was used to align pseudotime courses
of human and chimpanzee cortical pseudocells; the end-to-end was used in the truncated
alignment of pseudotime courses of different species.
Reconstruction of chimpanzee cerebral organoid differentiation from pluripotency.
We applied a similar procedure as mentioned above describing the reconstruction of human
cerebral organoid differentiation from pluripotency to reconstruct the organoid differentiation
trajectory from chimpanzee single-cell RNA-seq data. In brief, the single-cell RNA-seq reads
were mapped to the human-chimpanzee-macaque consensus genome and counted using Cell
Ranger. Seurat was used for further preprocessing including gene expression normalization,
confounding factor regression, PCA and clustering, Cells from organoid samples with predicted
primary cell type identity of ‘glycolysis’, as well as cells within clusters with more than 80%
cells having ‘glycolysis’ identity, were excluded. Pseudocells were then constructed with a seed
selection probability of 20% and constraints on samples and Seurat clusters. PCA was ap-
plied to expression levels of highly variable genes across pseudocells, and pairwise distances of
pseudocells were calculated as the Euclidean distances between the top-10 PCs. The kNN net-
work (k = 100) of pseudocells was constructed, linking every pseudocell with its 100-nearest
pseudocells representing the same or nearby stages. Three-month-old and four-month-old
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organoids were seen as the same stage. The Walktrap network community identification algo-
rithm was applied and the resulted community labels (walktrap communities) of pseudocells
were compared with the predicted community labels (projected communities) based on a Lasso
logistic regression model trained by ranks of gene expression levels of the human pseudocells
representing the human organoid differentiation from pluripotency as described above. Any
walktrap community with <1,000 kNN connections with other communities was discarded.
One of the four labels: early, cortical, ventral, non-telencephalon was assigned to one walktrap
community if more than 95% of pseudocells within the community were from the same group
according to their projected communities. For one community with more than 10% of pseu-
docells with projected communities belonging to both ventral and midbrain-hindbrain groups,
the non-telencephalon label was only assigned to pseudocells with projected communities in
the non-telencephalon group. The diffusion map algorithm was applied to each of the four
pseudocell groups, using the expression levels of highly variable genes as input, to estimate
their pseudotimes. For the cortical, ventral and midbrain-hindbrain groups, the ranks of DC1
was used as the pseudotimes. For the early group, a principal curve (implemented in the R
package princurve) was fitted in the DC1–DC2 space. The order of pseudocells projecting to
the resulted principal curve was used as the pseudotimes.
Human-chimpanzee-macaque consensus genome. The construction of the consensus
genome was performed using the procedure as described [141, 156]. In brief, the chained
and netted pairwise genome alignments of the human (hg38) and chimpanzee (panTro5)
genomes, and the human and macaque (rheMac8) genomes, were downloaded from UCSC
Genome Browser. Based on the downloaded pairwise genome alignments, a multiple genome
alignment of human-chimpanzee-macaque was constructed using multiz. Based on the human-
chimpanzee-macaque genome alignment, we constructed the consensus genome by masking
all discordant sites including mismatches, insertion/deletion (indels), as well as 6-bp flanking
regions of indels on the human genome. The obtained consensus genome was indexed with
gene annotation in GENCODE v.27 for read mapping to the consensus genome with Cell
Ranger.
Pseudotime estimation of cerebral organoid cells in different species. Single cell
RNA-seq data of organoids with ages from two-month-old to four-month-old in human, chim-
panzee, and macaque were mapped to the human-chimpanzee-macaque consensus genome
and counted using Cell Ranger. Further preprocessing using Seurat was applied separately for
data from the three species. Only cells with predicted primary cell type identities as radial
glia, intermediate progenitors, excitatory neurons, or inhibitory neurons were included in the
later analysis. Pseudocells were constructed for humans and chimpanzees, both with a coarse
grain ratio of 20% and constraints on samples and Seurat clusters. The RSS to the BrainSpan
dataset was calculated for each pseudocell, and the SVM model for lineage estimation was
99
CHAPTER 2
applied to estimate the lineage identity of each pseudocell. Focusing on the cortical lineage,
a diffusion map analysis was applied to cortical pseudocells of the three species, respectively.
The ranks of DC1 were used as the pseudotimes of the pseudocells. In macaque, similar
procedure was applied directly to single cells without pseudocell construction.
Truncated DTW-based alignment of pseudotime courses representing neural progen-
itors and deeper layer neurons in different species. We used the first DC discriminating
BCL11B+ and SATB2+ cortical neurons (DC3 in chimpanzee, DC4 in macaque) to identify
upper layer (UL) neurons, as the pseudocells in the branch with highest expression level of
SATB2. To identify potential upper layer neurons in human, we first retrieved markers of up-
per and deeper layer (DL) excitatory neurons [219]. The sum expression levels of UL and DL
markers was then calculated for each pseudocell in human and chimp, with the UL-specificity
score (sUL) being defined as the UL/DL markers expression ratio. The distribution of (sUL)
in UL neurons in chimpanzee was used to determine the threshold to discriminate UL neurons
from other cell types (sUL > 0). All UL neurons in the three species were excluded from the
following analysis.
To correct for the DL neuron maturation timing differences between human and the other
two species, a two-step pseudotime course alignment strategy was used. The first step, namely
the trimming step, aims to determine the pseudotime points in chimpanzee and macaque which
correspond to the latest pseudotime point in human. In brief, an SVR model with Gaussian-
kernel was first constructed, with chimpanzee or macaque pseudotimes as the response vari-
ables and the RSS as the dependent variables. Two models were trained with the chimpanzee
pseudocells and macaque cells respectively, and applied to the human pseudocells to predict
their corresponding chimpanzee and macaque pseudotime points. Two constrained B-splines
regression models (FHC, FHM) were then fitted (implemented in the R package cobs): human
pseudotimes of human pseudocells (t̂h) versus their predicted chimpanzee (t̂c) or macaque (tm)
pseudotimes, with constraints of FHC(th = 0) = FHM(th = 0) = 0. FHC(th = 1) and FHM(th
= 1) were used as the pseudotime thresholds to select chimpanzee pseudocells and macaque
cells. Chimpanzee DL neurons with pseudotime tC > FHC(th = 1), as well as macaque DL
neurons with pseudotime tM > FHM(th = 1), were excluded in the following analysis. The
second step, namely the alignment step, was then applied to the remaining pseudotime courses
of the three species. An end-to-end DTW-based alignment, as described above, was used to
align the human pseudotimes with pseudotimes of each of the other two species using the
human pseudotime course as the template.
Identification, clustering, and species specificity of differentially expressed genes
between humans and chimpanzees. Human genes resulting from duplication or rear-
rangement that do not exist in other apes were collected via literatures [61, 63, 65, 284].
In total, 41 genes were obtained, 24 of which were included in the human gene annotation
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in Cell Ranger. 23 of them were detected in at least one human cell, with FCGR1B being
the exception. Expression patterns of those genes were examined and summarized manually
(Supplementary Table 7).
To compare transcriptome changes of the developmental trajectory from cortical neural
progenitors to deeper layer neurons between human and chimpanzee, an F -test based compar-
ison was applied to the expression profile along pseudotimes of the two species. In brief, for
each gene, a natural spline linear regression model (df = 6) was constructed for human and
chimpanzee pseudocells along the aligned pseudotime course, without discriminating human
and chimpanzee samples, and used as the null model (m0). The alternative natural spline
linear regression model was also constructed, with each species having its own slopes and
intercept (m1). The residuals of the variation, which cannot be explained by each model, were
compared by an F -test. Non-ribosomal genes with BH-corrected P < 0.01 were identified as
differentially expressed (DE) genes between human and chimpanzee along the developmental
trajectory from cortical neural progenitors to deeper layer neurons (Supplementary Table 8).
To estimate the robustness of the identified differential expression to the number of used
lines, as well as the pseudocell distribution along the pseudotime course, we used a series of
replaceable pseudocell sampling procedure with constraints. In brief, in each round of replace-
able pseudocell sampling, the candidate pseudocells to be selected are restricted to be those
from a certain number of human cell lines. In addition, the subsampling in human pseudo-
cells is performed to recapitulate the pseudocell distribution along the aligned pseudotime of
chimpanzee pseudocells, that is, each of the ten pseudotime bins contains the same number
of human and chimpanzee pseudocells. This sampling procedure was performed 100 times
for each possible number of human lines, ranging from one to seven. Differential expression
analysis, as described above, was applied to compare gene expressions of human pseudocells
in each sampling with the chimpanzee pseudocells. Robust DE genes were determined as DE
genes which can be detected in at least 80% of tests performed with replaceable pseudocell
samplings with any number of used human cell lines.
A similar strategy was also used to estimate the false positive human-chimpanzee DE genes
due to differences between cell lines. In each sampling, two lines were randomly selected as
group one, and a certain number of lines, ranging from one to five, were selected from the
remaining lines as group two. For each group, pseudocells were randomly sampled from the
selected lines to recapitulate the pseudocell distribution along the aligned pseudotime of chim-
panzee pseudocells. Such sampling was performed 100 times for each possible number of lines
used in group two. The transcriptome trajectory from cortical neural progenitors to deeper
layer neurons in macaque organoids was used as the evolutionary outgroup to determine species
specificity of the identified human-chimpanzee DE genes. First, the cumulative expression di-
vergences of each gene between human and macaque (dHM), and between chimpanzee and
macaque (dCM), were calculated. The cumulative expression divergence was calculated by sum-
ming up absolute values of average expression differences between species at the 50 pseudotime
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bins of equal sizes along the aligned pseudotimes. The human-chimpanzee DE of one gene is
seen as human-specific if dHM – dCM > max(dHM, dCM)/2. Genes with chimpanzee-specific
differential expression were identified in the same way. Genes with human-specific differential
expression were then clustered based on their human–chimpanzee DE along pseudotimes. Av-
erage expression differences between human and chimpanzee at each of the 50 pseudotime bins
along the pseudotimes was calculated for each gene with human-specific differential expression






chical clustering (Ward algorithm) was then used to cluster those genes into nine clusters,
with distances between genes calculated as the Euclidean distances between their normalized
differential expression spectrums. Clusters with fewer than five genes were discarded. We an-
notated genes with human-specific expression patterns using the Homo sapiens Gene Ontology
Annotation file (validation date: 21 April 2017) provided by the Gene Ontology Consortium.
Processing of the Fluidigm C1 based scRNA-seq data of cerebral organoids. In
addition to the newly generated Fludigm C1 (SmartSeq2)-based scRNA-seq data, we fur-
ther retrieved published sequencing data of 786 and 344 single cells from human and chim-
panzee cerebral organoids [114, 222], in the format of FASTQ files from GEO accession
numbers GSE75140 and GSE86207 (CMK dataset). All the reads were mapped to the human-
chimpanzee-macaque consensus genome using STAR (v.2.6.1d) with ‘–quantMode’ parameter
set to TranscriptomeSAM and GENCODE v.27 annotation provided. Gene expression levels
in each cell were quantified as TPM by RSEM (v.1.3.1). Additionally, we retrieved the re-
cently published gene expression matrix representing 3,211 cells from human and chimpanzee
cerebral organoids (excluding redundant cells from GSE75140 and GSE86207) and 4,854 cells
from human and macaque fetal brains [20].
Based on the resulting gene expression profile, RSS to the fetal Brainspan dataset was cal-
culated as described above for each cell, with 248 genes with significant differential expression
between cortical neurons measured by Smart-seq and Smart-seq2 excluded from the references.
Distances between organoid cells were calculated as the Pearson’s coefficient distances between
RSS of cells. Distances between cells from fetal brains were calculated in the same way. The
resulted distance matrices of all organoid cells and fetal brain cells were used as the input
to generate t-SNE embeddings. A kNN network (k = 50) was generated for organoid cells
and fetal brain cells separated based on the RSS-based distances, and a Walktrap algorithm
for network community identification was applied to identify cell clusters, which were further
annotated based on their marker genes. Based on the cell type annotation, the diffusion map
analysis, with the RSS profiles as input, was applied to the dorsal forebrain NPCs and neurons
in organoids and fetal brains, respectively. The ranks of DC1 were used as the pseudotimes.
To validate the human-chimpanzee differential expression identified in our droplet-based
scRNA-seq data using the C1-based cerebral organoid data, the organoid dorsal telencephalon
pseudotemporal trajectory was first split into ten intervals. In each pseudotemporal interval,
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the human-chimpanzee DE was calculated as the log2-transformed fold change (log2FC) be-
tween the average expression of human and chimpanzee cells in the interval. Here, the CMK
dataset and other datasets which used a distinct quantification method were processed sepa-
rately. A similar strategy was also applied to the aligned droplet-based human and chimpanzee
pseudotemporal trajectories. Generalized log2-transformed fold change (g log2FC), defined as
the average log2FC across the pseudotemporal intervals, as well as the maximum log2FC across
the intervals (mlog2FC), was further calculated for each human-chimpanzee robust DE genes
in organoids. A DE gene is seen as being consistent in the two datasets if both g log2FC and
mlog2FC of the C1-based and droplet-based human-chimpanzee comparisons are of the same
signs (refer as consistent DE genes). The pseudotemporal intervals with the maximum fold
change in the droplet-based and C1-based trajectories were also obtained and compared for the
consistent DE genes. This procedure was also applied to compare human-macaque differential
expression of the human-specific DE genes along the droplet-based pseudotemporal trajectory
and the C1-based fetal brain pseudotemporal trajectory.
Single-cell and bulk ATAC-seq data generation. Two-month-old and four-month-old
organoids were washed twice with PBS in a Tissue-Tek Cryomold (Sakura), then embedded in
4% low-melting agarose (Sigma) and sliced into 150 µm sections using a vibrating microtome
(Ci 7000 smz, Camden Instruments). Slices were placed on microscope slides containing
Differentiation medium with vitamin A (Diff+VA) and inspected under a stereomicroscope to
dissect cortical regions. Selected regions were washed twice in 500 µL PBS and incubated at
37◦C in 500 µL Accutase (Sigma) plus 0.5 µL DNase I (New England Biolabs) for 45 min.
Trituration was performed for additional mechanical dissociation. Cells were passed through a
30 µm pre-separation filter (Miltenyi Biotec), washed with Diff+VA medium, and spun down at
300g (Heraeus Megafuge 40R, Thermo Scientific) for 5 min. The cell pellet was resuspended
in 200 µL of Diff+VA medium. Cells were viewed under a microscope to ensure a single
cell suspension was obtained, and then counted using a Countess Automated Cell Counter
(Invitrogen). Single cell suspensions for the early stages of organoid differentiation (iPS cells
to neuroepithelium) were obtained as described above.
From the cell suspension, 50,000 cells were used as input for bulk ATAC-seq as described
[285]. The remaining cells were diluted to a final concentration of 300 cells/µL and used
for microfluidics based single-cell ATAC-seq as described [197]. In brief, cells were mixed
with Suspension Reagent (Fludigm) at a 3:2 ratio and loaded onto a primed medium (10-
17 µm) integrated microfluidic circuit (Fludigm) for capturing. Cell capture sites were examined
under a microscope and noted for containing 0, 1, or multiple cells. Lysis, transposition, and
amplification were performed on the Fluidigm C1 platform. DNA from each cell was transferred
to an individual well of a 96-well plate and barcoded with unique combinations of 24 adaptor-
index i7 and 16 adaptor-index i5 primers [197]. Quantification and library size distribution was
assessed on an Agilent 2100 Bioanalyzer using High Sensitivity DNA chips. Excessive primer
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contamination was removed using SPRIselect (Beckman Coulter Life Sciences) size selection.
Up to 192 cells were pooled and sequenced in pairedend, dual-index mode for 50 + 8 + 50 +
8 cycles on one lane of an Illumina HiSeq 2500. A summary of all single-cell experiments can
be found in Supplementary Table 1.
Single-cell and bulk ATAC-seq data processing. Base calling was performed using Bus-
tard (Illumina), adaptor trimming with leeHom [261], and demultiplexing with deML [262].
Reads were aligned to hg19 for human, panTro4 for chimp, and rheMac8 for macaque using
bowtie2 with a maximum fragment length of 2,000. PCR duplicates were marked and removed
using Picard tools (http://broadinstitute. github.io/picard). Samtools [286] was used to re-
tain properly paired reads with mapping quality greater than 30, while reads mapping to the
mitochondrial genome, Y chromosome, and blacklisted genomic regions that show excessively
high read mapping, several of which correspond to nuclear mitochondrial DNA segments (iden-
tified in ref. [197] and the ENCODE Project [287]) were removed. For scATAC-seq, single cell
BAM files were merged, excluding data from any capture site with 0 or more than 1 cell, to
create an aggregated BAM file. Peaks, which represent regions enriched in mapped pair-end
sequences, were called using MACS2 [288] with options nomodel, nolambda, keep-dup all, and
call-summits. Peak summits were extended by ±250 bp. In the event of overlapping peaks,
the peak with the lowest P value was kept. A single-cell ATAC-seq consensus peak set was
obtained by requiring a peak to be accessible in a minimum of 5% of cells. Data visualization
was carried out using the Integrative Genomics Viewer (IGV) [289].
Enrichment for validated human VISTA enhancers. We overlapped scATAC-seq peaks
detected in human cerebral organoids with positive human VISTA enhancers using bedtools
intersect. For each tissue annotated in the VISTA Enhancer Browser, we counted the number
enhancers that did or did not overlap a peak. We compared these values to the number
of all other tissue elements that did or did not overlap a peak. Fisher’s exact tests were
performed to determine which tissues’ enhancers had a higher likelihood of being represented.
The significance values were corrected for multiple testing using the qvalue package in R.
Cell state identification using single-cell ATAC-seq on cerebral organoids and pseu-
dotime estimation. The accessibility at each site in the consensus peak set for every single
cell was used to create a count matrix. Cells with fewer than 5,000 read pairs and less than
5% of reads in peaks (fraction of reads in peaks, FRiP) were filtered out from further analyses.
chromVAR [278] was used to scan the peaks for transcription factor binding motif occur-
rences, using a curated collection of 1,765 human motifs from the cisBP database, and to
identify significantly variable motifs among cells. In addition to TF binding motifs, peaks were
scanned for 7-mers. Cell similarity was visualized in a two-dimensional t-SNE plot using the
bias-corrected deviations in accessibility for 7-mers.
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Each cell’s t-SNE coordinates and the consensus peaks were passed to Cicero [290] and
the densityPeak algorithm was used to identify two clusters of cells. Statistically significant
differences in TF motif accessibility between the two clusters was calculated using chromVAR,
and those motifs corresponding to marker transcription factors known to distinguish neural
progenitors and neurons was used as the basis for cell state identification. Statistically signif-
icant differences in accessibility of additional annotations between the two clusters were used
to support cell state identities. These annotations included differentially accessible chromatin
peaks identified as being enriched in developing mouse brain radial glial cells or excitatory
neurons [291], as well as accessibility in peaks nearby genes showing pseudotime-dependent
expression in cortical neural progenitors or cortical neurons identified as part of this study.
We identified differentially accessible (DA) peaks between the two clusters using the com-
mand differentialGeneTest in Cicero. A count matrix was generated with featureCounts [292]
using the top 250 DA peaks in each cluster. This count matrix was used as input for a diffusion
map in order to obtain a pseudotemporal ordering of the cells [293]. Projecting transcription
factor binding motif deviation Z -scores on the cells revealed a gradient of known neural pro-
genitor to neuronal markers along the first diffusion map component and we took a cell’s rank
along this component as its pseudotime value.
DA peaks identified between the two clusters were used as input test regions for GREAT
(v.3.0.0) [294] with all accessible organoid peaks serving as background regions. We used
the default basal plus extension genomic association rule with its default values. All gene
ontology (GO) Biological Process terms and their associated hypergeometric P values were
exported. For each term, we plotted the P value obtained using cluster 1 DA peaks and the
P value obtained using cluster 2 DA peaks. Terms with P < 0.05 were considered enriched.
Informative enriched terms were highlighted based on their significance value in one cell state
relative to the other, and for small differences between the cell states when highlighting terms
enriched in both.
Single-cell ATAC-seq pseudotime estimation for cells in early states of differentia-
tion and cerebral organoids. Similar to the analysis of the cerebral organoids, we used
chromVAR to calculate bias-corrected deviations in accessibility for TF motifs and 7-mers for
each cell across the differentiation trajectory. Here, we included the scATAC-seq consensus
peak sets called in the iPSC, embryoid body, neuroectoderm, and neuroepithelial time points,
in addition to the scATAC-seq consensus peak set from the cerebral organoid time point. In
the event of overlapping peaks, the peak with strongest signal was retained. Cells with fewer
than 5,000 read pairs and less than 5% of reads in peaks were removed from further analyses
(Supplementary Table 9). Cell similarity was visualized in a two-dimensional t-SNE plot using
the bias-corrected deviations in accessibility for 7-mers.
As the cerebral organoid cells’ pseudotimes were previously resolved, we focused on ordering
the earlier stages. For this we used Cicero’s differentialGeneTest to identify DA peaks among
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the iPSC, embryoid body, neuroectoderm, and neuroepithelial time points. A count matrix
was generated using the top 250 DA peaks in each time point and used as input for a diffusion
map. Projecting TF motif deviation Z -scores of the cells revealed a gradient of pluripotent
to more differentiated marker TFs along the first three diffusion map components. We fit a
principle curve through the map, and used the pluripotent cells as a starting point to guide
the curve. The rank of a cell along this curve was used as its pseudotime. We then added the
cerebral organoid cells’ pseudotime ranks to this earlier stage resolved pseudotime. We used
the pheatmap R package to visualize the dynamics of significantly variable TF motifs across
pseudotime.
Annotation of accessible chromatin peaks. Peaks were linked to an expressed protein-
coding gene using the nearest (maximum distance 1 Mb) transcription start site of the canonical
transcript as defined by GENCODE (comprehensive gene annotation, release 19). Promoter
regions were defined as 1,000 bp upstream a TSS, and distal regions refer to non-promoter
regions. Exon and intron annotations were also obtained from GENCODE (comprehensive gene
annotation, release 19). BEDtools [295] was used to annotate peaks for several evolutionary
signatures, including: human accelerated regions [296–298]; selective sweeps compared to
great apes [299] and archaic humans [300]; SNCs in modern humans that happened since
the split with great apes and before or after the split with the ancestor of Neandertals and
Denisovans, first identified in ref. [301] and updated for this analysis using the most current
1,000 Genomes Phase 3 allele frequencies, with a global allele frequency ≥ 99.5% defined
as fixed in all modern humans; small insertions and deletions (up to 5 nucleotides) fixed in
modern humans that happened since the split with great apes and before or after the split
with the ancestor of Neanderthals and Denisovans [302]; and, human deletions that are highly
conserved in mammals [60] (hCONDELs, Supplementary Table 11).
Identification of genomic regions with differential accessibility between human and
chimpanzee organoid neural progenitors and neurons. To compare the chromatin ac-
cessibility of NPCs and neurons in cerebral organoids between human and chimpanzee and
identify putative regulatory regions that may contribute to transcriptome divergence between
human and chimpanzee, we applied a likelihood ratio test based on a generalized linear model
with binomial error distribution to each regulatory region identified in human and chimpanzee
organoids. More specifically, we identified open chromatin regions in human and chimpanzee
organoids separately as described above. To compare an equal number of human and chim-
panzee regions, we took the top 77,611 peaks (corresponding to the number of human con-
sensus peaks) in each species and performed reciprocal liftOver, requiring a 50% minimum
ratio of bases that must remap, in order to identify their orthologous counterparts in the other
species. Peaks that successfully lifted over (≥99%) were merged using bedtools and re-named
(that is, mergePeak#). Count matrices were generated at these merged peaks in the species
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own genome, and the matrices were then joined on the common peak name. Considering
the higher read coverage in human cells, we subsampled reads in human cells to equalize the
medians of total number of reads mapped to the regions of interest in human and chimpanzee.
This procedure was applied separately to NPCs and neurons. The resulting count matrices
were binarized. We then fitted a generalized linear model for each region across all human and
chimpanzee cells, with the accessibility as the response variable and species as the independent
variable. Another model with the species variable replaced by a scaling coefficient was also
fitted as the null model. The scaling coefficient is fixed to one for human cells and pc/ph
for chimpanzee cells, where pc and ph are the average accessibility across all regions and all
cells in chimpanzee and human, respectively. We compared the two models and got the P
values by using the likelihood ratio test. Regions with BH-corrected P < 0.01 were defined
as DA regions (Supplementary Table 10). This procedure was applied to NPCs and neurons
separately to obtain DA regions in the two cell states.
Functional and evolutionary characterization of genomic regions with differential
accessibility. We performed permutations to determine if DA peaks were significantly more
likely to overlap a given annotation compared to non-differentially accessible (non-DA) peaks.
In more detail, we first resized all peaks to an equal length of 500 bp and calculated the
average accessibility of human and chimp cells in the resized DA and non-DA peaks. Peaks
were then placed into average accessibility bins of 5% intervals. Given the number of DA peaks
in each accessibility bin, the same number of non-DA peaks was chosen at random from the
corresponding accessibility bin. The random set of non-DA peaks was then overlapped with
the given annotation using bedtools intersect. The random sampling of non-DA peaks and
annotation overlap was repeated 2,000 times. For each annotation, we counted the number
of times a non-DA peak permutation resulted in a higher overlap than what was observed for
DA peaks. This number was divided by the number of permutations to determine significance
(P < 0.05).
We used fixed SNCs, organoid-specific peaks, and linked differentially expressed (DE) genes
as annotations. When overlapping peaks with fixed SNCs, we restricted the analysis to include
only regions that passed a stringent genome alignability filter (“map35 100%”)[301], in which
SNCs could be called. Organoid-specific peaks were defined as peaks detected in 2-month
and 4-month old cerebral organoid stages, but not detected in earlier stages of differentiation
(pluripotency to neuroepithelial stages). Cell state-specific peaks were those identified as
differentially accessible between NPCs and neurons in either human or chimp.
To study putative effects of fixed SNCs on transcription factor (TF) binding in the accessible
genomic regions, we used funseq2 [303] to scan and statistically evaluate all possible TF binding
motifs created by fixed SNCs in DA peaks. To generate a list of TF motifs lost on the human
lineage, we used the human allele as the reference allele and the ancestral allele [301] as the
alternative allele. To generate a list of TF motifs gained on the human lineage, we flipped
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the state of the reference and alternative allele. This allowed us to directly compare the
sequence scores of TF motifs gained or lost in humans. We subtracted the sequence score
with the alternative allele from the sequence score with reference allele and performed minmax
normalization. Human TF motif gains were plotted as positive values, while human TF motif
losses were plotted as negative values. The genomic location of SNCs predicted to alter TF
motif binding are provided in Supplementary Table 11. The alteration rate for TF motifs
gained in humans was calculated by dividing the number of gains in DA peaks by the number
of occurrences of that motif when scanning all organoid accessible peaks using chromVAR and
the human genome sequence. The alteration rate for TF motifs lost in humans was calculated
by dividing the number of losses in DA peaks by the number of occurrences of that motif when
scanning all organoid accessible peaks using chromVAR and the chimpanzee genome sequence.
The alteration rates of human TF gains and losses were also calculated per TF family, using
TF motif family assignments obtained from [304].
We used the macaque cerebral organoid scATAC-seq data to determine species specificity of
the peaks identified as differentially accessible between human and chimpanzee (Supplementary
Table 10). In brief, we counted read coverage of each accessible region we compared between
human and chimp which can lift over to the macaque genome in each macaque cell. Regions
failed during liftover were seen as inaccessible in all macaque cells. A random sampling of
reads in human and chimpanzee cells was applied to equalize median read coverage in the
three species. This procedure was applied 100 times and to the two cell states separately.
Accessible probability was then calculated for the two cell states in the three species. In human
and chimpanzee, averages across the 100 read-subsampling-based estimation were used. The
difference of accessible probability between human and macaque (H - M), and that between
chimpanzee and macaque (C - M), was then calculated for each human-chimpanzee DA peak
in each cell state. The identified DA was considered as human-specific if its H–M difference
is at least four times larger than the C–M difference, while its H–M difference is no less than
2%. Similar criteria were also applied to define chimp-specific DA.
To investigate potential biological processes that may be influenced by DA peaks, we used
human-chimp DA peaks for each cell state (NPC or neuron) as input test regions for GREAT
(v.3.0.0) [294] with all accessible organoids peaks serving as background regions. This analysis
was then carried out the same way as explained above.
Single-nucleus and bulk RNA-seq data generation. Tissue cubes were dissected from
frozen post-mortem prefrontal cortex tissue from human, chimpanzee, bonobo and macaque
individuals. In total, three healthy adult human (H. sapiens), two healthy adult chimpanzee
(Pan troglodytes), one healthy adult bonobo (Pan paniscus) and three healthy adult rhesus
macaque (Macaca mulatta) brains were used. The human samples were obtained from the
Chinese Brain Bank Center (CBBC) in Wuhan, China. For each of these individuals, written
informed consent to use human tissues for research was obtained either from the donors them-
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selves or from their next of kin. All subjects were classified as normal by forensic pathologists
at the brain bank, and suffered sudden deaths with no prolonged agonal state. One chim-
panzee sample was obtained from Biomedical Primate Research Centre, Netherlands; the other
chimpanzee sample was obtained from Yerkes National Primate Research Center, USA. The
bonobo sample was obtained from Lola ya Bonobo Sacturary, Congo. Tissue was shipped to
the Max Planck Institute for Evolutionary Anthropology under the institutional permit for the
transport of biological material derived from endangered species (DE216-08, http://cites.org/
common/reg/si/e-si-beg.shtml). Rhesus macaque samples were all collected at the Primate
Research Center in Goettingen, Germany. All the chimpanzee and bonobo individuals suffered
sudden deaths for reasons other than their participation in this study and without any relation
to the tissue used. All the macaque individuals were euthanized. The Biomedical Research
Ethics Committee of Shanghai Institutes for Biological Sciences reviewed the use and care of
the animals in the research project (approval ID: ER-SIBS-260802P).
Dissection was performed on dry ice aiming for cubes with minimal curvature to obtain
reproducible slicing results. In brief, the thickness of grey matter at all facets of the cube was
measured to obtain a mean grey matter thickness. The mean thickness was divided by 10
to obtain the thickness for each of the segments, whereby each of the segments consisted of
several slices at 50 µm thickness. Sectioning was performed in a cryostat (Microm, Thermo
Fisher), with slices being alternately immersed in Trizol (Invitrogen) for bulk RNA isolation
or transferred to a dry tube (low binding) for single nucleus isolation on dry ice. Segments
11 and 12 were collected as well but were considered being derived from white matter of the
cortex. Samples were then stored at −80 ◦C until further use.
For nuclei isolation from frozen tissue, all following steps were performed on ice with pre-
cooled buffers and centrifugation steps were performed at 4 ◦C. In brief, tissue was spun down,
thawed on ice and 1 ml PBSE (PBS (Gibco), 2 mM EDTA (Life Technologies)) was added
to the tissue. The tissue slices were incubated at 4 ◦C on a shaker at 1,500 r.p.m. for a
total of 45–60 min with trituration steps in between using 1,000p and 200p to homogenize
the tissue. Generally, segments 1–10 were used for single-nucleus experiments. Two segments
were pooled to obtain sufficient material for single nucleus isolation, resulting in 5 segments
per individual. To reduce batch effects and increase the number of nuclei per experiment, ma-
terial from three different individuals (originating from human, chimp/bonobo and macaque
respectively) was pooled for each segment. After homogenization, solutions were combined
in a 5 ml tube and spun down at 900g for 5 min. The pellet was resuspended in 1.5 ml
PBSE + 1% NP-40 (BioVision), triturated 20 times using 1,000p and incubated for 7 min
incubation on ice. Samples were then spun down at 900g for 5 min and resuspend in 1.5 ml
PBSE + 1% BSA (Serva) two times. Samples were then spun down again at 900g for 5 min
and resuspended in PBS + 1% BSA. Before sorting, samples were filtered through a 30 µm
cell filter (Miltenyi Biotec) and stained using DAPI (1:1,000, BD Pharmingen). Nuclei were
sorted in yield sort mode (BD FACS AriaIII and BD FACS Fusion) based on a defined nuclei
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population by excluding debris using FSC and SSC and by sorting DAPI positive events. Nuclei
were sorted in bulk into 96 well plates and spun down 5 min at 600g to enrich for nuclei in
the pellet.
For each of the pooled samples, two lanes on a 10x Chromium microfluidic chip were loaded,
aiming for the maximum possible number of nuclei to be targeted obtained from the sorting.
Single-nucleus experiments were performed using the 10x Genomics Single Cell 3’ kit v.2
to encapsulate nuclei along with barcode tagged beads, generate and amplify cDNA and to
generate sequencing libraries. Each pooled library was barcoded using i7 barcodes provided
by 10x Genomics. cDNA and sequencing library quality and quantity were determined using
Agilent’s High Sensitivity DNA Assay. Libraries were pooled and sequenced in 150-bp paired-
end mode on Illumina’s NovaSeq platform as provided in Supplementary Table 1.
RNA isolation for bulk-RNA Seq was performed using the Direct-zol 96 RNA kit (Zymo
Research) and was quantified using Agilent’s Bioanalyzer RNA 6000 Nano and Pico kit. Li-
braries were prepared using the NEBNext Ultra Low RNA Library Prep Kit (New England
Biolabs). Library quantification was performed using Agilent’s Bioanalyzer DNA 1000 chip
kit. All bulk RNA Seq libraries were pooled at equal ratios and sequenced on one lane of an
Illumina NovaSeq platform in 150 bp paired-end mode.
Processing of single-nucleus and bulk RNA-seq data from human, chimpanzee and
macaque adult brains. Single-nucleus libraries were demultiplexed based on their i7 index
sequences using 10x Cell Ranger (v.2.1). Mapping to the humanchimp- macaque consensus
genome and generation of count matrices was then performed using the same Cell Ranger,
with the GENCODE v.27 human annotation provided. Nuclei were assigned to species based
on species specific sites using a two-step approach by separating all great ape from macaque
nuclei first and subsequently assigning nuclei to either human or chimp/bonobo. Nuclei with
a support of less than 80% for either of the groups were removed from further anal ysis.
Moreover, nuclei with less than 200 and more than 6,000 genes detected, so as those with
more than 5% detected transcripts being transcribed from mitochondria, were removed from
further analyses.
The full snRNA-seq dataset including all species was further analysed using Seurat (v.3)
(Supplementary Table 13). Single-nucleus expression values were normalized and highly vari-
able genes were identified using a variance stabilizing function to detect the top 2,000 vari-
able genes (Supplementary Table 12). Data were then integrated by finding corresponding
anchors between the species using 30 dimensions. Scaling and PCA were performed using
the integrated data. The top-20 PCs were used to identify neighbours of cells and clusters
and to visualize the clustering using t-SNE embedding. Cluster identities were assigned us-
ing unbiased identification using cluster markers by running Seurat’s FindAllMarkers function
(Wilcoxon test, min.pct = 0.25, min logFC = 0.25) using non-integrated expression values,
known marker genes reported elsewhere [215, 221] and by cell type prediction using Seurat’s
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TransferData function to anchor to the published Dropseq based human adult frontal cortex
snRNA-seq data [221]. Two potential doublet clusters (c11, c19) were excluded from fur-
ther analysis. For analysis of the major cell classes (excitatory neurons, inhibitory neurons,
astrocytes, oligodendrocytes, oligodendrocyte precursor cells, microglia, endothelial cells) sub-
type clusters were combined and cell type markers recalculated using Seurat’s FindAllMarkers
function (Wilcoxon test, min.pct = 0.25, min logFC = 0.25) using non-integrated expression
values (Supplementary Table 14).
Since nuclei of the three species have significantly different transcriptome coverage, pseudo-
nuclei were constructed for more robust transcriptome measurement, as well as for more fair
and efficient comparison, using a similar procedure as described above to generate pseudocells,
under the constraint of merging only nuclei from the same segment of the same sample and
grouped in the same cell cluster. The probabilities of nuclei selected as pseudo-nuclei seed
were 1/13 for human, 1/8 for chimpanzee and 1/10 for macaque.
Reads of the bulk RNA-seq samples were mapped to the human-chimpanzee- macaque con-
sensus genome using STAR (v.2.6.1d). The Python utility hiseq-count was used to count the
numbers of uniquely mapped reads of genes annotated in GENCODE v.27 human annotations.
DESeq2 was used for normalization and retrieving FPKM as the expression level measurement.
To determine the laminar origin of each segment, genes with segment-dependent expression
were first screened for each cortical cube. In brief, an ANCOVA analysis was applied to compare
two models: the natural spline (df = 6) linear model with log10-transformed FPKM as the
response and the segment order as the variable; the null model of expression values without
any relationship with segments. For each of the resulted gene, its enriched segments in the
cube were identified, as the segments with the gene’s expression at least one standard deviation
higher than the mean across segments. Genes with enriched expression at each segment were
then overlapped with the layer markers identified in [141]. Segments with enriched genes
significantly overlapping with markers of only one layer were seen as pure-layer original, others
were seen as mixture of multiple layers. For each mixture segment, a quadratic-programming-
based transcriptome deconvolution [305] was applied to determine the relative contribution of
the enriched layers. A layer index was then obtained for each segment, as the average layers
weighted by contributed proportion of the enriched layers.
Estimation of cell type distribution across cortical layers and gene expression pat-
terns in neurons across cortical layers. To estimate the cell type composition of each
layer, nuclei from each sample were randomly assign to one layer, based on the layer mixture
proportions estimated above. The proportion of each of the six major cell classes: excita-
tory neurons, inhibitory neurons, astrocytes, oligodendrocytes, oligodendrocyte precursor cells
(OPCs), microglia and endothelial cells, was then calculated for nuclei assigned to each layer
in human. This procedure was repeated 100 times, with the resulted average as the final
estimation. The laminar distribution of each cell cluster was also estimated based on the de-
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scribed procedure. In addition, a subsampling procedure with replaceable manner of the same
number of nuclei (n = 200) from each layer was further applied to each of the 100 nuclei layer
random assignment to control differences on the detected nuclei number of each layer.
To get more precise estimation of layer origins on the nuclei level for excitatory and inhibitory
neurons, both of which show a distinct layer distribution pattern across different subtypes, we
trained an elastic net linear regression model (α = 0.5) on excitatory and inhibitory neurons
separately, with the sample layer indices as the training response and expression levels of the
highly variable genes as the variables. To enhance model robustness, pseudo-nuclei from all the
three species together were used for model trainings. The trained models were then applied
to the excitatory and inhibitory pseudo-nuclei again. The predicted layer indices were used as
the estimated relative laminar location of the pseudo-nuclei. The projection of the predicted
layer indices to layers were done by averaging expression patterns of markers of different layers
[141].
Differential expression analysis between human and chimpanzee cell types in adult
brains and determination of their species-specificity. Due to the sparse nature of the
snRNA-seq data and the unequal coverage of nuclei from different species, commonly used
statistical test for differential expression analysis (for example, Wilcoxon’s rank-sum test) failed
to provide reliable estimation of DE, even with the state-of-art VST normalization methods
[306]. As detection rates of genes are correlated with their expression levels [306], we therefore
compared gene expression levels of the same cell type in human and chimpanzee by comparing
their detection rates, using a GLM-ANCOVA analysis similar to the one described above to
identify genomic regions with differential accessibility. In brief, the pseudo-nuclei expression
matrix was binarized. A binomial GLM model was trained for each gene, with its detection
as the response variable and species of pseudo-nuclei as the independent variable. This model
was compared to the null model with the species variable replaced by a scaling coefficient.
The scaling coefficient is fixed to one for human pseudo-nuclei and pc/ph for chimpanzee
pseudo-nuclei, where pc and ph are the average detected gene numbers across pseudo-nuclei
involved in the test in chimpanzee and human, respectively.
While the described DE test was applied to four cell classes with sufficient numbers of
pseudo-nuclei: excitatory neurons, inhibitory neurons, astrocytes and oligodendrocytes, the
heterogeneity within the two neuron types, as well as their uneven distributions in human
and chimpanzee, needed to be considered. A subsampling procedure with replaceable manner
was therefore applied. In every subsampling, an equal number of pseudo-nuclei (n = 200)
from each species were sampled, with pseudonuclei in clusters annotated as the cell class of
interest sharing equal probability being selected. The described DE test was then applied to
the sampled nuclei of this cell class. This subsampling procedure was repeated for 100 times,
and DE genes of each cell class were defined as genes with significant DE (BH-corrected P <
0.005) in at least 80 times of the subsampling. Additional filtering was then applied, requiring
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the same direction of human-chimpanzee difference on detection rates and VST-normalized
expression values.
Macaque pseudo-nuclei were then introduced to investigate species specificity of the identi-
fied DE. Similar procedure sampling the same number of pseudo-nuclei from clusters annotated
to be the same cell class was repeated 100 times to the macaque pseudo-nuclei. For each
sampling, average VST-normalized expression values were calculated for each cell class in hu-
man, chimpanzee and macaque, with which differences between human and macaque (dHM),
as well as between chimpanzee and macaque (dCM), were calculated. The identified human-
chimpanzee DE was defined as human-specific if |dHM| > 4 x |dHC|. Genes with chimpanzee-
specific DE were identified in the same way (Supplementary Table 15).
Statistics and reproducibility. In the box plots of Figs. 1g, 2d, boxes represent IQR,
whiskers represent minimum and maximum with outliers removed. In the box plot of Fig. 4c,
boxes represent IQR, and whiskers represent 1.5 x IQR. In the bean plots of Extended Data
Fig. 3g, shapes of beans represent Pearson correlation distributions, dashed lines represent
medians of groups.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this paper.
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Extended Data Fig. 1: Differentiation and immunohistochemical characterization of human
and chimpanzee cerebral organoids. a, Phase contrast (PSC to neuroepithelium; scale bar,
200 µm; H9 for human, SandraA for chimpanzee) and bright-field images (organoid; scale bars, 1
mm; H9 and Wibj2 for human, JoC and SandraA for chimpanzee) showing examples of different
stages of organoid development for human and chimpanzee. b, Immunohistochemical staining for
PAX6 (green) and BCL11B (also known as CTIP2) (pink) of a 63-day human organoid from iPSC
line 409b2 (left) and a 63-day chimpanzee organoid from iPSC line SandraA (right), with a magnified
view into a cortical-like region (scale bars, 100 µm). c, Immunohistochemical staining of human (top
left, Sc102a1, 50-day; top middle, 409b2, 63-day, the same organoid as the human organoid in b) and
chimpanzee (bottom left, SandraA, 50-day; bottom middle, SandraA, 63-day) organoids (scale bars,
200 µm) for progenitor (PAX6) intermediate progenitor (TBR2) and deep-layer neurons (BCL11B)
in whole organoids. Staining for deep-layer (BCL11B) and upper-layer neuron (SATB2) markers for
human (top right, Sc102a1, 45 day) and chimpanzee (bottom right, SandraA, 63 day) organoids.
115
CHAPTER 2
Extended Data Fig. 2: Heterogeneity analysis during human cerebral organoid development
from pluripotency. a, Cells from different human cell lines (23,226 cells from H9 and 20,272 cells
from 409b2) were integrated using canonical correlation analysis and visualized using t-SNE. b, t-
SNE colour coded on the basis of cell line and batch. c, t-SNE coloured on the basis of time point.
Heterogeneity analysis was performed on combined cells from day 0 of differentiation to 4-month-old
organoids for iPSC and ESC-derived cells. d, Distribution of number of genes and UMIs for different
time points and cell lines. e, Clustering was performed using the top-20 PCs as input for t-SNE
and cluster names were assigned on the basis of expression of cluster marker genes and known
marker genes. SC, stem cells; NEC, neuroectoderm-like cells; NSC, neural stem cells; g/oRGC,
gliogenic/outer radial glia cells; G2M/S NPC, neural progenitor cells in G2M/S phase; G2M/S DP,
dorsal progenitor cells in G2M/S phase; CN, cortical neurons; G2M/S vP, ventral progenitors in
G2M/S phase; M/H, midbrain/hindbrain; CP, choroid plexus; M, mesenchymal-like cells. f, t-SNE
plot coloured by expression level of selected marker genes on the basis of non-integrated expression
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g, Heat map showing averaged cluster expression for representative marker genes for clusters ordered
according to their differentiation time from early to later stages and regional identity from dorsal to
ventral forebrain and non-forebrain cells. h, In situ hybridization images from the Allen Developing
Mouse Brain Atlas (available from https://developingmouse.brain-map.org/) showing expression of
Foxg1, Neurod6 and Dlx5 in the mouse developing forebrain and human whole-trajectory SPRING
plots coloured by the corresponding genes. i, Pseudotemporal expression of example genes marking
different stages of development over the whole human cerebral organoid developmental trajectory.
j, Umbrella plot showing the similarity of each organoid cell to a cell ‘prototype’ generated from a
reference scRNA-seq cell atlas of the human fetal cortex19. k, Plots show the proportion of organoid
cells per time point that match a reference prototype.
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Extended Data Fig. 3: Analysis of human cerebral organoid single-cell transcriptomes from
seven individuals. a, scRNA-seq was performed on two-month-old cerebral organoids from one
human ESC and six iPSC lines. b, All data (49,153 cells) were combined and cell heterogeneity
was assessed using t-SNE with the top 20 PCs as the input. Cells are also coloured by marker gene
expression and RSS. c, t-SNE plot with RSS against Brainspan fetal reference data as the input
(RSS-t-SNE), coloured by cell lines. Cells from different lines are well integrated. d, SPRING plot
of two-month-old human organoid pseudocells (9,650), coloured by neuronal trajectory branches
and pseudotimes. e, SPRING plot of twomonth old human organoid cells, coloured by marker
gene expression. f, SPRING plots coloured by cell line show contributions of each line to different
branches of the trajectory. g, Correlations of expression trajectories of genes with pseudotime-
dependent expression patterns between cortical cells from each line to the others (pink), ventral
cells from each line to others (blue), and cortical and ventral cells from the same lines after or
before aligning the cortical and ventral pseudotimes (purple). h, Spatial location inference of neuron
subtypes in human cerebral organoids. Left, bar plots show proportion of cells of each cell type
that show highest gene expression pattern similarity to the average expression patterns in different
structures, on the basis of the processed in situ hybridization image data (E13.5) provided in the
Developing Mouse Brain database of Allen Brain Atlas (available from https://developingmouse.
brain-map.org/). Expression similarity was calculated based on highly variable genes of the scRNA-
seq data (top) or regional markers defined with the in situ hybridization data (bottom left). Right,
correlation patterns of average regional marker gene expression of each neuron subtype to voxels in
five example sections (E13.5), as well as the structural annotation of the sections. i, Expression of two
marker genes of diencephalon inhibitory neurons (PCP4 and RSPO3) in the SPRING embeddings,




Extended Data Fig. 4: Heterogeneity analysis during chimp cerebral organoid development
from pluripotency. a, Heterogeneity analysis for iPSC-derived chimpanzee cells (36,884) from day
0 of differentiation to 4 months of organoid development for one cell line (SandraA). b, Heat map
visualizing averaged cluster expression for marker genes with columns ordered based on differentiation
progress from early-to-late time points and regional identity sorted from dorsal to ventral forebrain
to nonforebrain cells and non-ectodermal-derived cells. c, Cluster identification and t-SNE using
the top-15 PCs for clustering. Cluster assignment was on the basis of cluster markers as well
as expression patterns of known marker genes. SC, stem cells; G2M/S DP, dorsal progenitors in
G2M/S phase; dlN, deep-layer neuron; ulN, upper-layer neurons; vP/N, ventral progenitor/neuron;
M – mesenchymal-like cells; OL, off-lineage cells. d, t-SNE plots coloured on the basis of gene
expression of representative marker genes used to assign cluster identities. e, SPRING plots of whole
developmental trajectory for human and chimpanzee coloured by marker genes. f, Pseudotemporal
gene expression patterns showing marker genes for early, dorsal and ventral branches for human
and chimpanzee. g, Schematic showing alignment of human and chimpanzee pseudotimes after
combining pseudocells from the early stages and the dorsal forebrain lineage. The later chimpanzee
pseudotime points fail to align with human pseudocells.
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Extended Data Fig. 5: Analysis of cell type heterogeneity of cerebral organoids and fetal




Each dot represents a cerebral organoid or fetal brain sample from one cell line or species at a certain
age, with its size showing the number of cells measured. The left panel shows organoid sample
information as published in Pollen et al. (2019) [20] (excluding redundant cells from Camp et al.
(2015) [114] and Mora-Bermudez et al. (2016) [222]), including the data initially published in Sloan
et al. (2017) [133]The middle panel shows organoid sample information generated in Camp et al.
2015 [114], Mora-Bermudez et al. 2016 [222] and in this study. The right panel shows fetal prefrontal
cortex sample information reported in Nowakowski et al. 2017 [219]. b, All cerebral organoid data
(5,838 cells) were combined and cell heterogeneity was assessed using t-SNE with the RSS profiles to
the fetal Brainspan data as the input. Cells are coloured by cell type or cluster, species, institutions
generating the data, dorsal trajectory pseudotimes and marker gene expression. c, t-SNE plots for all
fetal brain data (5,080 cells) to assess cell heterogeneity, with the RSS profiles to the fetal Brainspan
references as the input. Cells are coloured by cell type or cluster, species, dorsal excitatory neuron
trajectory pseudotimes and marker gene expression. d, Heat map showing marker gene expression
patterns across different cell types in the droplet-based organoid scRNA-seq data generated in this
manuscript and the above described C1-based scRNA-seq data.
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Extended Data Fig. 6: Analysis of neuron maturation timing difference in human, chim-
panzee and macaque cerebral organoids. a, Box plots (interquartile range with minimum and
maximum, outliers removed) showing sum expression levels (in reads per kilobase of transcript per
million (RPKM)) of genes with GO annotation neuron projection (1,487 genes), neuron differenti-
ation (1,367 genes), synapse assembly (168 genes) and neurotransmitter secretion (169 genes) in
bulk RNA-seq data from Brainspan fetal cortical samples from 8 PCW to 17 PCW. b, Box plots
showing sum expression levels of the same gene lists in fetal human dorsal excitatory neurons along
the estimated developmental pseudotimes (Nowakowski et al. (2017) dataset [219]). c, Projection
of human and chimpanzee organoid cells to human fetal brain data reveals higher similarity of chim-
panzee organoid cells to later stages of development compared to human organoid cells. d, Box plots
showing sum expression levels of genes with specific annotation to only one of the four GO terms in
human and chimpanzee pseudocells (1,791 human and 4,304 chimp) along the cortical pseudotimes.
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Heat maps showing expression of example genes from the GO terms for human and chimp along
pseudotime bins. The Venn diagram on the left shows the overlap of genes related to the four
GO terms. e, Distribution of neuron projection scores of human and chimpanzee cortical cells (388
human and 355 chimp) reported in Pollen et al. (2019) along the cortical pseudotimes [20]. Each
dot represents one cell, and is coloured by the organoid cell line. Light colours represent human cell
lines and dark colours represent chimpanzee ones. Two-sided Wilcoxon’s rank-sum test *P = 0.013
and **P = 0.004). f, Observed timing difference of upper-deeper layer specification in human and
chimpanzee cerebral organoids from 10x Genomics data generated in this study. The left panel shows
expression of cortical deep (BCL11B, left) and upper (SATB2, right) layer marker genes projected
onto the chimpanzee (top) and human (bottom) SPRING plot. BCL11B and SATB2 become anti-
correlated in their pseudotemporal expression profile in both human and chimpanzee (right), while
the onset of anticorrelation happens earlier in chimpanzee than in human. g, Abundance of upper
layer neurons relative to deeper layer neurons in human and macaque fetal prefrontal cortex samples
[219] in Nowakowski et al. (2017) grouped by early time points (<100 days old) or all time points
combined. h, scRNA-seq was performed on two-to-four month cerebral organoids from a macaque
iPSC line. The SPRING plot of pseudocells (2,913) was constructed with the top-20 PCs as the
input. The heterogeneity analysis suggests multiple cell types in the macaque organoids, including
cortical neurons, NPCs, astrocytes and other cell types such as retina and mesenchyme-like cells. i,
SPRING plot coloured by pseudotimes of cortical pseudocells, which are the pseudocells’ quantiles
of diffusion component (DC) 1 of the cortical pseudocells diffusion map. j, SPRING plot coloured
by marker gene expression. k, The onset of anti-correlation between SATB2 and BCL11B occurs
earlier along the macaque pseudotime (1,107 pseudocells), relative to human (1,118 pseudocells) and
chimpanzee (1,645 pseudocells), when focusing on the two-month cerebral organoids. l, Box plots




Extended Data Fig. 7: Pseudotime alignment between primates and differential expression
between human and chimpanzee. a, SPRING plots visualizing the kNN networks of human
(10,063) and chimpanzee (5,612) pseudocells, and macaque cells (6,580), which represent NPCs and
neurons of different brain regions. Cortical NPCs and neurons are coloured by their pseudotimes.
b, Ratios of upper layer (UL) to deeper layer (DL) neuron marker expression in human (black),
chimpanzee (dark grey) and macaque (light grey) organoids. The dashed line indicates the cut-off
applied to human pseudocells to filter out those representing UL neurons. c, Truncated dynamic time
warping (DTW)- based alignment was applied to align human, chimpanzee and macaque cortical
pseudotime courses. Two support vector regression models were trained to predict chimpanzee (top)
and macaque (bottom) pseudotimes of human pseudocells. A constrained B-splines regression model
was fitted to determine the trimming point at the chimpanzee and macaque pseudotime courses,
respectively. An end-to-end DTW-based alignment was applied to the human pseudotime course
to the trimmed chimpanzee and macaque pseudotime courses for the final alignments (middle). d,
Pseudotemporal expression profiles of GLI3, EOMES and BCL11B along the human, chimpanzee and
macaque cortical pseudotimes, before (left) and after (right) the pseudotime alignment procedures.
e, Robustness and false-positive rate of differential pseudotemporal expression between human and
chimpanzee based on the number of cell lines involved in the analysis with constrained replaceable
pseudocell subsampling. In each subsampling, pseudocells representing cells from a certain number
of human lines were sampled in a replaceable manner to recapitulate pseudocell distribution along
pseudotime course of the chimpanzee pseudocells. Differential expression analysis was applied to
compare all chimpanzee pseudocells and the sampled human pseudocells to estimate robustness
to cell line numbers (dark grey boxes), and to compare sampled human pseudocells to human
pseudocells from another two lines sampled with the same procedure to estimate false-positive rate
(light grey boxes). In box plots, boxes represent 100 times of subsampling IQR, the line represents 1.5
x IQR and dots represent outliers. f, Robustly detected human–chimpanzee differentially expressed
genes (robust DE genes) are defined as the non-ribosomal genes which were detected as DE in at
least 80% of the subsampling-based human–chimpanzee DE analysis using any number of human
lines (black). 124
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The dendrogram shows the hierarchical clustering of robust DE genes, based on their human– chim-
panzee pseudotemporal DE patterns along the aligned pseudotimes of cortical organoid pseudocells,
resulting in eight clusters of robust DE genes. g, Pseudotemporal differential expression patterns be-
tween human and chimpanzee (without including macaque cells) of the eight clusters of genes along
the pseudotimes of cortical organoid pseudocells with 50% and 95% confidence intervals shown in
dark and light grey, respectively. Numbers of genes in each cluster are shown in parenthesis. h, Num-
ber of differentially expressed genes in chimpanzee versus human and macaque comparison grouped
by gain or loss of expression in chimpanzees. A gain of expression specifically in chimpanzees is more
likely than a loss of expression pattern conserved in the other primates. i, Comparison of the reported
human–chimpanzee pseudotemporal differential expression based on 10x Genomics data with the Flu-
idigm C1-based scRNA-seq data of human and chimpanzee cerebral organoids. The two rows show
the results based on C1 data generated in this manuscript and combined with data from refs [20, 114,
222]. The first two columns show estimated human– chimpanzee differential expression directionality
and magnitude in the reported droplet-based scRNA-seq data and the C1-based measurement, with
the first column presenting the generalized differential expression along the whole cortical pseudo-
times, and the second column presenting the maximum differential expression along the pseudotimes.
The red dots represent consistently differentially expressed genes, which have consistent differential
expression directionalities in the two datasets. The right panel shows pseudotime intervals with the
largest human–chimpanzee differential expression in the two datasets in comparison to the consis-
tent differentially expressed genes. Dot sizes represent frequencies. j, Comparison of the estimated
human–macaque differential expression directionality and magnitude of the human-specific differen-
tially expressed genes using human and macaque fetal prefrontal cortex scRNA-seq data [20, 222]. k,
Functional annotations of genes with humanspecific expression patterns based on GO annotations re-
lated to brain development and neurogenesis. Only the human-specific differentially expressed genes
with consistent human–chimpanzee or human–macaque differential expression detected in at least
one of the three C1-based scRNA-seq datasets are shown. l, Ventral telencephalon cell heterogeneity
in organoids was investigated by t-SNE embeddings with RSS profiles of human (3,385) and chim-
panzee ventral (773) pseudocells combined as the input. Pseudocell clusters were annotated on the
basis of marker gene expression. Pseudocells were also coloured by species and diffusion map based
on medial ganglionic eminence (MGE) neuron developmental pseudotimes. m, t-SNE plots coloured
by marker gene expression and in situ hybridization images from the Allen Developing Mouse Brain
Atlas (available from https://developingmouse.brain-map.org/) showing expression of Dlx5, Isl1 and
Sox6 in the mouse developing ventral forebrain embryonic day 13.5 (E13.5). n, Human–chimpanzee
ventral differentially expressed genes are largely shared along the dorsal forebrain developmental tra-
jectories. o, Human–chimpanzee DE directionalities and magnitudes and DE genes detection rates
on the two trajectories. DE directionalities and magnitudes are consistent on the dorsal and MGE
trajectories, with most of the shared DE genes showing the highest humanchimpanzee expression
divergence at NPC. DE genes specifically detected on one trajectory have the tendency of higher
detection rates on the trajectory where human–chimpanzee differential expression is detected.
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Extended Data Fig. 8: Chromatin accessibility in cerebral organoids during development.
a, t-SNE projection of highly variable gene expression in Fluidigm C1-based scRNA-seq data of
cerebral organoids. 126
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Cortical cells are coloured red, with larger points corresponding to cells with paired expression and
chromatin accessibility data (data generated from the same cell suspension). A total of 94.4% (219
out of 232 cells) of cells with paired data are cortical, validating the cortical origins of the dissected
cerebral organoid regions. b, Cerebral organoid accessible peaks are significantly and highly enriched
(Fisher’s exact test) for overlapping human VISTA enhancers active in the forebrain relative to all
other tissues (left). Three representative human VISTA enhancers with validated activity in E11.5
mouse forebrain that overlap cerebral organoid peaks (out of 268 such enhancers). c, Percentage
of genes with accessible chromatin at the promoter of genes that are expressed or not expressed in
human cerebral organoids. d–f, t-SNE projection of bias-corrected deviations in accessibility for 7-
mers within organoid scATAC-seq peaks per cell, with cells colour coded by cell state (NPC, neuron)
for human (d, 221 cells), chimpanzee (e, 543 cells), and macaque (f, 118 cells). Binding motif
deviation Z-scores for representative transcription factors are shown, as well as deviation Z-scores for
overlapping DA snATAC-seq peaks in mouse developing forebrain excitatory neurons [291]. g, Signal
intensity tracks of aggregated and individual single-cell chromatin accessibility data per cell state
in human organoids at a NPC-specific promoter peak (left) and a neuron-specific promoter peak
(right). For comparison, cerebral organoid bulk ATAC-seq chromatin accessibility data and human
fetal brain bulk DNase-seq is shown. h, Enrichment of representative enriched biological process GO
terms associated with human NPC DA peaks (gold) or human neuron DA peaks (light red) relative
to all human organoid accessible peaks. Each point in the scatter plot represents a GO term and is
coloured by their enrichment in NPCs (yellow), neurons (red), both (dark red) or neither (grey). i,
t-SNE plots coloured by pseudotime, and heat maps showing binding motif deviation Z-scores for
chosen transcription factors (rows) in all cells (columns) ordered in pseudotime for human (left) and
chimpanzee (right). j, t-SNE projection of bias-corrected deviations in accessibility for 7-mers within
scATAC-seq peaks per cell (518 cells), with cells colour coded by time point, and organoid data
colour coded by cell state. Binding motif deviation Z-scores for representative transcription factors
are shown to the right. k, t-SNE plot with cells coloured by their deviation Z-score for overlapping
differentially accessible snATACseq peaks from mouse developing forebrain [291] radial glia cells (left)
or excitatory neurons (right). l, Diffusion map projection using the top-250 differentially accessible
peaks per time point or cell state. The principle curve fit through the cells is shown as a black line.
m, Proportion of cells scaled by row for each time point or cell state over pseudotime. n, Heat map
representing the deviation Z-score of transcription factor motifs that significantly vary over the time
course plotted for each cell across pseudotime.
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Extended Data Fig. 9: Chromatin accessibility differences in human and chimpanzee cere-
bral organoids. a, Signal intensity tracks of aggregated single-cell and bulk chromatin accessibility
data from human, chimpanzee and macaque at a human-specific NPC-specific DA peak (left) and
a human-specific neuron-specific DA peak (right). b, The eight most significant human–chimp
organoid DA peaks containing a fixed SNC and accessible only in the cerebral organoid stage that
overlap a VISTA human enhancer with validated activity in the developing mouse forebrain (out of
68 such cases). For each DA peak, the accessibility across pseudotime is shown for human and chim-
panzee with heat maps depicting cells where the peak is accessible (yellow) or inaccessible (black).
The activity pattern of the overlapping VISTA enhancer in E11.5 mouse embryos is shown to the
right. c, The proportion of DE genes (dark colour) or all expressed genes as background (light colour)
with a human–chimp organoid DA peak overlapping the promoter region (blue) or is distal to the
promoter region (pink). The plot shows that DE genes between human and chimpanzee organoids
are more likely to have a nearby DA peak than background. d, Fixed SNCs predicted to significantly
alter transcription factor binding within human–chimp organoid DA peaks, with the name of the
altered motif shown for peaks linked to DE genes (red points). On the right, signal intensity tracks
for a human motif gain (top) and human motif loss (bottom) within a human–chimp DA peak. e,
Altered transcription factor motifs grouped by family plotted for their alteration rate, which is the
number of times a family member’s motif is altered in human–chimp organoid DA peaks divided by
the number of times it is detected in all accessible organoid peaks. f, Twenty transcription factors
with the highest alteration rate, which is the number of times a motif is altered in human–chimp
organoid DA peaks divided by the number of times it is detected in all accessible organoids peaks.
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Heat maps show their expression level in human and chimpanzee NPCs and neurons, with the
bars to the left representing the average expression level across NPCs and neurons. g, Example
of an accessible peak in chimpanzee and macaque that overlaps a computationally verified, non-
polymorphic human conserved deletion (hCONDEL). h, i, Signal intensity tracks of aggregated
single-cell or bulk chromatin accessibility data from human, chimpanzee and macaque for two genes,
LYPD1 (h) and RAC1 (i), that have higher expression and specifically in humans, with genomic




Extended Data Fig. 10: Supplementary analysis of human, chimpanzee and macaque adult
brain snRNA-seq. a, The snRNA-seq data of adult brains in human (50,035), chimpanzee and
bonobo (33,847) and macaque (50,403) were integrated using Seurat v.3. b, Box plots (boxes
show IQR and whiskers show 1.5 x IQR) showing the number of detected genes in single nuclei
and pseudonuclei (3,420 human, 3,831 chimpanzee and 4,623 macaque pseudonuclei). c, Heat
map showing the average prediction scores of each of the 20 identified clusters to each of the cell
types reported [215] by Lake et al. (2016), as well as their estimated distributions in different
cortical layers in humans. Clusters are grouped in major cell classes. d, Cell type composition
of layers and layer distribution of cell types in human. Left, stacked bars showing the estimated
cell type composition of different layers. Right, box plots (boxes show IQR and whiskers show
1.5 x IQR) showing the estimated proportion per layer for four cell classes: excitatory neurons,
inhibitory neurons, astrocytes and oligodendrocytes. e, Genomic conservation based on average
phastCon scores of developmental stage markers (in total 2,000 genes) from iPSCs to neurons in
human cerebral organoids (***P < 10-10, two-sided Wilcoxon’s rank-sum test, n1 = 818 genes,
n2 = 188 genes). f, Hierarchical clustering of the average transcriptome of seven cell classes
in the three species. g, Expression of layer markers (RASGRF2, RORB, ETV1 and TLE4) in
excitatory neurons and inhibitory neuron subtype markers (PVALB and SST ) in inhibitory neurons,
along the predicted laminar origin of the pseudonuclei in human, chimpanzee and bonobo, and
macaque. h, Detection rate in adult tissue of genes being differentially expressed between NPCs
and neurons in organoids. i, Comparison of human–chimpanzee DE in adult excitatory neurons and
that in organoid dorsal neurons for the robust DE genes detected in the organoid dorsal forebrain
trajectory. Three categories of DE genes are highlighted: ubiquitous DE in organoids (top), DE
only in NPCs (middle) and DE only in neurons (bottom).
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j, Comparison of gene detection rates in organoid dorsal neurons and adult excitatory neurons, with
human–chimpanzee DE genes in adult excitatory neurons coloured in yellow, DE genes in organoid
dorsal neurons coloured in green, and shared DE genes coloured in black. The dashed curve shows the
fitted relationship between the two systems using all genes. Area below the curve represents higher
detection rate in organoid neurons than adult neurons and area above the curve represents higher
detection rate in adult neurons. k, Comparison of human–chimpanzee DE (left) between organoid
dorsal neurons and adult excitatory neurons, and between organoid ventral MGE neurons and adult
inhibitory neurons (right). Densities are shown as grey scale shadows, with human–chimpanzee DE
genes highlighted (yellow, DE only in adult; green, DE only in organoids; black, DE in both). l,
Number of human and chimp DE genes for cell classes based on all cell types, a subset of cell types
and specific cell types. m, Number of chimpanzee-specific DE genes across cell classes. The majority







Supplementary tables can be found in the online version of the article (doi: 10.1038/s41586-
019-1654-9).
Supplementary Table 1: Overview of single-cell genomic experiments
Supplementary Table 2: Highly variable genes used in SPRING and Reference Sim-
ilarity Spectrum analyses. Highly variable genes were determined using Seurat (v2.3, vst
method)
Supplementary Table 3: Metadata annotations of human cells from scRNA-seq
Supplementary Table 4: Cluster marker genes from heterogeneity analysis of human
whole trajectory data. Markers were identified using Seurat (v2.3, two-sided Wilcoxon’s rank
sum test, Bonferroni corrected P<0.05)
Supplementary Table 5: Metadata annotations of chimpanzee cells from scRNA-seq
Supplementary Table 6: Cluster marker genes from heterogeneity analysis of chim-
panzee whole trajectory data. Markers were identified using Seurat (v2.3, two-sided
Wilcoxon’s rank sum test, Bonferroni corrected P<0.05)
Supplementary Table 7: Expression of human-specific genes in human whole trajec-
tory data
Supplementary Table 8: Metadata annotations of differentially expressed genes
between human, chimpanzee, and macaque in cerebral organoids
Supplementary Table 9: Metadata annotations of cells from scATAC-seq
Supplementary Table 10: Metadata annotations of differentially accessible peaks
between human and chimpanzee cerebral organoids
Supplementary Table 11: Metadata annotations of peaks overlapping human con-
served deletions and single nucleotide changes in differentially accessible peaks
Supplementary Table 12: Highly variable genes used in adult brain single-nuclei
RNAseq data integration from human, chimpanzee and macaque. Highly variable
genes were determined using Seurat (v3.0, vst method).
Supplementary Table 13: Metadata annotations of nuclei and pseudonuclei from
snRNA-seq
Supplementary Table 14: Major cell class marker genes of human, chimpanzee and
macaque adult brain. Markers were identified using Seurat (v3.0, two-sided Wilcoxon’s rank
sum test, Bonferroni corrected P<0.05)
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Supplementary Table 15: Metadata annotations of differentially expressed genes
between human, chimpanzee and macaque in adult brains
SUPPLEMENTARY NOTES
Progression of major cell types during cerebral organoid culture We used the time
course single-cell RNA-seq data from cerebral organoids to track a progression through pluripo-
tent, neuroectodermal, and neuroepithelial stem cell states during the first 15 days of differen-
tiation. By 1 month, cells diversify into neural progenitors from multiple brain regions including
the forebrain (dorsal and ventral telencephalon, diencephalon), midbrain (mesencephalon), and
hindbrain (rhombencephalon). A small subpopulation resembling retinal progenitors of the de-
veloping eye field is also present, but these cells were only detected in an iPSC 409b2-derived
organoid. In addition, a nonneuronal mesenchymal population appears from both cell lines
early in the differentiation time course. By 2 months, excitatory and inhibitory neuronal fates
have differentiated from progenitors of multiple brain regions, and by 4 months astrocytes
have emerged.
Focusing on 2-month organoids, we observed neuronal differentiation trajectories represent-
ing ventral and dorsal telencephalon, as well as distinct populations of cortical excitatory (GLI3,
EOMES, NEUROD6), ventral telencephalon inhibitory (DLX1, SOX6, GAD1/2), diencephalon
excitatory, diencephalon inhibitory (with Cajal-Retzius cell signatures), mesen- (or midbrain)
and rhombencephalon (hindbrain) excitatory, and mesenand rhombencephalon inhibitory neu-
rons. Each iPSC line contributed cells to multiple differentiation trajectories, however the
proportions of cells in each trajectory varied across organoid and iPSC. For example, over
90% of cells from the line Kucg2 were on the cortical excitatory (dorsal) trajectory in each
of the 3 organoids, whereas Hoik1-derived organoids predominantly contained cells from non-
telencephalic regions.
In the single-cell RNA-seq data we generated from human, chimpanzee, and macaque 2 and
4 month organoids using 10X Genomics, we observed very strong signatures of deep and upper
layer cortical neuron differentiation in chimpanzee and macaque organoids. This bifurcation
of deep and upper layer cortical neurons was much less pronounced in human organoids from
the same time point. We analyzed additional scRNA-seq data (Smart-seq2, Fluidigm C1)
data from 52 human organoids from 15 individuals, 38 chimpanzee/bonobo organoids from
11 lines, and one macaque organoid from one line. Based on this data, we find that there
is variation in the degree of specification of upper and deep layer cortical neurons, which
makes it unclear whether this is a reliable measure of organoid maturation. It is unclear if
this variation is due to batch, lines, organoid or scRNA-seq protocols. However, we found
that neuron projection, synapse, and neurotransmitter related genes were consistently and
significantly expressed higher at an earlier time point in the chimpanzee organoids compared




Potential biological significance of chosen genes with differential properties between
human and chimpanzee We compared scATAC-seq data of human and chimpanzee cere-
bral organoids and identified 8,099 peaks (7.4% of all accessible peaks) that gained accessibility
in humans relative to chimpanzee, whereas 9,836 peaks (9% of all accessible peaks) lost ac-
cessibility. We annotated peaks that are DA between humans and chimpanzees with various
evolutionary signature. For instance, we identified 62 human accelerated regions that overlap
DA peaks (32 gain accessibility in human, 30 gain accessibility in chimpanzee), with one of
these sites being nearby a gene with human-specific expression. In this case, the potential
regulatory region is 244 Kb away from cadherin 7 (CDH7), a gene with higher expression
specifically in human cortical neurons, and has increased accessibility in human neurons rel-
ative to chimpanzee and macaque. We also find DA regions nearby two genes, Ly6/PLAUR
domain-containing protein 1 (LYPD1) and Ras-related C3 botulinum toxin substrate 1 (RAC1),
that have human-specific expression in NPCs and neurons, respectively. LYPD1 is involved in
neurotransmitter receptor-binding and anxiety-related behaviors [307] and RAC1 is a GTPase
involved in diverse processes including glucose uptake and cytoskeletal reorganization and ge-
netic variants in this gene can lead to micro-or macrocephaly [308]. In addition, we identify
22 regions that are accessible in chimpanzee NPCs or neurons that are highly conserved in
mammals, but the DNA has been deleted in humans (so-called human conserved deletion,
hCONDELs) [60] and 1 of these are located nearby a DE gene (FADS1). FADS1 encodes the
fatty acyl desaturases (delta-5 desaturase) which catalyze key steps in the ω-3 and ω-6 lipid
biosynthesis pathways [309], and has been reported to be abundantly expressed in the brain
[310], and therefore could have contributed to the fast divergence of lipids between human
and other primates like chimpanzee and macaque [52].
With the single-nucleus RNA-seq data of human, chimpanzee and macaque adult prefrontal
cortex, we identified 479 DE genes in adult excitatory neurons between human and chimpanzee.
Among them, 53 overlap with DE genes in dorsal telencephalon cells between human and
chimpanzee organoid. They include COL6A1, the gene encoding alpha1-chain of collagen VI,
the broadly distributed extracellular matrix protein. COL6A1 has been suggested to play roles
in central nervous system development and diseases [279], and has been shown to have a
protective role limiting autophagy and apoptosis in aging neurons [311]. Another example
is RIC3, which shows not only human-specific DE in adult neurons, but also human-specific
DE in organoids in a neuron-specific manner. RIC3 encodes a protein which functions as a
chaperone influencing the folding, assembly of specific 5-hydroxytryptamine type 3 receptor
and nicotinic acetylcholine receptor subtypes, and regulates the number and maturation of




Altered neuronal migratory trajectories in human cerebral
organoids derived from individuals with neuronal
heterotopia
Johannes Klaus, Sabina Kanton, Christina Kyrousi, Ane Cristina Ayo-Martin,
Rossella Di Giaimo, Stephan Riesenberg, Adam C. O’Neill, J.Gray Camp,
Chiara Tocco, Malgorzata Santel, Ejona Rusha, Micha Drukker, Mariana
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Malformations of the human cortex represent a major cause of disability [79]. Mouse models
with mutations in known causal genes only partially recapitulate the phenotypes and are there-
fore not unlimitedly suited for understanding the molecular and cellular mechanisms responsible
for these conditions [313]. Here we study periventricular heterotopia (PH) by analyzing cere-
bral organoids derived from induced pluripotent stem cells (iPSCs) of patients with mutations
in the cadherin receptor–ligand pair DCHS1 and FAT4 or from isogenic knockout (KO) lines
[79, 227]. Our results show that human cerebral organoids reproduce the cortical heterotopia
associated with PH. Mutations in DCHS1 and FAT4 or knockdown of their expression causes
changes in the morphology of neural progenitor cells and result in defective neuronal migration
dynamics only in a subset of neurons. Single-cell RNA-sequencing (scRNA-seq) data reveal a
subpopulation of mutant neurons with dysregulated genes involved in axon guidance, neuronal
migration and patterning. We suggest that defective neural progenitor cell (NPC) morphology
and an altered navigation system in a subset of neurons underlie this form of PH.
Main text
Mammalian neocortical development represents a highly orchestrated process that depends on
the precise generation, migration and maturation of neurons. The importance of a coordinated
sequence is underlined by the conditions with its disruption: malformation of cortical develop-
ment. PH represents one of the most common forms of these disorders and is characterized
by heterotopic neurons lining their sites of production. Patients with PH typically present with
intellectual disability, and this is frequently associated with epilepsy [226, 314–319]. The iden-
tification of mutations in the protocadherins DCHS1 and FAT4 put the spotlight on defects
in NPCs as a causal mechanism of the condition. Here we explore the functions of DCHS1
and FAT4 in the developing cortex using human iPSC-derived NPCs, neurons and cerebral
organoids.
We first reprogrammed fibroblasts from control individuals and patients with PH who carry
mutations in DCHS1 or FAT4 into iPSCs (Extended Data 1a,b). Specifically, fibroblasts were
collected from two different previously characterized patients [79, 227]: one was compound
heterozygous for mutations in the FAT4 gene and one homozygous for mutation in the DCHS1
gene. Additionally, to control for differences due to the different genomic background in the
patients, we generated KO iPSC lines for both genes using CRISPR–Cas9 genome editing in
control iPSCs. We programmed the iPSCs toward NPCs and neurons in two-dimensional (2D)
culture and generated three-dimensional (3D) cerebral organoids [250] (Extended Data 1c,d).
Using in situ hybridization, we identified that both genes were expressed in the periventricular
structures of cerebral organoids and neurons (Extended Data 1e–h’), a pattern consistent with
that detected in mouse and human [79, 320]. These findings were confirmed by scRNA-seq of
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cells derived from cerebral organoids, where the expression of DCHS1 and FAT4 was found in
both progenitors and neurons (Extended Data 1i,j).
To investigate whether PH is recapitulated within cerebral organoids (Extended Data 1k,l), we
scrutinized ventricular zone structures for such phenotypes. In control organoids, a clear dis-
tinction of the neuronal (MAP2+ cells or NEUN+ cells) layer from the germinal zone (PAX6+
cells) was identified (Fig.1a,d, Extended Data 2a,e,h and Extended Data 3g,k). Organoids de-
rived from mutant or KO iPSC lines exhibited a significant number of neuronal nodules at
ventricular positions (Fig.1a–c, Extended Data 2e–j, and Extended Data 2l–l”’). In addition
to this neuronal heterotopia-like phenotype, mutant and KO organoids presented poorly orga-
nized germinal zones (Fig.1d,e and Extended Data 2d). This feature was especially apparent
in germinal zones of FAT4 -mutant organoids, with most not showing evident separation of
the neuronal band from the germinal zone, with neurons intruding in most cases. In the case
of DCHS1 -mutant or knockdown organoids, performed via electroporation of specifically de-
signed microRNAs (miRNAs) that target the human gene (Extended Data 2k), clusters of neu-
rons were found within the germinal zones where NPC processes where disrupted (Fig.1f–f”’
and Extended Data 2l–l”’). Although DCHS1 -mutant organoids displayed clearer separations
between the germinal zones and neuronal layer, the neurites showed an altered morphology
compared with controls, with many processes appearing as thick bundles (Extended Data
2m–o). These findings show that cerebral organoids recapitulate the hallmarks of PH. The
loss of organization (germinal zone versus cortical plate) in mutant organoids starts early, after
20 d of cerebral organoid development (Extended Data 3a–f), even though the sizes of the
two zones (VZ and CP) are not altered (Extended Data 3g–j).
In mice, knockdown of Dchs1 or Fat4 leads to overproliferation of progenitors1. This increase
in proliferation was not observed in human organoids derived from patient iPSCs (Extended
Data 3k–s), highlighting fundamental species-specific differences. We analyzed the morphol-
ogy of the processes of NPCs in organoids by NESTIN immunostaining in mutant or KO
organoids. Whereas in control organoids the processes appeared to be aligned and straight, in
FAT4 -mutant or KO organoids, these processes were often disrupted and exhibited a twisted
morphology (Fig.1g,i,m and Extended Data 4a,c). NPC morphology in DCHS1 -mutant or KO
organoids was less severely compromised (Fig.1g–i,m and Extended Data 4a–c). To scrutinize
the morphology of single NPCs, we elec- troporated a Gap43-GFP plasmid [321] to label the
cell membrane in mutant organoids. Analysis 4 d after electroporation showed that FAT4 -
mutant organoids had disrupted progenitor morphology (Fig.1j,l,n). Consistent with previous
results, this phenotype was also observed in DCHS1 -mutant organoids (Fig.1j,k,n).
To ensure that the observed phenotypic differences are not caused by the different genetic
backgrounds of the cells of origin, we respectively and selectively knocked down DCHS1 and
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Fig. 1: Mutations in DCHS1 and FAT4 cause neuronal heterotopia and disturbances in the
morphology of NPCs in cerebral organoids. a–c,f–f”’, Micrographs of sections of organoids
immunostained as indicated in the panels. Note the mispositioning of neurons marked by arrows
in mutant or in electroporated cerebral organoids. a–c, batches (b) = 5, organoids (o) = 15 per
condition, f–f”’, b = 2, o = 6 per condition. d,e, Classification of organoids according to phenotypes
(v = 24 CTRL, 11 DCHS1, 16 FAT4, v = 23 CTRL2, 17 DCHS1 KO, 32 FAT4 KO based on MAP2
staining; v = 7 CTRL, 31 DCHS1, 14 FAT4, 12 CTRL2, 23 DCHS1 KO, 17 FAT4 KO based on
NEUN staining). Mutant or KO organoids show significantly more disorganized germinal zones and
exclusively show a heterotopia phenotype (chi-squared test, χ2(4) = 84.79, P = 0.000 for d in mutant
organoids, chi-squared test, χ2(4) = 40.33, P = 0.000 for d in KO organoids, chi-squared test,χ
2
(4)
= 27.69, P = 0.000 for e in mutant organoids, Chi square test, χ2(4) = 16.94, p = 0.000 for e
in KO organoids). b,c, Ectopic nodule of MAP2+ neurons in the germinal zone of DCHS1 and
FAT4 -mutant organoids. f–f”’, Nodule of DCX+ neurons intermingling with NESTIN+ processes
of NPCs in the germinal zone after DCHS1 miRNA electroporation in control organoid. Dotted
lines highlight ventricles (V). g–i, Micrographs of sections of mutant cerebral organoids (day 42)
immunostained for NESTIN. Arrows indicate the disrupted morphology of NPCs. g–l, b = 3, o =
9 per condition. j–l, Micrographs of sections of mutant organoids electroporated with Gap43-GFP
at day 42 and analyzed at day 46. Progenitors in mutant organoids (k,l) show disrupted pattern
(arrows). m–o, Quantification of the tortuosity index of NPCs based on NESTIN (v = 8 CTRL (c
= 43), 4 DCHS1 (c = 38), 6 FAT4 (c = 65)) (m) or GFP (v = 9 CTRL (c = 44), 5 DCHS1 (c
= 25), 7 FAT4 (c = 34)) (n) staining in mutant organoids, or based on GFP staining in control
organoids electroporated with miRNAs against DCHS1 or FAT4 (v = 11 CTRL (c = 52), 13 DCHS1
(c = 71), 7 FAT4 (c = 49)) (o). Results are z scores; significance is based on one-way ANOVA;
P = 0.000; Holm–Sidak multiple-comparisons test was performed for defining statistical differences
between the three genotypes in each graph. Data in graphs are represented as mean ± s.e.m. Scale
bars, 100 µm in a–c and 30 µm in f–f”’ and g–l. Dotted lines highlight ventricles (V). ***P < 0.001,
****P < 0.0001. 139
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FAT4 in NPCs via electroporation of miRNAs in control organoids. 7 d post electroporation, we
similarly observed a disruption in the morphology of NPCs upon DCHS1 and FAT4 knockdown
(Fig. 1o and Extended Data 4d–f), suggesting that the morphology of NPCs is disturbed in
organoids derived from cells with mutations or reduced DCHS1 and FAT4.
Dchs1 and Fat4 have been described to localize apically and to form a heterophilic complex
in the developing mouse brain [320]. We therefore hypothesized that DCHS1 and/or FAT4
could be key molecules in the maintenance of the polarity of NPCs. We found mislocaliza-
tion of cilia labeled by ARL13B (Extended Data 5r), but the total proportion of apical and
basal cilia was not altered (Extended Data 5p–s); in FAT4-mutant germinal zones and, to
some extent, in DCHS1-mutant germinal zones, the apical surface exhibited a disrupted or
discontinuous morphology with increased distance between the apical surface and the NPCs
(Extended Data 5f–o). This finding further underlined that the defects in NPCs are more
pronounced in FAT4 -mutant organoids, but it also revealed that both mutations do not pre-
clude the establishment of apicobasal polarity. To evaluate whether cytoskeletal dynamics are
affected and possibly contributing to the disrupted morphology of NPCs in the patient-derived
organoids, we performed immunohistochemistry for ACETYLATED TUBULIN, which labels
stable microtubules. While the stable microtubules were not strongly affected in DCHS1 -
mutant NPCs, FAT4 -mutant NPCs showed not only decreased organization but also markedly
diminished levels of stable ACETYLATED TUBULIN (Extended Data 5a–c). To specifically
detect levels of stable microtubules in NPCs, we performed a western blot analysis of ACETY-
LATED TUBULIN in NPCs from monolayer cultures and detected a significant decrease in
ACETYLATED TUBULIN in FAT4 -mutant NPCs. In contrast, TYROSINATED TUBULIN,
which reflects the more dynamic form of tubulin, was not altered (Extended Data 5d,e).
In order to gain deeper insight into the molecular changes in progenitors and neurons of
DCHS1 and FAT4 organoids, we next performed scRNA-seq to dissect the cell composition
and transcriptional landscapes in DCHS1, FAT4 and control (CTRL) organoids. We analyzed
805 single cells from three microdissected organoid cortical regions for each condition (nine
organoids in total; 50–60 d) and identified progenitors and neurons based on known marker
genes (Fig. 2a,b). In an unbiased principal component analysis (PCA), the first two com-
ponents separate NPCs (e.g. VIM, PAX6, SOX2, HES1) and neurons (e.g. DCX, STMN2,
TUBB3, SNAP25, MYT1L) independent of the condition (control, DCHS1, FAT4) (Fig. 2a,b
and Supplementary Table 1). However, the third principal component segregates control cells
from DCHS1 - and FAT4 -mutant cells, which remarkably intermingle, suggesting that cells de-
rived from patients with mutation in DCHS1 and FAT4 share common transcriptome features
distinct from the control cells (Fig. 2c). Interestingly, among the genes upregulated in all
mutant cells, there are genes involved in patterning (HOX genes, MEIS1) as well as RND3, a
negative regulator of RHOA that is essential for correct neurogenesis [228].
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Fig. 2: scRNA-seq reveals alterations in mutant NPCs. a, Schematic of scRNA-seq experimental
procedure. Number of organoids and cells analyzed: 9 organoids (3 for each condition), 805 single
cells (316 CTRL, 255 DCHS1, 234 FAT4). b, Heat map showing expression of selected marker
genes (rows) for NPCs and neurons for all three conditions (CTRL, DCHS1, FAT4), with single cells
represented in columns. Top side bar visualizes experiment (shades of green) and maximal zone
correlation for each single cell (VZ, ventricular zone, yellow; iSVZ, inner subventricular zone, orange;
oSVZ, outer SVZ, red; CP, cortical plate, purple). Cells are ordered based on their PC 2 loading,
corresponding to the trajectory from NPCs to neurons. c, Hierarchical clustering on all 805 single
cells (rows) and genes (columns) identified by PCA to correlate and anticorrelate with PC 2 and PC
3 (Supplementary Table 1). The first two components commonly separate progenitors (light gray)
from neurons (dark gray) for all experiments. The third component separates CTRL cells (red) from
DCHS1 (cyan) and FAT4 (blue) cells. Results of gene ontology (GO) enrichment analysis for each
gene group are shown below the heat map. d, Pairwise correlation network reveals a differentiation
topology from NPCs correlating with the VZ (yellow) via cells correlating with iSVZ (orange) and




Fig. 3: Time-lapse imaging of mutant or knockdown neurons reveals an altered migration
pattern. a–c,g, Examples of the movement of neuronal somata in control organoids after control,
DCHS1 or FAT4 miRNA electroporation monitored in 3D time-lapse experiments (a–c) and in
control and mutant neurons monitored in 2D time-lapse experiments (g). Scale bars, 30 µm in a–c
and 10 µm in g. a–c, b = 1, o = 3 per condition; g, b = 4. d–f,h–j, Quantification of velocity,
number of resting time points and tortuosity differed according to the mutation. d–f,h–k, CTRL
miRNA b = 1, o = 3, v = 7, c = 63; DCHS1 miRNA b = 1, o = 3, v = 7, c = 56; FAT4 miRNA
b = 1, o = 3, v = 7, c = 42; CTRL b = 4 c = 136; DCHS1 b = 4 c = 220; FAT4 b = 4 c = 126.
Results are z scores; statistical analysis was performed in d,e based on one-way ANOVA, P = 0.000,
Holm–Sidak’s multiple comparisons test was performed for defining statistical differences between
the three genotypes in each graph, in h–j based on one-way ANOVA with Tukey HSD post hoc and
through multivariate ANOVA (h, F (6,956) = 84.20, P = 0.000; i, F (6,956) = 43.10, P = 0.000, j,
F (6,956) = 10.68, P = 0.000). k, Hierarchical and two-step cluster analysis of migration dynamics
across the whole cell population (chi-squared test, χ2(2) = 70.32, P = 0.000). Data in graphs are
represented as mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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Previously, we identified a group of genes (Supplementary Table 2) that described the different
cell populations in the human fetal neocortex and found that cerebral organoids recapitulate
the expression pattern of these genes [114]. Using these genes, we reconstructed the lineage
relationships between cells and visualized the relationships as intercellular correlation networks
for control, DCHS1 and FAT4 organoids. As expected, control cells form a network with a
topology that recapitulates the layered structure of the healthy developing cortex (Fig. 2d). In
contrast, the networks from mutant organoids have a generally deformed architecture, consis-
tent with the observed heterotopia and disorganization of mutant organoids (Fig. 1). Mutant
progenitors from DCHS1 and FAT4 organoids showed a higher correlation with signatures
of the cells located in the inner and outer subventricular zone, at the expense of ventricu-
lar zone signatures (Fig. 2b,d and Extended Data 3o). This finding supports the observed
morphological changes in mutant progenitors, which prematurely delaminate, typical of more-
differentiated basally located progenitors (Fig. 1f–o, Extended Data 2l–l”’ and Extended Data
4). Consistent with these findings, more differentiated neurons were found in mutant organoids
compared with control organoids in each experiment (Fig. 2b and Extended Data 3p). We fur-
ther validated these results by analyzing the proportion of proliferating and differentiated cells
in patient-derived cerebral organoids by means of FACS analysis (KI67, cycling progenitors;
DCX, newborn neurons) from whole organoids (Extended Data 3q–s).
We also aimed at specifically characterizing the migration abilities of neurons with defective
DCHS1 or FAT4. To this end, we electroporated control organoids with specific miRNAs
targeting DCHS1 or FAT4. 7 d later, we tracked the migratory behavior of the electropo-
rated neurons via time-lapse imaging in 300 µm-thick slices of the organoids with preserved 3D
structure (Fig.3a–c). We measured speed of migration (velocity), time neurons spend without
moving (resting time points) and ability to move in a straight direction (tortuosity), a typical
feature of radially migrating neurons generated in the cerebral cortex. For all three parame-
ters measured, the cells with DCHS1 or FAT4 knockdown displayed a significant difference
compared with control cells. Specifically, the number of resting time points and the tortuosity
were increased, whereas the velocity of the cells decreased (Fig. 3d–f). To investigate if this
behavior is an intrinsic feature of the defective neu- rons or due to the changed NPC scaffold,
which we observed in mutant and knockdown DCHS1 and FAT4 organoids (Fig. 1 and Ex-
tended Data 2,4), we performed time-lapse imaging in cultured mutant cells in a monolayer
[322] (Extended Data 6a–f) and tracked the same parameters as those measured in 3D. In
accordance with the behavior of migrating neurons observed in 3D, mutant neurons in 2D
showed the same significant differences in their migration compared with controls (Fig. 3g–j).
To see whether these changes affected only a specific population of cells, we performed hierar-
chical clustering analysis on the migration behavior of each cell based on all three parameters
combined (velocity, resting time points and tortuosity). These data revealed that control cells
cluster in two main distinct migration behaviors (cluster 1 and cluster 2). Remarkably, in
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mutant cells, cluster 2 remained the same as that in the control cells, whereas another type of
migration behavior, cluster 3, emerged at the expense of cluster 1 (Fig. 3k). This change in
the migratory dynamics of a specific cell population of patient-derived neurons could elucidate
the phenotype observed in patients where only a limited number of neurons fail to migrate to
their final location, resulting in heterotopic neurons residing at the ventricular surface.
We searched for a molecular signature that might explain the altered migration dynamics in
a subset of mutant neurons. We used PCA and lineage reconstruction analysis (Monocle2)
[323] of the organoid scRNA-seq data and found a subpopulation of neurons in DCHS1 - and
FAT4 -mutant organoids that was not present in control organoids (Fig. 4a and Supplementary
Table 3). This altered neuronal state consisting of mutant cells bifurcates from a progenitor-
to-neuron trajectory that includes cells from all three conditions (Fig. 4b). Notably, this
lineage bifurcation is not due to the emergence of neuronal cells with a different regional
identity in the mutant organoids, because mutant, KO and control organoids express basic
neuronal and cortical markers in a similar way (Extended Data 7a–m). The genes upregulated
in the altered neuronal population are involved in fundamental neurodevelopmental processes
like axon guidance, neuronal migration and patterning (e.g., ROBO3, NDNF, DCC, CNTN2,
EPHB3, EFNA3, ITGB1, GNG5, HOX ) (Fig. 4c). Interestingly, some genes such as GNG5
are expressed in progenitors, and are turned off in neurons from control organoids, but stay on
in this altered neuronal state. Other genes such as ROBO3 or CNTN2 are only found in this
subpopulation. On the contrary, the genes downregulated in these cells are involved in synapse
formation, ion channel, axon guidance and cytoskeleton (e.g., GRIA2, SNCA, MAPT, MAP1B,
GNAI1, SPTAN1, FLRT2). Interestingly, three of the dysregulated genes-MAPT, MAP1B
and SPTAN1 -are associated with epilepsy, a phenotype found in these patients [318, 324].
Variants in the MAP1B locus have also been associated with PH [318]. To further validate
these data, we performed scRNA-seq (10X genomics) on neuronal cells derived from control
or DCHS1 -mutant cells in 2D cultures (Fig. 4d). Consistent with previous results, Monocle2
lineage reconstruction analysis revealed an altered neuronal state enriched for DCHS1 -mutant
cells (83% of altered neuronal cells) compared with control cells (17% of altered neuronal
cells), which was characterized by a dysregulation of the same set of genes, as found in the
organoid data (Fig. 4c), such as GNG5, CNTN2 and GRIA2 (Fig. 4e).Taken together, these
findings suggest that the subpopulation of the heterotopically located neurons could be the
consequence of alterations in migration dynamics due to incorrect regulation of specification
and guidance gene programs. Similarly, not all neurons are affected in human patients with
PH, but only a subset of them form periventricular clusters. It remains to be explored why
the majority of neurons are able to navigate their way up to the cortical plate, despite the fact
that they harbor the same gene mutation as the neurons located in the heterotopic clusters.
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Fig. 4: scRNA-seq reveals an altered population of neurons. a, Hierarchical clustering on all
neurons (rows, 467 single cells) and genes (columns) identified by PCA (Supplementary Table 3).
A specific subpopulation of neurons (yellow) is identified that is only found in DCHS1 or FAT4
patient-derived organoids. Results of GO enrichment analysis for each gene group are shown below
the heat map. b, Monocle2 lineage reconstruction of all 805 single organoid cells (circles) using
genes identified by PCA (Supplementary Table 3) on all cells and on all neurons reveals a specific
subpopulation of neurons only existing in mutant organoids that bifurcates from the general NPC-
to-neuron trajectory. The three top right visualizations show cells from each condition separately
in their respective color, with all other cells in gray. The three bottom right visualizations show
the lineage reconstruction color coded by the expression of three selected genes marking neurons
(STMN2), NPCs (PAX6) and the altered neuronal state (ROBO3). c, Violin plots show distribution
of expression of genes that are up- (top) or downregulated (bottom) in the population of altered
(black) compared with normal (dark gray) neurons. NPCs, light gray. Violin plots were plotted using
ggplot2 default kernel density settings. d, Monocle2 lineage reconstruction of 10X genomics-based
scRNA-seq data (437 CTRL, 751 DCHS1) from control and DCHS1 -mutant neuronal cells grown
in 2D culture reveals an altered neuronal subpopulation that bifurcates from the general NPC-to-
neuron trajectory and is strongly enriched for mutant cells (83% of cells on this branch are DCHS1
mutant). For the lineage reconstruction, the same genes were used as in b. e, Violin plots show
distribution of expression of genes that are up- (top) or downregulated (bottom) in the population
of altered (black) compared to normal (dark gray) neurons. NPCs, light gray. Note that these genes
are the same as those found differentially expressed in the organoid altered neuronal state (c). IC,
independent component. 145
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Molecular and cellular analysis of organoids and cells derived from patients with mutations
in DCHS1 and FAT4 or upon knock-down of these genes revealed a speciesspecific role of
DCHS1 and FAT4 in human cells. Neuronal heterotopia develops as a consequence of multiple
defects: the defective radial progenitor cells, which should guide the neurons to the correct
final destination, and a specific subpopulation of neurons that acquire an altered navigation
system, which changes their migratory dynamics and leads to compromised equipment for
synaptic signaling. It is also clear that in patients, PH is induced by mutations in different
genes, and thus it may involve the dysregulation of different molecular pathways [318].
Although the precise molecular regulation of DCHS1 and FAT4 remains to be clarified, we
propose that changes in the expression of genes involved in the cytoskeleton and cell junction
or axon guidance could affect the morphology of progenitor cells and migrating neurons,
respectively.
The knowledge of the new molecular signatures acquired from disease neurons could ultimately
be used to develop new strategies for targeting neurons that are aberrantly integrated into
cortical circuits and possibly cause neuronal heterotopia in patients.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, state-
ments of data availability and associated accession codes are available at https://doi.org/10.1038/
s41591-019-0371-0.
Acknowledgements
We thank the families participating in this study for their involvement. We thank Y. Lu for
help generating the microRNAs, M. Karow and I. Buchsbaum for helping with experiments and
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Methods
Genetic mutation in DCHS1 and FAT4. Details about the genetic mutations found in
DCHS1 and FAT4 patients can be found in the Supplementary Table 4.
iPSC culture. iPSCs were regularly maintained on Geltrex-coated dishes (Thermo Fisher,
Waltham, MA, USA) in mTesR1 medium (Stem Cell Technologies, Vancouver, Canada) at
37◦C, 5% CO2 and ambient oxygen level. Passaging was done manually by scraping the cells
after 10 min of collagenase treatment (Stem Cell Technologies). Generation of iPSC lines were
generated with patient consent, and this study was ethically approved (CEN/11/12/066 Cen-
tral Regional Ethics Committee, New Zealand and 115–16 Ethical Committee LMU Munich,
Germany).
Reprogramming of fibroblasts. 2.5 x 10-5 NuFF3-RQ human newborn foreskin feeder fi-
broblasts (GSC-3404, GlobalStem) were seeded per well of a 6-well tissue culture dish with
advanced MEM (12491015, Thermo Fisher Scientific) supplemented with 5% HyClone FBS
(SV30160.03HI, GE Healthcare), 1% MEM NEAA and GlutaMAX (11140050; 35050061
Thermo Fisher Scientific). Patient fibroblasts were obtained from skin biopsies. Day 1, patients
and control fibroblast cultures (CTRL-2522, ATCC) of 70–80% confluency were dissociated
using 0.25% trypsin-EDTA (25200056, Life Technologies), counted and seeded on the NuFF3-
RQ cells at two different densities: 2 x 10-4 cells/well and 4 x 10-4 cells/well. Day 2, medium
147
CHAPTER 3
was changed to Pluriton Reprogramming Medium (00–0070, Stemgent) supplemented with
500 ng/ml carrier-free B18R Recombinant Protein (03–0017, Stemgent). Days 3–18, mod-
ified mRNA (mmRNA) cocktail was transfected daily combining OCT4,SOX2, KLF4, LIN28
and C-MYC mmRNAs at a 3:1:1:1:1 stoichiometric ratio and Opti-MEM I Reduced Serum
Medium (13778150, Thermo Fisher Scientific) in a total volume of 105 µL with a mix of
92 µL Opti-MEM I Reduced Serum Medium and 13 µL Lipofectamine RNAiMAX Transfection
Reagent (31985062, Thermo Fisher Scientific) after incubation at room temperature (RT)
for 15 min. Cells were transfected for 4 h, then washed, and fresh reprogramming medium
supplemented with B18R was added to the cultures. The mmRNA factors were provided by
the RNA CORE of the Houston Methodist Hospital and contained the following modifications:
5-methyl CTP, Pseudo-UTP, ARCA cap and a 150-nucleotide poly-A tail. The first morpho-
logical changes were noticed as early as day 5 after the first transfection, and the first iPSC
colonies appeared by day 12–15. On day 16, medium was changed to STEMPRO hESC SFM
(A1000701, Thermo Fisher Scientific) for 5 d. The iPSC colonies were then harvested using
2 mg/ml collagenase, type IV (17104019, Thermo Fisher Scientific) solution in DMEM/F12
(31331093, Thermo Fisher Scientific) by 40- min incubation at 37 ◦C. The iPSCs were plated
on γ-irradiated mouse embryonic fibroblasts (MEFs) and grown in STEMPRO for ten addi-
tional passages before adapting the iPSCs to a feeder-free culture system using plates coated
with LDEV- Free Geltrex (A1413302, Thermo Fisher Scientific) and mTeSR1 (05850, StemCell
Technologies).
CRISPR genome editing for generation of knockout iPSC lines. 409-B2 human iP-
SCs with a doxycycline-inducible Cas9 nickase (D10A mutation) were incubated with media
containing 2 µg/mg doxycycline (Clontech, 631311) 2 d prior to the addition of gRNA by
lipofection or electroporation, as described by Riesenberg and Maricic [325]. Genome edit-
ing of DCHS1 and FAT4 was done by lipofection and electroporation of gRNA (duplex of
chemically synthesized crRNA and tracrRNA, alt-CRISPR IDT), respectively. Lipofection by
RNAiMAX (Invitrogen, 13778075) was done using a final concentration of 7.5 nM of each
gRNA (DCHS1 target1: GTGGACATCAGCATTGTGCC, DCHS1 target2: GGGCACTGGGTT
CTGCCTGT). Electroporation was done using the B-16 program of the Nucleofector 2b De-
vice (Lonza) in cuvettes for 100 µL Human Stem Cell nucleofection buffer (Lonza, VVPH-
5022) and 0.3 nmol gRNA (FAT4 target1: TTTGATGCTTTCAAAGAAGG, FAT4 target2:
GAGATCCTTCTCCGGCAGAG). Edited cells were plated in different wells for analysis and
further propagation. 3 d after addition of gRNA, cells for analysis were dissociated using Ac-
cutase (SIGMA, A6964), pelleted, resuspended in 15 µL QuickExtract (Epicentre, QE0905T)
and incubated at 65 ◦C for 10 min, 68 ◦C for 5 min, and finally 98 ◦C for 5 min. PCR was done
in a T100 Thermal Cycler (Bio-Rad) using the KAPA2G Robust PCR Kit (SIGMA, KK5024)
with supplied buffer B and 3 µL of cell extract in a total volume of 25 µL. The thermal cycling
profile of the PCR was: 95 ◦C 3 min; 34 x (95 ◦C 15 s, 65 ◦C 15 s, 72 ◦C 15 s); 72 ◦C 60 s
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(DCHS1 forward: GGGTTGTGTGCCTGGACTAT, DCHS1 reverse: TTCCTCTCAGGGCT-
GTTGAC, FAT4 forward: TAGGGACTGCTGTGCAACTG, FAT4 reverse: AGCTCACAGC-
CAATCTTCGT). Sample-specific indices on P5 and P7 Illumina adapters were added in a
second PCR reaction using Phusion HF MasterMix (Thermo Scientific, F-531L) and 0.3 µL
of the first PCR product. The thermal cycling profile of the second PCR was: 98 ◦C 30 s;
25x (98 ◦C 10 s, 58 ◦C 10 s, 72 ◦C 20 s); 72 ◦C 5 min. The indexed amplicons were puri-
fied using Solid Phase Reversible Immobilization (SPRI) beads [326]. Double-indexed libraries
were sequenced on a MiSeq (Illumina), giving paired-end sequences of 2 x 150 bp. After base
calling using Bustard (Illumina), adapters were trimmed using leeHom [261], and sequences
were analyzed using SAMtools [286]. After confirmed bulk editing success, cells were plated
in a single-cell dilution that gave rise to single-cell-derived colonies. DNA isolation and further
genotyping of these colonies was done as described above.
DCHS1 genotypes:








F L S G L L T V A W P L A R R A N S V V Q L E I G A E D G G G L Q A E P S A R V
D I S I V P GT P T P P I F E Q L Q Y V F S V P E D V A P GT S V GI V Q A H N







F L S G L L T V A W P L A R R A N S V V Q L E I G A E D G G G L Q A E P S A W










F L S G L L T V A W P L A R R A N S V V Q L E I G A E D G G G LQ A E P S L C L
E P P H H P Y L S N Y S Met F F L C Q R Met W H Q A P V W A Stop S R H T T
FAT4 genotypes








G T A V Q L Y S A Y E E N N R T F L L A A V K R N H N Q Y V N PS G V A T F F
E S I K E I L L R Q S G V K V E S V D H D S C V H G P C Q N G G S C LR R L A VS







G T A V Q L Y S A Y E E N N R T F L L A A V K R N H N Q Y V N PS G V A T F S







G T A V Q L Y S A Y E E N N R T F L L A A V K R N H N Q Y VN P S G V A T F F
P A E W S K G G I C G S Stop L L C A W P Met S E W R E L S T K I G C E







G T A V Q L Y S A Y E E N N R T F L L A A V K R N H N Q Y V N P S G V A T F S










G T A V Q L Y S A Y E E N N R T F L L A A V K R N H N Q Y V N P S G V A T F F
E S I K A E W S K G G I C G S Stop L L C A W P Met S E W R E L S T K IG C E
Generation of microRNA against DCHS1 and FAT4. Three miRNA targeting FAT4 or
DCHS1, respectively, were cloned into a pENTR entry vector (BlockIT, Invitrogen, Thermo
Fisher) and then recombined into a PCAGGS destination vector according to the manufac-
turer’s protocol (BlockIT, Invitrogen, Thermo Fisher). For validation, vectors were electropo-
rated into SH-SY5Y cells and expression of FAT4 and DCHS1 quantified using qPCR.
The sequences of the oligos chosen for experiments are:
DCHS1 : TGCTGTACACTGTCAGGTTGATCTCCGTTTTGGCCACTGA CTGACGGAGATC
ACTGACAG
FAT4 : GCTGATCAGTTGCAGTAACAGAGGAGTTTTGGCCACTGACT GACTCCTCTGTCT-
GCAACT
The qPCR primers sequences used for validation are:
DCHS1 -fw: 5’ TGCACCTGAAGACACGGTAT 3’
DCHS1 -rev: 5’ CAGAGGCCTCATAAGCCGTA 3’
FAT4 -fw: 5’ CTTCCAAATGGACCCTGAGA 3’
FAT4 -rev: 5’ CGGTGCCCACTTGAGCATTC 3’
Generation of NPCs and neurons. Neural progenitors were generated as described pre-
viously [327] with modifications. In short, embryoid bodies were generated from iPSCs by
plating colonies in suspension in neural induction medium consisting of DMEM F12 with N2
and B27 supplements (Thermo Fisher). Embryoid bodies were plated on polyornithine and
laminin (Sigma Aldrich, St. Louis, MO, USA) coated dishes and cultured for 7 d in neural
induction medium. Neural rosettes were manually picked using a stereological microscope
(Nikon, Tokyo, Japan) and a P1000 tip, manually dissociated and further cultivated in neural
progenitor medium (neural induction medium supplemented with bFGF at 20 ng/ml, Pepro-
tech, Rocky Hill, NJ, USA). For passaging, the cells were dissociated using Accutase (Stem
Cell Technologies) and split at a maximum ratio of 1:3.
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Generation and analysis of cerebral organoids. Cerebral organoids were generated as
previously described [92]. Organoids were kept in 10-cm dishes on an orbital shaker at 37 ◦C,
5% CO2 and ambient oxygen level with medium changes every 3 to 4 d. Organoids were
analyzed at 20 d, 42 d and 70 d after plating. For immunostaining, 16 µm sections of organoids
were prepared using a cryotome. At least five different organoids for each of three different
batches were analyzed.
Electroporation of organoids. For electroporation, organoids were kept in neural differ-
entiation medium as described [319] without antibiotics. The organoids were placed in an
electroporation chamber (Harvard Apparatus, Holliston, MA, USA), and plasmid DNA was
injected at a concentration of 1 µg/µL at several positions. The organoids were then subjected
to five pulses at 80 V with a 50-ms duration in an interval of 500 ms using an ECM830
electroporation device (Harvard Apparatus).
3D time-lapse imaging. For 3D time-lapse imaging, slices of electroporated cerebral organoids
were prepared and imaged as described previously [328]. Briefly, organoids were sliced at
300 µm thickness on a vibratome (Leica VT1200S) in ice-cold DMEM/F12 (Invitrogen) sup-
plement with sodium bicarbonate, glucose and 10% antibiotics, oxygenated with 100% O2 for
20 min before cutting. The slices were placed on a cell culture insert (Millicell) and further
cultured in normal organoid medium. The slices were kept in an atmosphere with 5% CO2 at
37 ◦C. Live imaging was performed for 48 h using Leica TCS SP8 Confocal microscope (Le-
ica, Germany), taking an image every twenty minutes. The cell movement was tracked using
ImageJ software and the Manual Tracking Plugin, and the movement parameters calculated
and analyzed in GraphPad Prism.
2D time-lapse imaging. For 2D time-lapse imaging, cultures of neural progenitor cells
were kept in neural progenitor medium without bFGF for 7 d to allow cells to differentiate.
Consequently, live imaging was performed for 3 d using Zeiss Axiovision Observer Fluorescent
Microscope (Zeiss, Germany) and Zen Software, taking an image every 5 min. The cell move-
ment was tracked using ImageJ software and the Manual Tracking Plugin, and the movement
parameters calculated and analyzed using R. Neuronal identity was confirmed using TUBB3
immunostaining at the end of the imaging experiment.
Dissociation of organoids and neuronal cells in 2D culture for scRNA-seq. Organoids
were microdissected to enrich for cortical tissue and washed twice with 2 ml of HBSS (-Ca2+/
-Mg2+ (w/o), Sigma). The tissue was dissociated using a papain-based neural tissue disso-
ciation kit (Miltenyi) with multiple intermittent triturations using wide-bore pipette tips and
p1,000 and p200 pipettes. After dissociation, cells were filtered through a 30 µm strainer and
a 20 µm strainer, washed with HBSS (+Ca2+/+Mg2+ (w), Sigma) and spun down at 300g for
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10 min. Cells were then washed again with HBSS (w), spun down for 5 min at 300g and were
resuspended in HBSS (w). Counting and viability assessment were performed using Trypan
blue staining (Countess automatic cell counter, Invitrogen) for further FACS-based single-cell
transcriptomics.
2D differentiated neurons from DCHS1, FAT4 and two controls were detached from wells
of a 24-well plate on day 14 after initiation of differentiation into neurons. First, cells were
washed with PBS (w/o, Gibco) twice and incubated with 0.5 mM EDTA (Invitrogen) in DPBS
(Gibco) + 1% Accutase (v/v, Sigma) for 5 min at 37 ◦C to detach cells. After incubation,
HBSS (w/o, Sigma) was added to the wells, and cells were washed off by rinsing with a 1,000p.
Detached cells were spun down 5 min at 300g and washed with HBSS (w/o), spun down again
and resuspended in HBSS (w/o) for counting.
RNA-seq experiments. Organoids were microdissected to enrich for cortical regions, and
the tissue was dissociated using a papain-based neural tissue dissociation kit (Miltenyi). Neu-
ronal cells in 2D culture were brought into single-cell suspension using 1% (v/v) Accutase
(Sigma) in DPBS/EDTA (0.5 mM, Gibco, Invitrogen). Single-cell transcriptomic analysis was
performed using either the Smart-seq2 protocol [195] (for all organoid experiments), or the
10X genomics chromium platform (for neuronal cells in 2D differentiation). Libraries were
prepared using the Illumina Nextera XT DNA Sample Preparation kit (SS2) or according to
the 10X genomics Single Cell 3’ v2 protocol. Quantification and quality control of the resulting
cDNA was performed using high-throughput capillary gel electrophoresis (Fragment analyzer,
Advanced Analytical; for SS2) or the Bioanalyzer High Sensitivity DNA Assay (Agilent; for
10X cDNA, for SS2 and 10X libraries). Single-cell cDNA libraries were sequenced on an Illu-
mina HiSeq2500 platform. Reads were processed and aligned to the genome (hg38 sourced
from Ensembl or 10X genomics) using TopHat [329] or using the 10X Genomics Cell Ranger
software (v 2.1.0), respectively. Data analysis was performed using custom-written R scripts
and using the following packages in R: Seurat (v 2.3.0), Monocle2 (v2.0.0 for SS2 data, v
2.6.3 for 10X data), igraph, ggplot2 and FactoMineR.
For Smart-seq2-based scRNA-seq (organoid scRNA-seq dataset), single cells were isolated
by FACS of individual cells into individual wells of 96-well plates. cDNA was prepared from
each single cell using the previously described Smart-seq2 protocol [195]. Size distribution and
concentration of single-cell cDNA was assessed by high-throughput capillary gel electrophoresis
(Fragment analyzer, Advanced Analytical). Sequencing libraries were constructed in 96-well
plates using the Illumina Nextera XT DNA Sample Preparation kit as described previously
[161]. Libraries were quantified by Agilent Bioanalyzer using the High Sensitivity DNA analysis
kit. Up to 192 single-cell libraries were pooled and each cell was sequenced 100-bp paired-end
on Illumina HiSeq2500. Base calling, adaptor trimming, and demultiplexing was performed as
described in refs. [260, 262]. For 10X Genomics Chromium based scRNA-seq (2D neuronal
differentiation dataset), the 10X Chromium Single Cell 3’ Kit v2 was used. Control and mutant
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cells were mixed for multiplexing (FAT4/ CTRL and DCHS1/ CTRL) and were loaded on one
lane of a 10X microfluidic chip. cDNA cleanup, amplification and library preparation were
performed by following the Single Cell 3’ protocol. Quantification and quality control of the
resulting libraries was performed using Bioanalyzer (Agilent) High Sensitivity DNA Assay. The
resulting two libraries were pooled at equal ratios and sequenced on two lanes of an Illumina
HiSeq2500 platform.
Processing, analysis, and graphic display of Smart-seq2-based scRNA-seq data.
Raw reads were processed using a custom script and aligned to a Bowtie2 (ref. [330]) in-
dexed human genome (hg38 sourced from Ensembl) using TopHat [329] with default settings.
Transcript levels were quantified as Fragments Per Kilobase of Mapped reads (FPKM) gener-
ated by Cufflinks [331] using gencode protein coding genes (hg38 Havana). We excluded cells
that had less than 100,000 reads or expressed less than 1,000 genes. Transcript levels were
converted to the log-space by taking the log2 (FPKM). R studio (https://www.rstudio.com/)
was used to run custom R scripts to perform principal component analysis (PCA, FactoMineR
package), hierarchical clustering (stats package), covariance analysis and to construct heat
maps, violin plots, scatter plots and dendrograms. Generally, ggplot2 and gplots packages
were used to generate data graphs. The Monocle2 package [323] (https://bioconductor.org/
packages/release/bioc/html/monocle.html) was employed to analyze cell lineage relationships
using 289 genes (Supplementary Table 3) identified via PCA on all cells and on all neu-
rons. Covariance network analysis and visualizations were done using igraph implemented in
R (http://igraph.sf.net). Gene ontology enrichment analyses were performed using DAVID
informatics Resources 6.7 (ref. [265]). To assign a cortical zone (VZ, iSVZ, oSVZ, CP) to
each individual cell, we calculated for each single cell the Spearman correlation of its tran-
scriptome (all genes) with bulk transcriptome data from each of four microdissected cortical
zones (VZ, iSVZ, oSVZ, CP, mean expression value of each gene across 4 replicates)[31] as
described previously [114]. Generally, we performed PCA on variable genes (variance > 0.5)
expressed (> 1 FPKM) in more than two cells. For Figs. 2c and 4a, we extracted the genes
positively and negatively correlating with PC2 and 3, using an absolute PC loading threshold
>0.2 with a maximum of 50 genes per PC to avoid individual PCs swamping the analysis,
resulting in 200 genes (Supplementary Tables 1 and 3). These genes were plotted in the heat
map. The heat map in Extended Data 3o presents the top 50 genes positively and negatively
correlating with PC 1. To construct the intercellular correlation networks in Fig. 2d, we com-
puted a pairwise correlation matrix for all cells and using genes discovered in the PCA analysis
on cells from the primary human fetal cortex at gestational week 12 and 13 (Supplementary
Table 2) as described [114]. We then generated a weighted adjacency network graph using
the graph.adjacency() command in igraph and visualized cells as vertices connected to other
cells via edges if the Pearson pairwise correlation between two cells was higher than 0.4. The
Fruchterman–Reingold layout was used to plot the network graph.
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Processing, analysis, and graphic display of 10X genomics–based scRNA-seq data.
For the 10X genomics data, base calling, alignment to the human reference GRCh38 (as
provided by 10X) and identification of valid cell barcodes was performed using 10X Genomics
Cell Ranger software (v 2.1.0). Genotypes for demultiplexing the pooled cell lines in each library
were called from merged scRNA-seq organoid datasets of the respective cell lines (DCHS1,
FAT4, CTRL) using bcftools (v 1.4) mpileup and bfctools call. Genotypes for the respective
combinations of pooled cell lines were merged using bcftools merge. Demuxlet [282] was
used to assign single cells to their respective cell line, taking only valid barcodes into account
as defined by Cell Ranger. Cells with insufficient likelihood difference or ALPHA value >0.3
were considered as doublets, and all remaining cells were assigned with their first best cell line
assignment as provided by demuxlet. After demultiplexing, most of the cells in the FAT4/
CTRL dataset were assigned as CTRL cells, whereas most of the cells in the DCHS1/ CTRL
dataset were assigned as DCHS1 cells, which was consistent with the number of cells per
line in the cell suspensions loaded on the 10X microfluidic chip device. Thus, we focused the
analysis on comparing sufficient numbers of cells of DCHS1 and CTRL.
Single-cell data were analyzed using the Seurat (v 2.3.0) toolkit for prefiltering and clustering
of data. Cells with less than 500 and more than 6,000 genes per cell and more than 10%
mitochondrial genes expressed were filtered from the dataset. The normalized data were
scaled, and the effect of mitochondrial gene expression and number of UMI’s were regressed
out. Identification of clusters and t-Stochastic Neighbor Embedding (t-SNE) clustering was
performed using the first ten principal components based on the highly variable genes in the
dataset. Mesenchymal-like cells as revealed by clustering and high expression of DCN and
COL1A2 and cells with high cycling gene expression (MKI67 and TOP2A > 1.5 UMI after
normalizing) were filtered from the data. Cells were ordered along a pseudotemporal trajectory
using Monocle (v 2.6.3) by using DDRTree for dimension reduction and using the same ordering
genes that were applied to construct differentiation trajectories for organoids.
Immunohistochemistry. Immunostainings were performed as described previously [79]. Nu-
clei were visualized using 0.1 µg/ml DAPI (Sigma Aldrich). Immunostained sections were
analyzed using Olympus or Leica laser-scanning microscopes. F-ACTIN was visualized by in-
cubation with Alexa Fluor 488-conjugated PHALLOIDIN (Thermo Fisher) according to the
manufacturer’s protocol. Antibodies list is included in the Supplementary Table 5.
FACS analysis. Cerebral organoids (55–60 d in culture) were collected for FACS analy-
sis. Three to six samples were analyzed; every sample contained two individual organoids.
Organoids were enzymatically dissociated with Accutase at 37 ◦C for 30 min. During incuba-
tion, every 10 min, the organoids were triturated with a P1000 pipette. After dissociation,
samples were washed in PBS via centrifugation at 1,200 r.p.m. for 5 min. The cell suspension
was filtered through a 100 µm cell strainer and centrifuged at 1,200 r.p.m. for 5 min, and the
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cells were fixed in 70% ice-cold ethanol. After 1 h at −20 ◦C, samples were centrifuged for
30 min at 2,000 r.p.m. and then resuspended in 5 ml staining solution (PBS containing 1%
FCS). After further centrifugation for 30 min at 2,000 r.p.m., the cell pellet was resuspended
in staining solution containing anti KI67 antibody (1:200, see antibody’s table), or anti DCX
antibody (1:1,000, see Supplementary Table 5) and incubated for 30 minutes. After wash-
ing in staining solution, cells were resuspended in staining solution containing AlexaFluor546
anti–guinea pig, for DCX, or anti-mouse (1:800), for KI67, secondary antibodies and incu-
bated for 30 min. After washing in PBS, cells were resuspended in PBS. FACS analysis was
performed on a FACS Aria (BD) in BD FACS Flow TM medium, with a nozzle diameter of
100 µm. Debris and aggregated cells were gated out by forward scatter and sideward scatter;
single cells were gated out by FSC-W/FSC-A. Gating for fluorophores was done using samples
stained with secondary antibody only. Flow rate was below 500 events/s.
Western blot. Cells were lysed in lysis buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10%
saccharose in H2O) with protease and phosphatase inhibitors (Roche, Basel, Switzerland),
and 20 g of protein was separated by SDS-PAGE with a 12% gel. Proteins were trans-
ferred to a nitrocellulose membrane (GE Healthcare, Chalfont St Giles, Buckinghamshire,
Great Britain). For detection, membranes were incubated with primary antibodies overnight,
then with horseradish peroxidase-labeled secondary antibodies at room temperature, and then
treated with ECL Western Blotting Detection solution (Millipore, Billerica, MA, USA) to
visualize bands. Bands were quantified using ImageJ software.
In situ hybridization. Probes for in situ hybridization were generated as described in ref.
5. Linearized in situ plasmids were in vitro transcribed using DIG NTP labeling mix, RNA
polymerase T7 and Sp6 as well as RNase inhibitor (Roche). In situ mRNA transcript detection
was performed according to standard procedures.
Cell and tissue quantifications. For quantification of proliferating apical NPCs, all apically
located PH3-positive cells were quantified. Cell counts were normalized by the length of the
apical surface. MAP2 and ARL13B fluorescence intensity was quantified using ImageJ software.
MAP2 signal was quantified only where progenitors are enriched (ventricular zone). ARL13B
signal was quantified at the apical surface and at basal positions. In particular, the ARL13B+
fluorescent signal intensity from all the cilia facing the ventricular lumen versus the rest of
the cilia found in the germinal and cortical zones was measured using ImageJ software and
normalized per area. The analysis of disorganization of the ventricles in mutant and KO lines
was done based on the MAP2 staining. More precisely as heterotopic were called the ventricles,
which have clusters of MAP2-positive cells in the germinal zones, and as disorganized were
defined the ventricles in which the boundaries between the cortical and germinal zone was not
clearly distinguished. The percentage of ventricles with NEUN+ cells only in the cortical plate
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or having more than five NEUN+ cells the germinal zone in addition to the normal NEUN layer
in the cortical plate was quantified. The apical surface was identified using β-CATENIN and
PALS1 immunostaining, and the apical distance was measured from the apical surface, defined
by the immunostainings, to the cell nuclei, defined by the DAPI, in at least five positions per
germinal zone using ImageJ software. The organoid size was measured based on the surface
of the organoids using ImageJ software. The thickness of the ventricular zone and cortical
plate were manually outlined and measured using ImageJ software. NPCs radial morphology
and tortuosity were assessed via manual outlining of the NESTIN+ processes or the GFP+
processes after electroporation using ImageJ software. The tortuosity index was calculated
by dividing the total (segmented) length of the NESTIN+ of GFP+ processes divided by the
straight line connecting the beginning and end of the segmented line. The identity of cells
tracked through time lapse in 2D culture was assessed by the expression of MAP2 and DCX.
More details regarding statistical tests applied and individual experiments replicates are found
in the figure legends, where b refers to batches, o refers to organoids, v refers to ventricles
and c refers to cells.
All analysis was done using the R statistical software package, the GraphPad software and
SPSS 20.0.
Reporting Summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The scRNA-seq data used in this study have been deposited in the Gene Expression Omnibus
under accession number GSE124031. All relevant accession codes are provided. Further details
on the methods can be found in the Life Sciences Reporting Summary. Additional data that





Extended Data Fig. 1: Expression of DCHS1 and FAT4 in cerebral organoids and temporal
development of DCHS1- and FAT4-mutant organoids. a, Axial T1 image demonstrating laminar
PH lining the occipital horns and peritrigonal region of the ventricles (arrows). b, Axial T2 demon-
strating linear lesions iso-intense with cortical gray matter adjacent to the lateral walls of the bodies
of the lateral ventricles [313]. c, Schematic representation of the main experimental approach used.
d, Timeline of the organoid generation. EBs, embryoid bodies; hESC, low-bFGF human embryonic
stem cell medium; NIM, neural induction medium; Y, Rock inhibitor; NDM, neural differentiation




e–h’, Detection of DCHS1 and FAT4 by in situ hybridization, b = 2, o = 5 per condition. i,j,
mRNA expression of DCHS1 and FAT4 in single cells (c = 316) derived from control organoids,
showing similar expression patterns between DCHS1 and FAT4 but often in different cells. i, Cells
(columns) are ordered based on their PC 2 loading, corresponding to the trajectory from NPCs to
neurons. Side bar shows maximal zone correlation for each single cell (ventricular zone, VZ, yellow;
inner subventricular zone, iSVZ, orange; outer SVZ, oSVZ, red; cortical plate, CP, purple). j, Biplot
showing transcript levels (in log2(FPKM)) of FAT4 (x axis) and DCHS1 (y axis) in 316 single cells of
control organoids. k,l, Temporal development of patient-derived cerebral organoids compared with
control organoids (o = 14 CTRL, 17 DCHS1, 17 FAT4); the diameters of organoids derived from
DCHS1 - and FAT4 -mutant cells are slightly smaller compared to those of control organoids until day
12 (d12), shown in k. Significance based on twoway ANOVA, P = 0.000, Tukey HSD post hoc for
multiple comparisons was performed for defining statistical differences between the three genotypes.
Dotted lines highlight ventricles (V). Data in graphs are represented as mean ± s.e.m. Scale bars,
100 µm in e–h’,k
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Extended Data Fig. 2: Heterotopically located neurons in DCHS1 and FAT4-mutant and
KO organoids. a–c,e–j,l–o, Micrographs of sections of mutant or KO organoids immunostained
as indicated in the panels. Note the mispositioning of neurons marked by arrows in mutant or in
electroporated cerebral organoids. a–c, b = 2, o = 6 per condition; e–j, b = 2, o = 6 per condition;
l–l”’, b = 5, o = 15 per condition; m–o, b = 5, o = 15 per condition. d, MAP2 fluorescence
intensity measured only in the ventricular zones (VZ) (v = 6 CTRL, 18 DCHS1, 11 FAT4 ; significance
based on one-way ANOVA, P = 0.0166, Tukey HSD post hoc for multiple comparisons for defining
statistical differences between the three genotypes). k, Quantification measured by qPCR of the
knockdown of DCHS1 and FAT4 by microRNAs (miRNA) against DCHS1 or FAT4, respectively (b =
2, independent cultures per time = 3 CTRL, 3 miRNA DCHS1, 3 miRNA FAT4, significance based on
one-way ANOVA, P = 0.0377, Tukey HSD post hoc for multiple comparisons for defining statistical
differences between the three genotypes) in SH-SY5Y cells 48 h after nucleofection. l–l”’, Nodule of
TUBB3+ neurons intermingling with NESTIN+ processes of NPCs in the germinal zone of DCHS1 -
mutant organoids. m–o DCHS1 - and FAT4 -mutant organoids show changes in the morphology and
thickness of their neuritis, as depicted by arrowheads. Dotted lines highlight ventricles (V). Data




Extended Data Fig. 3: Neural progenitor proliferation and signatures in mutant organoids.
a–i,k–m, Micrographs of sections of mutant cerebral organoids from day 20 immunostained for
NESTIN (a–c) and DCX (d–f) and from day 42 immunostained for PAX6 (g–i) and PH3 (k–m).
a–f, b = 1, o = 3 per condition; g–i,k–m, b = 3, o = 9 per condition. j, Quantification of thickness
of ventricular zone (VZ) and cortical plate (CP) structures in cerebral organoids (v = 6 CTRL, 11
DCHS1, 12 FAT4). n, Quantification of PH3+ cells per length of apical surface (o = 3, v = 23
CTRL, 41 DCHS1, 17 FAT4, F (2,80) = 2.41, P = 0.097, comparison between CTRL and FAT4
F (1,39) = 5.18, P = 0.029). o, Hierarchical clustering visualizing for all NPCs (338 single cells),
expression of genes identified by PCA (top 50 positively and negatively correlating with PC 1) on all
NPCs. p, Number of NPCs and neurons for each experiment shown in o. q, FACS plots depicting
the definition of the sorting gates (secondary antibodies control) and sorting of KI67+ or DCX+
cells in control, DCHS1 - and FAT4 -mutant organoids (b = 2, o = 6 CTRL, 6 DCHS1, 3 FAT4).
r,s, Z scores of the quantification of KI67+ cells (r) and DCX+ cells (s) from FACs analysis shown
in q. Statistical analysis was performed using two-tailed Mann Whitney test. r, CTRL to DCHS1
P = 0.0022, CTRL to FAT4 P = 0.0238. s, CTRL to DCHS1 P = 0.0317, CTRL to FAT4 P =
0.0357. Results are mean ± s.e.m. (j,n) or z scores as mean ± s.e.m. (r,s). Dotted lines highlight
ventricles (V). Scale bars, 30 µm for a-f and 50 µm for g-m.
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Extended Data Fig. 4: Morphological changes in the NPCs upon DCHS1 and FAT4 deletion.
a-c, Micrographs of sections of KO cerebral organoids day 40 immunostained for NESTIN. Arrows
indicate the disrupted morphology of NPCs (b,c). d-f, Micrographs of sections of control organoids
electroporated with miRNA against DCHS1 or FAT4 at day 42 and analyzed at day 49. Arrows
indicate the disrupted morphology upon downregulation of DCHS1 and FAT4 (e,f). a-c, b = 2, o




Extended Data Fig. 5: Apicobasal polarity in cerebral organoids. a-c, Micrographs of sections
of organoids (day 42) immunostained for ACETYLATED TUBULIN, b = 2, o = 6 per condition.
d,e, Western blot and quantification of ACETYLATED TUBULIN (d) (independent cultures = 5
CTRL, 4 DCHS1, 4 FAT4, significance based on one sample two-tailed t test, P = 0.562 CTRL vs
DCHS1, P = 0.013 CTRL vs FAT4) and TYROSINATED TUBULIN (e) (independent cultures =
3 CTRL, 3 DCHS1, 3 FAT4) levels in NPCs, significance based on one sample two-tailed t test, P
= 0.967 CTRL vs DCHS1, P = 0.728 CTRL vs FAT4. f-n,p-r, Micrographs of sections of cerebral
organoids (day 42) immunostained as indicated in the panels. f-n,p-r, b = 3, o = 9 per condition.
o, Quantification of the distance from the apical surface (positive for β-CATENIN and PALS1) and
DAPI+ nuclei of NPCs (v = 27 CTRL, 26 DCHS1, 26 FAT4 ; 5 different positions were measured
and averaged for each ventricle; significance based on one-sample two-tailed t test, P = 0.0025
CTRL vs DCHS1, P = 0.001 CTRL vs FAT4). s, Ratio of ARL13B fluorescence intensity measured
at the apical surface (cilia facing the ventricular lumen) and at basal position (all the rest of the cilia
in the germinal and cortical zones) (b = 5, o = 15, v = 9 CTRL, 4 DCHS1, 14 FAT4, significance
based on one-sample t test). Results are mean ± s.e.m. Dotted lines highlight ventricles (V). Scale
bar, 50 µm (a-c) and 20 µm (f-r).
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Extended Data Fig. 6: 2D time-lapse imaging experimental design and morphological
changes of mutant neurons. a, Experimental design for 2D live imaging of migrating neurons.
Neural progenitors were differentiated for 7 d and imaged for 3 d every 5 min. b, Quantification
of the percentage of cells expressing DCX, MAP2 or both markers in neuronal cultures after 10
d in culture. c–c”, Immunostaining for DoubleCortin (DCX), MAP2 (mature neurons) and VG-
LUT (glutamatergic neurons) in 2D neurons derived from control cells in monolayer culture, b =
3, independent cultures = 9 per condition. d–f, Immunostaining for TUBB3 in 2D neurons derived
from control and mutant cells in monolayer culture, b = 3, independent cultures = 9 per condition.
Results are mean ± s.e.m. Scale bar, 20 µm. Nat
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Extended Data Fig. 7: Characterization of mutant and KO organoid regions. a-l, Micrographs
of sections of mutant and KO organoids immunostained as depicted in the panels. a-c,g-i, b = 3,
o = 9 per condition; d-f,j-l, b = 2, o = 6 per condition. m, Heat map showing expression of genes
marking neurons in the cortex/forebrain (columns) for all neuronal cells from control and mutant
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